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ABSTRACT 
This Thesis reports a full scale study of cognition and mood in Chronic Fatigue 
Syndrome (CFS) longitudinally during recovery. Previous studies fail to cover the scope 
of this study and/or fail to define adequately the syndrome for subject selection. 
47 CFS patients were compared with 41 normal and 26 Crohns/colitis controls in a 
longitudinal study of cognitive performance and depression/anxiety scores. 
CFS patients performed significantly worse than controls on many of the cognitive tests 
at first testing. Small but significant differences between CFS and normal controls were 
found on memory tests (Logical Memory, Word Recognition and, more significantly, Rey 
Complex Figure) but Crohns/colitis patients scored similarly to CFS, suggesting that this 
might relate to a general problem such as attention. Much larger and more significant 
differences between CFS and both control groups were found on tests involving a 
psychornotor component (e. g. Reaction Time, Finger Tapping and Digit Symbol). CFS 
patients' performance improved over time (above practise) on word recognition, Stroop 
(colours), Reaction Time (Movement) and Digit Symbol. 
CFS patients were significantly more depressed/anxious than the control groups and 
scored higher on Middlesex Health Questionnaire (Psychiatric). Depression/anxiety did 
not diminish significantly by second testing. Differences on depression scores accounted 
for some of the differences in cognitive test performance, in particular Word Fluency and 
Stroop; however, significant differences remained after ANCOVA removed depression: 
significant differences remained on Logical Memory, Word Recognition, Digit Symbol, 
Finger Tapping and Reaction Time. 
It was concluded that CFS patients were slowed on psychornotor tasks and that this was 
only partly accountable by depression as suggested by depressed score. CFS patients 
performed slightly worse on some other tests possibly dependant upon the task demand. 
Digit Symbol, Reaction Time, and Finger Tapping seemed to be most sensitive to CFS. 
Brain damage was not necessarily indicated by the results: differences in psychornotor 
performance could be caused by difficulties in the transmission of instructions to the 
muscle or slowness in the nerves and muscles themselves. CFS patients' performance 
significantly improved on a number of tests over time, and did not significantly deteriorate 
on any test; therefore, the trend of CFS patients' test performance overall was to get 
better not worse over time. 
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CHAPTER 1. INTRODUCTION 
This thesis examines patients' cognitive performance during recovery from Chronic 
Fatigue Syndrome (CFS). 
In the literature up to 1989 little had been done to establish why CFS patients 
complained of problems with cognition, particularly memory. Later literature did not look 
at cognition in terms of change during the illness. This research firstly attempts to 
establish the extent and nature of CFS patients' cognitive problems and secondly how 
performance changes during recovery. 
The literature shows that CFS patients are more depressed and anxious than normal 
controls. This has not previously been assessed in relation to performance on cognitive 
tests. This thesis examines thirdly the extent to which mood variables in CFS patients 
could account for poorer performance on cognitive and psychomotor tests. 
The design of the study is longitudinal with three groups: CFS, normal controls and 
Crohns/colitis controls. CFS patients were from Ruchill Hospital (Glasgow) 
Outpatients'department, normal controls were from St Andrews' Ambulance evening 
classes and Crohns/colitis patients were from Stobhill Hospital (Glasgow) 
Gastroenterology outpatients' clinic. 
Patients were seen up to three times with a minimum of 4 months in between. They were 
tested on a standard set of cognitive and psychological tests and some tests of attention 
and speed developed at Stirling University. The memory tests were varied as necessary 
at each testing. The drop out rate for patients was high and not all patients completed 
the test set. The data were analysed using SPSS-PC. 
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CHAPTER 2. LITERATURE SURVEY 
1. What is CFS ? 
Chronic Fatigue Syndrome (CFS) is a syndrome, recognised by a pattern of symptoms. 
CFS was first recognised in the medical domain but has subsequently been thought to 
involve psychological factors. 
1.1 Estimated prevalence of MEICFS 
CFS is a term recently given to a syndrome the main symptoms of which are chronic 
fatigue and muscle fatiguability. It is a new term largely replacing that of Myalgic 
Encephalomyelitis (ME), with which it is associated, but it may not be synonymous. The 
number of patients suffering from CIFS or ME in 1988 was put at 150,000 sufferers in the 
UK, 10,000 in Australia, 3,000 in New Zealand and 3,000 - 5,000 in South Africa 
according to Spracklen (1988). Numbers in America may be much higher: Gorensek 
(1991) estimates that new cases of CFS approximate 6000 per annum. The effect in 
terms of lost earnings in the UK is placed at E300 million annually by Ramsay and 
Dowsett (1992). 
1.2 Naming of CFS 
Myriad names have been given to, or thought to be the same as, CFS. The main ones 
are discussed below. Hyde (1 992(a)) has produced a compendium of associated names, 
which is reproduced in Appendix 1 Table 2. The problem of defining and naming this 
syndrome is discussed here with reference to its history. The use of the new term CFS 
which is defined by symptom-based criteria is in itself an attempt to move the illness 
away from its historic links and its presupposed organic components. Early terms include 
names referring to the first outbreaks: 'Royal Free Disease' and 'Iceland/Akureyi 
Disease'. The term Myalgic Ence phalo myelitis (ME) is a medical description based on 
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the early assumptions about the illness, myalgia meaning muscle pain, encephalitis 
inflammation of the brain, myelitis meaning inflammation - usually of the spinal cord. 
Hence the literal meaning is muscle pain with inflammation of the brain and spinal cord. 
The literal meaning of ME is not a description which fits the majority of today's patients. 
The term benign was often attached to names to indicate the non-progressive nature of 
the disease. Wookey (1978(b)) objected to the term benign being used on the grounds 
that the syndrome can have serious after effects. Coupled with the term benign, the 
name neuromyasthenia, literally meaning neurological muscle debility, was widely used. 
Compston (1978(b)) describes myasthenia as muscle weakness or fatigue, its literal 
meaning, but Behan (1978) objected to neurornyasthenia on the grounds that it 
unjustifiably implied a lesion in the neuromuscular junction. 
In America the name Post Infectious Neuromyasthenia (PIN) became popular; it 
suggested a post-illness syndrome. In Britain the name Post Viral Fatigue Syndrome, 
widely used in the late 70's and early 80's, also indicated a post illness syndrome. The 
hunt for a trigger illness began but what soon became evident was that no one illness 
could be said to be the cause. In America it was called Chronic Epstein Barr Syndrome 
as a reflection of the association with EBV virus. In most places it was first associated 
with polio and then Epstein Barr Virus but in Scotland in the 80's it became attached to 
another virus, Coxsackie B virus. Today the Americans call the syndrome Chronic 
Fatigue Syndrome, and Chronic Fatigue and Immunodeficiency Syndrome (CFS and 
CFIDS), indicating either a neutral or immune basis. In Britain the term CFS is used but 
not CFIDS. In this thesis the term used is that of the paper discussed, or ME to describe 
the early epidemics and CFS to describe the syndrome in general. 
1.3 The pattern of symptoms 
Descriptions of CFS and ME vary, but Table 1 shows the main symptoms as observed 
by various doctors and researchers from 1955 - December 1992. Apart from fatigue and 
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muscle fatiguability, symptoms included lymphadenopathy and fever, prolonged painful 
muscle spasm, bladder dysfunction, paraesthesia, neck rigidity, tenderness in ribs, liver 
edge palpability, headache, vertigo, pain in limbs, sore throat, impairment of sensation, 
allergies, weakness and fatigue (Compston 1978(a), Ramsay 1981). 
The two key symptoms described in the earliest reports of ME and the latest reports of 
CFS are fatigue and muscle weakness. These symptoms among others are considered 
in the following sections. 
1.3.1. Fatigue 
Fatigue symptoms are very common in everyday life. Grafman et al. (11991) say that the 
seventh most common presenting symptom in the USA is fatigue. They quotes Kennedy 
(1988) as estimating that half of these cases are due to psychiatric problems. 
Wessely has made an important contribution by looking at the type of fatigue in CFS. 
Wessely (Wessely and Powell 1989) shows fatigue in PVFS patients to be more like that 
in depressed patients than in those patients suffering from neuromuscular disorders. 
Wessely (1990(b)) reports finding psychiatric indicators which could be causing fatigue 
symptoms in over 70% of 47 consecutive fatigue patients. 
Wessely (1989) considers both fatigue and viral infection to be very common and 
occurring more in women. Wessely (1989) quotes 20% (30% in women) of the adult 
population (Britain) as complaining of fatigue. He reports that in the 35-54 age group, 
30% report having had a virus infection in the last month; there is, therefore, a large 
overlapping population, who suffer fatigue following a virus. 
Strong associations with fatigue are physical activity (a lot of athletes complain of CFS: 
Shaw 1987; Holoway 1993), depression, anxiety and emotional stress. Therefore 
Wessely (1989) considered CFS to be a label for the common occurrence of fatigue 
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which is commonly caused by these factors. 
The argument that CFS is just a label for common fatigue is not borne out by looking at 
the distribution of fatigue in the population. In a paper of which Wessely is co-author 
(Lewis and Wessely 1992) the authors point out that the distribution of fatigue in the 
general population shows the opposite direction of gradient to that of CFS patients: i. e. 
fatigue is higher in working class populations but CFS is commoner in middle class 
populations. He attributes this to health utilisation differences (i. e. middle classes use 
the health service and get a CFS diagnosis) but nevertheless it somewhat weakens his 
case that CFS may just be the extreme end of the common complaint of fatigue. 
The problem is that fatigue is hard to define and even harder to measure (Barofsky and 
Legro 1991). Since measurement of fatigue is linked to activity, motivational or 
psychological explanations are often considered. The following papers suggest other 
explanations for fatigue. Wood et al. (1992) found diumal variation in energy in patients 
with CFS, with peaks at 10.00-12.00 a. m.; this is similar to controls but the average at 
any one point in time is lower for CFS patients, and recovered CFS patients fall between 
the two groups. They find energy levels, both mental and physical (they are highly 
correlated to each other), to be highly correlated with positive affect but to be not 
significantly correlated with negative affect. This suggests that positive enhancement of 
mood does decrease fatigue in CFS patients but that, contrary to what might be 
expected, negative mood is not causing fatigue. Moldofsky's (1989) review suggests that 
CFS patients have abnormal alpha EEG (non REM sleep) tests; this might indicate non- 
restorative sleep leading to extreme fatigue. Stephenson (1989) saw children with 
Coxsackie B and fatigue. Their families were social class 1 and 2. He used a modified 
Romberg to test the patients and suggests that the results show a central brain origin of 
fatigue. Wong et al. (1992) tested muscle and performance in US and concluded that 
US patients reach exhaustion much more rapidly than normals due to a metabolic 
defect. They suggest that the US patients experience of overwhelming tiredness at rest 
might have a similar etiology. 
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Fatigue in CFS patients is a difficult symptom to assess. There is little evidence for any 
organic cause to fatigue in CFS patients and a strong argument for psychological 
etiology. Extensive tests in 100 severely fatigued patients, by Lane et al. (1990), found 
scant physiological evidence of abnormality except for a few cases of thyroid abnormality. 
1.3.2 Medical abnormality and symptoms in CFS 
In the early ME literature, four pieces of objective evidence suggested an organic basis 
to CFS. Firstly, Jelinek (11956) discovered that it appeared possible to transmit CFS via 
blood from humans to monkeys. Secondly, Cerebral Spinal Fluid (CSF) was found to be 
abnormal in patients identified in particular outbreaks of ME ("A New Clinical Entity" 
1956; see Appendix 1 Table 6). Thirdly, Electroencephalograph (EEG) scans on 40 CFS 
patients showed 75% had an excess of irregular, intermediate slow activity similar to that 
found in glandular fever or MS patients (Pampiglione et al. 1978). Fourthly in Akureyi 
the spread of a later polio epidemic failed to occur in the area where the Akureyi (ME) 
epidemic had taken place and children from the Akureyi area when vaccinated against 
polio showed greater antibody increase than other children. (Hyde 1988, Hyde and 
Bergman 1991, Sigurdsson 1958 in Hyde 1991). More recent evidence suggests 
pituitary-hypothalamic dysfunction in a group of CFS patients, and single photon 
emission computed tomography (SPECT) scans on CFS patients suggest possible 
decreased blood flow in parts of the brain (see Neuropsychology part 3.5). 
Redmond (199 1) writes that the way abnormal tests in CFS patients are reported leaves 
much to be desired, and a more scientific, statistical analysis of such results is needed. 
The evidence for organic causes of symptoms has been fragmentary, as described in the 
following paragraphs. When discussing the CFS symptoms below, account is taken of 
the possibility of organic abnormality being their cause. 
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1.3.3 Muscle Weakness 
Muscle fatiguability, tired and aching muscles are the second most important problem in 
CFS. By muscle fatiguability we mean the loss of performance of the muscle (as 
perceived by the patient) not just the general feeling of tiredness all over. Other illnesses 
show similar combinations: the combination of muscle weakness and fatigue is found in 
hypothyroidism and hyperthyroidism and as is indicated by Dernitrack et al. (1991), mild 
thyroid problems are found in larger than normal proportions in CFS patients. In these 
thyroid conditions weakness can be accompanied by wasting although muscle enzymes 
are normal; thus the weakness experienced by CFS patients may be real even if muscle 
tests are inconclusive. 
Differences in muscle tissue are also found in healthy people. Simply not using the 
muscles will cause deterioration, so that if a patient goes to bed for a long period he/she 
is likely to experience loss of muscle tone and tired and aching muscles. Athletes show 
differences according to the type of activity, for example where athletes require speed 
as opposed to stamina more type 11 than type I muscles are found. Therefore not only 
might one have muscle problems without corresponding evidence but abnormalities 
which we do find may in fact be no different than that found in some groups of normal 
people. 
The muscles undergo chemical and other changes during exercise, and in CFS patients 
problems occur most on exercise. In polio the muscles attacked are those normally most 
used, and polio is an echo virus with associations with ME. In terms of activity, 
abnormalities are found in CFS patients on exercise. R. P. Taylor (1989) reports a 
muscle abnormality in the rotation of energy; by this he means abnormality in the 
chemical changes that take place in muscle during exercise; he estimates a 20% 
decrease in energy, and an increase in energy store utilisation. Arnold et al. (1984) 
reports a case study showing increased acidosis in the muscle during aerobic work. 
Wong et al. (1992) reports that duration of exercise in 22 CFS patients is markedly 
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shorter, changes in phosphocreatine, inorganic phosphate and pH occur more quickly 
in CFS patients and they have less adensonine triphosphate at exhaustion. Wong et al. 
conclude that CFS patients have a defect of oxidative metabolism with a resultant 
acceleration of glycolysis in the working skeletal muscle. McClusky (1990) shows an 
overproduction of lactic acid during activity in CFS patients. Behan et al. (1985) report 
that muscle biopsies were done on CFS patients, showing muscle to be abnormal and 
patients to have muscle weakness up to 3 hours after continuous exercise of 1 hour. 
Not everybody has found the muscle performance to be poorer in US patients; Stokes 
et al. (1988) tested muscle strength in 30 patients, they found that patients were neither 
weaker nor more fatiguable than controls. Coakley (1989) refutes the statement in 
Shepherd (1989) argues that change in muscle protein synthesis occurs in CFS and 
suggests changes are due to inactivity in CFS patients and that gradual increase of 
exercise tolerance should be encouraged for CFS patients. 
On testing of the muscle tissue, other abnormalities have been found. Byrne et al. 
(1985) find a moderate increase in Type II fibre in muscle. Doyle (1990) finds this Type 
11 predominance and abnormalities in nerve ending and muscle meeting places. Doyle 
does not think these could be accounted for by disuse. Jamal finds abnormal jitter in 
muscle (Jamal and Hansen, 1985) in ME patients; in a recent debate on his work (Jamal 
1990) he suggests that this is due to a defect in the way nerve impulses are transmitted 
along the muscle fibres. The presence of Coxsackie B virus has been found in muscle 
tissue (Behan 1985; Archer 1987) and ribonucleic acid (RNA) from entero viruses has 
been found in 24% of ME patients' muscle biopsies (Gow et al. 1991). 
Lewis and Haller (1991) advocate that exhaustion from whole body exercise is most 
important in CFS and treadmill or similar exercise in CFS should be tested. They 
discuss other disorders and say that increase in arteriovenous oxygen difference 
accompanied by normal maximal cardiac output is suggestive of an impairment in the 
utilization of oxygen by muscle 'but that present biopsy data on a muscle oxidization 
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abnormality is inconsistent'. Wong et al. (1992) however show cardiac abnormality does 
not seem to be the problem in CFS, rather the problem is of metabolic changes, as found 
in eadier studies. 
In CFS patients various muscle abnormalities have been found but the importance of 
these and the extent to which they are part of a disease process is debatable. Further 
evidence from studies using more patients and control data needs to be obtained. The 
problem is that, so far, a high incidence of an abnormality has not been found across 
many groups. There is also uncertainty as to the meaning of such results as are 
available. 
In conclusion, from the evidence that is available, it seems probable that: 
1) CFS patients fatigue more quickly than normal with prolonged or repeated exercise; 
2) the muscle of CFS patients may contain enteroviruses; 
3) the muscle of CFS patients has more Type 11 fibres than normal; 
4) the muscle of CFS patients during exercise fails to uptake enough oxygen and 
chemical changes occur more quickly. 
1), 3) and 4) may possibly be accounted for, in part, by differing patterns of exercise and 
2) is not shown in all patients. 
1.3.4. Viral infection and implications in CFS 
Viral illness, as stated earlier, is extremely common and a particular virus may have more 
effect on some people than on others. 
It is important to note that certain features of epidemics of ME have similarities to viral 
epidemics. This is perhaps easiest to see in the early outbreaks, for example at the 
Royal Free, where lymph ad en opathy, fever and length of transmission seem consistent. 
The same type of symptoms are still seen in CFS. Temperature changes and swollen 
glands, normally regarded as signs of infection, are common in the early stages, hence 
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the "post viral" and "yuppie flu" labels. The more severe symptoms of ME - 
paraesthesia, photophobia, psychotic symptoms, and symptoms associated with 
encephalitis - have been observed in echo viruses, e. g. polio, Coxsackie B and herpes 
virus. Neurological symptoms (including photophobia, confusion and loss of 
concentration) in US are similar to those caused by some viruses. Symptoms that are 
usually regarded as psychiatric, e. g. depression, sleep problems and anxiety, are often 
seen in prolonged or severe bouts of viral illness and the echo viruses that have been 
implicated in ME and CFS have been known to produce psychiatric symptoms (Abbey 
and Garfinkel, 1991). 
CFS could be caused by a new virus: over the last decade the number of neurotropic 
viruses and bacteria has increased. This includes an increasing range of familiar 
pathogens as well as new pathogens (Kennedy 1990). 
The first waves of US (as it has become known) were seen in association with polio. 
The 1981 wave in Scotland in association with Coxsackie B and in America and the 
South of England in connection with Epstein Barr virus (EBV). In the case of EBV and 
Coxsackie B the presence of these viruses has been definitely identified in high levels 
in CFS patients (Strauss et al. 1985; Keighley and Bell 1983). In the Lake Tao outbreak 
however, raised antibodies were found to many viruses not just EBV (Buchwald et al. 
1992). Mowbray (1992) reports that 25% of CFS patients had active enteroviruses. 
Jenkins (1991) suggests that CFS illness may occur largely in temperate climates being 
spread at similar times to that when echo viruses are known to be most active. Evidence 
of numerous viruses were found in the early epidemics, not just those with which CFS 
has been associated. Acheson reports the large number of viruses found in tests in early 
epidemics: see Appendix 1 Table 8 (Acheson 1959). However no one particular virus 
has been consistently found and although viruses are harder to isolate than bacteria, the 
evidence does not favour a single viral cause. 
- 11 - 
Other explanations of how viruses might be part of a combined causal etiology follow a 
number of themes: 
1) Poor response to viral infection 
Miller (1991) discusses the need to assess the role of a virus in a patient's illness more 
thoroughly, rather than just taking one viral measure. He suggests studying viral burden, 
strains of virus, sites of viral replication, and state of virus. Factors such as the inability 
of patients to make antibodies to a component of Epstein Barr Virus Nuclear-Antigen 
(EBNA-1) and functioning of T cells may be more important than the level of virus in the 
blood. This type of approach on large groups of patients might give us a better overall 
picture of viral involvement. 
2) Poor psychological response to viral illness 
Byrne (1988) states that "a reasonable view of the RF epidemic is that an infective agent, 
probably viral, led to an illness ... against this background some patients develop 
hysterical neurological signs probably due to hyperventilation". 
3) Viral damage 
Weir (1989) proposes that viral infection leads to an incomplete immune response, 
causing chronic infection, which results in inflammation and thus clinical features. EBV 
affects deoxyribonucleic acid (DNA) and can profoundly affect T cell suppression. It is 
not enough to look at short term effects in the patient; this virus and others may be 
profoundly modifying immuno-response in later years. 
4) Persistent viral infection 
Southern and Oldstone (1986) show how viruses manage to evade the immune system 
and remain in the body. They may mutate frequently thus avoiding annihilation by 
antibodies. The resulting illness may not be directly caused by the virus but the illness 
may result from the body's successive attempts to produce antibodies causing an 
overload in the immune system. Thus the changing properties of viruses, rather than 
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a particular virus may cause CFS. 
Mims (1978) argues that persistent viruses are not new but that there have been, for a 
long time, viruses that are well adapted parasites able to elude the immune system and 
maintain themselves. He states "Most persistent viruses infect lymphoreticular tissues" 
and this is interpreted by suggesting that it results in an impaired immune response to 
the infecting virus which in turn favours persistence. Mims goes on to say that the 
biological function of transformation and the integration of viral into host DNA means that 
the infection is able to persist in the host and undergo reactivation. This sort of evidence 
has been found in CFS patients; Hughson (1988) finds enterovirus infection persisting 
in muscle tissue. Archer (1987) reports evidence of excessive muscle fatigue due to 
persistent viral infection in CFS patients. 
Therefore, it is possible that viruses are persisting longer in the body than previously and 
causing longer, variable but persisting illness. Most of the viruses mentioned so far in 
connection with CFS and ME are echo viruses; it is suggested that a virus of that family 
similar in constitution and residing in the gut may be the cause of CFS. It could be 
parasitic in some way linked to the virus. It is possible that CFS is caused by any 
echo/enterovirus. The early epidemics of ME tended to occur in temperate regions 
between May and October this is the time when echo viruses would be most active 
(Jenkins 1991). 
5) Viruses in combination 
Some theories as to the role of viruses in US involve a combination of viruses, for 
example: Coulter (1988) suggests that CFS may be caused by virus combination, 
possibly cytomegornegalovirus or HHV6 (human herpes virus 6, previously called HBLV) 
in combination with EBV. Dubois et al. (1984) describe myalgia and fatigue symptoms 
as in US with reference to persisting EBV and Cytornegalovirus. 
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Others attribute CFS to viruses in general; Bishop (1980) describes the syndrome in 
current cases; he considers it most likely to be an antecedent of viral illness. 
1.3.5 Immune competence in CFS patients 
The immune competence of a patient is of vital importance in the patient's ability to cope 
with illness. The importance of viral illness in the development of CFS may be in its 
effect on the immune system. 
EBV virus, with which CFS/ME has long been associated, is well known to cause longer 
term immune problems in some patients. In rare cases, infectious mononucleosis may 
cause a fatal lymphoproliferative disease. DuBois et al. (1984) state that infectious 
mononucleosis develops in approximately 50% of adults and life-long viral latency is 
established. In his study 71 % (n=1 0) have mild deficiency of one or more immunoglobulin 
isotypes and minor T cell abnormalities are seen in 6 out of 7 patients studied. Hamblain 
et al. (1983) examined patients with infectious mononucleosis and who went on to 
develop chronic ill health. They find an increased number of T suppressor cells and 
fewer T helper cells inpatients after infectious mononucleosis. Evans (1991) discusses 
the relationship of immune changes to EBV virus. He says that some patients with EBV 
virus have lack of antibody to all or part of EBNA; however, similar EBV and 
immunocompetence findings are seen in people with high stress by Kiecolt, et al. (1984), 
who discuss first year medical students before and after an exam and care-givers to 
Alzheimer sufferers. 
The problem is that most people come into contact with EBV without long term 
complications, so that presence of EBV does not help us to distinguish CFS patients from 
the normal population. Holmes et al. (1988) discuss the role of EBV in CFS, and 
suggests that EBV is not an adequate explanation for CFS. Fifteen symptomatic cases 
are reported and compared to non-case serologically positive controls; they suggest an 
immunological origin. However, neither serological positive tests nor EBV titres 
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necessarily distinguish case and non case. 
When looking at CFS patients, many abnormal immune complexes have been recorded. 
For example: DuBois (1984) reports that sereological tests on CFS patients show 
abnormal immunology due to previous major illnesses. The following deficiencies in CFS 
have also been reported: Read et al. (1988) report IgGl Subclass deficiency and 
Staines (1985) adenylate deaminase deficiency syndrome. Simpson (1990; 1986) finds 
that ME subjects have the lowest percentage of normal red cells and the highest 
incidence of cup forms compared to blood from Multiple Sclerosis patients and healthy 
controls. Prieto et al. (1989) find that increased opioid activity, through a classical 
receptor mechanism, is active on a higher proportion of ME patients than controls. 
Mayne (1970) reports transient gross abnormalities in red cell morphology from ME 
patients from Adelaide; he suggests, therefore, that abnormality in oxygen delivery is the 
cause of ME. 
These kind of studies on CFS patients show, however, the characteristic findings of 
minor abnormalities or unusual test results that are found with a CFS patient population. 
These results have not been consistently found or found in large samples; thus the 
importance of them is still very debatable. The most common finding (Thomas and Dillon 
1978) is of positive monospot tests indicating a high white blood cell count, suggestive 
of allergy or infection or possibly immune overactivity. 
Some researchers into CFS have pointed out the similarity with effects of high Interferon 
levels in the blood in patients (Strauss et al. 1988(a); Lloyd et al. 1988; Lever et al. 
1988). Smith (1989) suggests that slowed reaction time in CFS patients is similar to 
patients with high Interferon levels due to a cold. 
The use of immunoglobulin as a treatment for CFS to counteract immune problems has 
not met with great enthusiasm. Although Lloyd et al. (1990(b)) find significant 
improvement above placebo with immunoglobulin, Petersen (1990) does not, and the 
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procedure is costly and intrusive. The use of Acyclovir, an anti viral agent used in 
herpes type 6 virus, has also been used to treat US without much success (Strauss et 
al. 1988(b)). Thus viral involvement in CFS appears to involve a complex relationship 
with the illness, and treatments directed at a virus or immune abnormality have not 
worked as a cure for CFS. 
1.3.6 Symptoms compared to normal population 
CFS patients present as a distinct group because their individual histories of illness are 
similar and because they report a similar group of symptoms, with fatigue and muscle 
problems the highest. Dumdell (1988) shows that their symptom-reporting cluster is 
distinct. Dumdell examines the symptoms of ME patients (as diagnosed by General 
Practitioners (G. P. 's) or consultants) compared to normal controls. What he finds is not 
common symptoms exaggerated by the ME group but a different pattern of symptoms 
with high agreement within the ME group. The report about the cluster of ME patients 
at Glasgow's College of Technology records the incidence of symptoms for ME and 
controls. ME patients complained of the following symptoms in the percentages given: 
fatigue 91 %, weakness 95%, loss of concentration 91 %, sore eyes 86%, looking pale or 
grey 86%, heavy legs 82%, feeling hot or cold 82%, depression 82%, loss of memory 
77% and sensitivity to light 73% as the most common of their symptoms. Normal 
controls reported all these symptoms at a much lower level (12%, 12%, 31%, 27%, 23%, 
8%, 19%, 12%, 3%, 19% respectively). Normals reported different symptoms as most 
common; the top being headache 62%, sore throat 46%, cold in the head 42%, muscle 
pain in back, arms or legs and these are reported at a similar level in CFS patients. This 
suggests that CFS patients are not just overstating, nor are they at the extreme end of 
the symptom range of normal healthy people, but rather that they are giving a different 
set of symptoms, plus some ordinary symptoms common to the general population at the 
normal rate. 
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Durndell's analysis suggests symptoms such as headache or sore throat may not be the 
most distinctive symptoms of CFS. His study suggests that there are more unusual 
symptoms that seem indicative of CFS but are rare in the normal population. These 
symptoms include loss of memory/concentration, sore eyes, looking pale, feeling hot/cold 
and sensitivity to light. These symptoms fall into two categories: 1. a problem with 
autonomic regulation e. g. temperature and 2. neurological type symptoms. 
One problem with Durndell's (1988) study is that cases are defined by diagnoses from 
a wide group of people i. e. different consultants and G. P. 's. However, the population 
from which he selects is limited to the Glasgow Polytechnic over a specific time period; 
this is similar to the way early ME epidemics were defined (type I definition: see 
following section 1.4.3). 
1.3.7 Summary of 1.3 
The main symptoms of CFS are common in the normal population; they are not 
symptoms which are distinctive taken individually. The symptom combination and 
weighting of some symptoms is distinctive, according to the work of Dumdell 
(1988,1989). The medical evidence for abnormality in CFS is fragmentary; most reports 
of such abnormalities are of small groups. 
1.4 Diagnosis and Definition 
1.4.1. The need for clear defining of CFS 
The early accounts of ME describe its symptoms. This, in itself, is not adequate to allow 
comparisons between individual patients or groups of patients. In order to be able to 
compare information and research, the basis on which diagnosis of CFS takes place 
must be known. Ideally, the same criteria would be used for all research on CFS; today 
this is still a long way off. However, papers from the 1980's onwards have at least begun 
to state the grounds on which patients have been diagnosed as CFS. 
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One of the reasons definition has been more complicated in CFS is that it has been dealt 
with by different medical specialist departments. Sharpe et al. (1991) make the 
observation about US that: 'research (is) carded out by investigators in different 
disciplines using different criteria to define the condition'. 
The situation today is described by Holmes who sums up the problem of definition as 
follows: 'many investigators have continued to use their own diagnostic and screening 
criteria for CFS-like illnesses but fail to adequately describe their methods, negating the 
scientific value and comparability of their results with other reports. ' (Holmes 1991). 
1.4.2 The way in which CFS has been defined 
CFS has been defined largely by its symptoms. Section 1.3 points out that the evidence 
of organic abnormality in CFS is largely fragmentary and insubstantial. For a long time 
CFS type illnesses were not evaluated against any definite criteria. Modem definitions 
of CFS vary substantially and depend on clinical judgement of symptoms. 
Why now do we have definitions largely based on subjective assessment of symptoms? 
US / ME cannot be shown to be related to (only) one virus, it does not affect (only) one 
area or process in the body, it cannot be distinguished by one specific physical test and 
its symptornatology has varied over time. Acheson (1959) indicates a number of 
important points about defining the syndrome: (a) no deaths have occurred, (b) no 
causative or toxic agent has been discovered, (c) recognition must be on the clinical and 
epidemiological pattern. Since definition according to epidemiology has problems due 
to the change from epidemic to sporadic occurrence, the clinical picture - i. e. symptoms 
- has become the main criterion. 
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1.4.3 Type of definition of CFS in the literature 
The ways CFS has been identified or defined in the literature can be classified into four 
methods: 
1) The syndrome is defined by describing a group of patients' symptoms, e. g. 
Pampiglione et al. (1978). 
2) The patient group is defined by being diagnosed as CFS or PVFS or ME by a 
particular group of doctors e. g. Dumdell (1988), Stricklin et al. (1990). 
3) Criteria used are from published papers such as Holmes (1988) e. g. Hickie et al. 
(1990); Lane et al. (1991); Hayden (1991); and Mckenzie criteria in Blakeley et al. 
(1991); Dawson (1990) criteria are given in Lynch et al. (1991). 
4) Researchers' own criteria are given for the definition of the group, often based on 
method 3 above e. g. Wheiton et al. (1992). 
The use of definition method 1) involves no strict applied criteria and therefore definition 
is poor, although its use is becoming less common. The problem with definition 2) above 
is that we are not privy at all to what criteria has been used. Katon et al. (1991) say that 
Holmes' criteria are not used and that patients are referred from G. P. 's or self-referred. 
It is inadequate scientifically not to know which criteria are being used. 3) and 4) are the 
most satisfactory methods but Holmes' criteria has been subject to much criticism. 
1.4.4 Mis-inclusions and exclusions 
The differences in diagnosis of CFS/ME/PVFS has created the problem of people who 
are diagnosed CFS who should not be (i. e. false positive) or not diagnosed CIFS who 
should be (false negative or not selected as a possible diagnosis). Note that these refer 
to exclusions and inclusions in criteria for the diagnosis of CFS, not exclusions for 
methodological reasons in research. 
Definition 1) in the previous paragraph would tend to include false positive mistakes since 
the syndrome was described from all the similar patients that were seen, rather than the 
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patients symptoms being checked against those known in CFS/ME. There is evidence 
of this kind of mistake where patients diagnosed as ME were found to have Multiple 
Sclerosis (MS) at post-Mortem ("Epidemic Myalgic encephalomelitis" 1978). The signs 
and symptoms of MS are given in Appendix 1 Table 12 from Poser (1992). The early 
symptoms of MS overlap considerably with those of ME patients (muscle weakness, 
visual problems, paraesthesia, dysarthria) but it would be rare to see the signs Poser 
mentions. The inclusion of a MS patient under the diagnosis of CFS/ME is less likely 
today with clearer diagnostic guidance. The inclusion of patients who are suffering from 
primary psychiatric disorder, particularly Major Depressive Disorder (MDD) is a more 
major diagnostic issue as discussed in Section 1.4. (These psychiatric patients may be 
included in some studies and not in others and fundamentally change the results for any 
one group of patients. ) 
Mis-inclusion is a problem, but in defining CFS the exclusion of patients is as great a 
problem. When definition of CFS is by symptomology, and then exclusion is by certain 
criteria, as in 3) and 4), it can seem to be rather arbitrarily drawing a line between 
patients who are to be included and those who are to be excluded when in fact there is 
little difference between them. Price et al. (1992) in their study of the prevalence of CFS 
in the community show this quite clearly. Ninety percent of those diagnosed by positive 
criteria (fatigue and disability) for CFS were excluded by negative criteria in the Price 
population study. The exclusion criteria for Price's study include prior psychiatric history, 
medical diagnosis of a different substantive medical condition, substance abuse or weight 
loss. 
The exclusion criteria for defining CFS in Price's study have become more important than 
positive criteria. The over-importance of exclusion criteria causes two main problems: 
1) people may be included whose medical condition is not different from that of 
excluded patients, who will later be diagnosed as having recognised physical or 
mental disorder. 
2) People may also be excluded who are experiencing CFS in addition to the problems 
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for which they are excluded. 
Apart from the mis-inclusion of Multiple Sclerosis, which is perhaps less likely today, 
there are a number of conditions which may considerably overlap with CFS. These are 
discussed in Section 1.5. Other illnesses share similar early signs but can be 
distinguished easily if the right test is done e. g. hypothyroid and other thyroid conditions. 
1.4.5 Established criteria and differences in inclusions and exclusions 
The need to classify individual cases and compare outbreaks and the demand for 
research meant that researchers recognised the need for agreement about classification 
and diagnosis of the illness. As a result groups of experts got together to define the 
syndrome. The most commonly used criteria has been Holmes et al. (1988) but different 
criteria were developed in other countries. Holmes et al. (1988) and Lloyd et al. (1988), 
quoted in Hickie et al. (1990), developed criteria in North America. In Britain, criteria are 
given in Sharpe et al. (199 1) and Dawson (1990), in Scotland by Ho Yen (1990), in New 
Zealand by McKensie (1988) and in Canada by Whelton et al. (1992). The last two are 
criteria given in a study, the others are widely acknowledged and are given in detail. 
Appendix I Table I gives the Lloyd et al. (1988), Ho Yen (1990), Dawson (1990), 
McKensie (1988) and Holmes et al. (1988) and Holmes (1991) criteria. 
The main differences in these criteria are: - 
1) Psychiatric diagnosis. 
In Dawson's (1990) criteria, psychiatric diagnosis is only considered as an alternative if 
it predates the illness, or there are bizarre or inconsistent symptoms or a family history 
of mental disorder. Subjects were excluded as having CFS by Whelton et al. (1992) if 
'there was any underlying primary medical or psychiatric illness'. Ho Yen does not make 
any such exclusion on psychiatric grounds. Holmes excludes all chronic psychiatric 
disease including hysteria in Holmes et al. (1988) but excludes only pre-existing 
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psychiatric disorders in Holmes (1991). Lloyd et al. (1988) do not exclude psychiatric 
disorder. Lane et al. (1991) discuss the problem of psychiatric diagnosis in CFS. They 
maintain that CFS is very rare if psychiatric symptoms exclude the subject from the 
diagnosis and that even excluding those with pre-diagnosed psychiatric disorder is highly 
suspect since research suggests prior psychiatric disorder may predispose to CFS. The 
Centre for Diseases Control (CDC) set of criteria by Holmes et al. (1988) was much 
criticised for excluding all patients with psychiatric problems past or present. Katon et al. 
(1991) tell us that their patients do NOT meet CDC criteria: only 19 out of 98 did, the 
majority of the remainder failed to meet the criteria because of current psychiatric 
referral. The requirement to exclude people with present psychiatric problems was 
removed as a requirement from CDC in 1990 (Holmes 1991). 
2) Onset. 
Dawson's criteria requires that there is a definite onset to the disorder and Whelton's 
criteria requires a flu-like illness at the start of the illness. Ho Yen, Holmes and Lloyd 
make no such stipulation. This part of the criteria really relates to the previous theories 
about a trigger to the illness, in other words the belief that the illness is started by a viral 
illness. This is an argument used in support of organic theories of etiology, that a 
previously healthy person suddenly becomes ill. However, the presence of a trigger has 
not been proved to be universal and the Post Viral label has been largely dropped in the 
UK (Sharpe et al. 1991, Wood et al. 1992). If a proven trigger is a pre-requisite to 
diagnosis, patients who do not remember onset, as well as those for whom onset was 
more gradual, will be excluded. 
3) Excluded illness and physical testing criteria. 
The sets of criteria vary considerably about what they consider excludes a person from 
CFS diagnosis. There is agreement generally that tests should be made to exclude other 
conditions, but in some criteria testing is much more extensive. There is clear agreement 
about exclusion of some illnesses, for example Multiple Sclerosis (MS) and Myasthenia 
Gravis (MG), but in practise diagnosis is often delayed in these illnesses leaving open 
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the complication of previously diagnosing as ME (Jelinek 1956), or the diagnosis of MS 
may turn out not to have been justified (Wookey 1986). For other illnesses their 
exclusion occurs in only some criteria, for example brucellosis which is specifically 
excluded in the CDC list given by Holmes (1991). The problem with excluding such 
illness as brucellosis, infectious mononucleosis, or toxoplasmosis or toxic poisoning is 
that the triggers of CFS may in fact be excluded and, therefore, exclude a group of 
patients central to CFS. In the literature some of these illnesses have been reported as 
causing a fatigue syndrome (chronic brucellosis: Cluff 1991, chronic infectious 
mononucleosis: Coulter 1988, discussed in Lloyd and Wakefield 1988). 
4) Neuropsychological symptoms 
Ho Yen (1990) requires the presence of neuropsychological symptoms e. g. memory and 
concentration problems. Since it is widely debated, and so far not backed up by a body 
of research, that CFS patients have true neu ro psychological deficit this requirement can 
be considered to be pre-empting a valid debate and prematurely excluding patients. 
Considerable differences in the number of patients regarded as CFS arise depending on 
the use of different exclusions. The psychiatric and neuropsychological symptoms 
present in any particular CFS population may be dependent on which criterion has been 
used. Although not as yet reported in full in the literature, Bates et al. 's (1994) study 
indicates the amount of variation in diagnosis which occurs if different recognised criteria 
are used for diagnosis. 
Bates et al. (1994) show that the same group of patients are diagnosed as CFS at 
different rates depending on the criteria used. They use criteria from three different 
countries and, of the 808 patients, 44% are diagnosed CFS under CDC criteria, 62% 
under the British criteria and 82% under the Australian criteria. Bates also shows 
abnormal tests to be evenly distributed through the patients diagnosed, irrespective of 
the criteria used. Thus differences are seen in the numbers diagnosed as CFS, without 
any particular criteria being superior on the grounds of distinguishing more abnormal or 
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distinct patients. 
1.4.6 CFS a diagnosis by exclusion? 
Differences in criteria, in the main, revolve around who is excluded from the diagnosis 
of CFS. The Price et al. (1992) paper shows, as does the discussion of fatigue and 
viruses in Part one, that the symptoms of CFS occur widely. However Price et al. 
indicate that exclusion criteria prevent the majority of their symptomatic patients being 
diagnosed as CFS. The question that should be asked is : Is CFS a diagnosis by 
exclusion? This would mean that CFS is a diagnosis that is used because of a failure 
to identify other causes of fatigue and muscle debility. If this is the case, CFS diagnosis 
is very weak, since positive criteria are a much stronger scientific basis for diagnosis than 
negative (exclusion) criteria. If it were established that in US exclusion criteria rejected 
90% of the cases selected by positive criteria, then it may be that CFS does not exist as 
a separate entity. CFS might simply be an indication of physical or psychiatric illness 
that has as yet not been diagnosed or is not severe enough for diagnosis. 
1.4.7 Summary 
As a result of failing to find consistent abnormality or test for the condition, diagnosis has 
been largely by symptoms. The confusion over what is or is not Chronic Fatigue 
Syndrome occurs over many features even after wide acceptance of Holmes' criteria as 
a starting point. Problems remain with: 
- the inclusion or exclusion of patients with positive testing for an illness; 
- the inclusion or exclusion of patients with abnormalities in immunity; 
- differential symptom criteria; 
- exclusion of patients with similar symptoms but no viral history; 
- inclusion or exclusion of currently depressed patients; 
- inclusion or exclusion of those with a psychiatric history; 
- variability of length of illness considered necessary to confirm as ME or post viral 
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syndrome; 
- the existence of neurological and neuropsychological deficit; 
- overlap with conditions such as fibromyalgia or hyperventilation. 
Modem criteria for CFS rely heavily on exclusion criteria and this may indicate that CFS 
overlaps with other medical diagnoses. 
As a result of problems with definition, populations defined as CFS may vary widely in 
their psychiatric and neuropsychological profile. Mis-inclusions may result in people with 
different illnesses being assessed within the groups. Mis-exclusions may well result in 
an underestimate of psychiatric conditions. 
'The problem of any kind of research into the CFS is that, like backache, it covers a large 
heterogeneous group of patients in whom physical, psychological, and social factors, 
may be interacting. Researchers should therefore not be surprised to find that the 
outcome varies considerably when the aetiology is not more clearly defined. ' Shepherd 
(1992). 
1.5 CFS and overlapping syndromes 
CFS has strong similarities to other modem syndromes and may overlap considerably 
in symptomatology and definition. 
1.5.1 Syndromes with overlapping symptomatology 
1. Sick Building Syndrome (SBS) is a well documented phenomenon where workers 
in a particular building complain of a high level of general symptoms. A recent advice 
bulletin (Kirkton 1990) quotes a 1987 survey of 4000 workers in 46 buildings: 80% 
of the work force experienced symptoms of ill health associated with their workplace. 
The five most common symptoms were: lethargy 57%, stuffy nose 47%, dry throat 
46%, dry/itchy eyes 46% and headaches 43%. Lethargy and headaches are 
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prominent complaints in CFS. 
2. Allergy syndromes have similarities in symptoms to CFS, notably fatigue. Buchwald 
et al. (1988) report a study of US patients where 50% of patients were found to be 
reactive to allergens compared to the rate of 15-20% in the normal population. 
Strauss et al. (I 988(a)) find that cutaneous reaction and histories strongly suggestive 
of atopy occurred in 50% and 83% respectively of their patients tested. 
3. Pre-Menstrual syndrome (PMS); the high proportion of women of childbearing age 
with CFS means that for that reason alone, apart from similarities in the syndromes, 
premenstrual and menopausal symptoms may overlap with CFS. Symptoms of 
premenstrual syndrome include complaints about memory and feeling confused; but 
these are not objectively substantiated (Richardson 1988). One of the most usual 
symptoms is headache which is a symptom common to CFS patients. Painful joints, 
allergy symptoms and backache are also common symptoms in PMS. 
4. Toxic Poisoning; CFS shares similarities to toxic poisonings of various kinds. Mild 
symptoms of toxic poisonings, e. g. from industrial paint, are commonly fatigue, poor 
concentration, irritability and headache. Lehrer and Hoover (1988) compare the 
symptoms of US to cocaine and other substance abuse. Symptoms of cocaine 
abuse include sleep problems and fatigue, headache, sore throat, nausea/vomiting, 
depression/initability, memory and concentration problems, sexual disinterest and 
panic attacks. 
5. Minor/Mild Head Injury (MDI); Post Concussion Syndrome (PCI). This syndrome has 
a different starting point, head injury, to CFS but is mentioned because of the 
similarity in symptoms and the similarity in neurological findings. Patients complain 
of headache, fatigue, dizziness, blurred vision, they are bothered by noise and light, 
insomnia, difficulty concentrating, irritability, anxiety, memory difficulties and loss of 
temper. Patients experience slowed reaction time and problems on Stroop and the 
Paced Auditory Serial Addition Test (PASAT) (Dikmen et al. 1986(a), 1986(b)). 
Patients' symptoms are regarded as possibly psychological (Rutherford 1979). 
Dikmen et al. (1989) suggests neuropathological and neurophysiological causes for 
symptoms, including reduced blood flow, brainstern evoked potentials, and reduced 
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speed of information processing. The symptomology and neurological findings are 
similar to those of CFS. 
1.5.2. Syndromes which may be the same as CFS 
1. Fibromyalgia 
Fibromyalgia is a syndrome where muscle pain predominates. The American 
College of Rheumatology 1990 classification for fibromyalgia is of widespread pain 
and pain in 11 of 18 tender points on digital palpitation. Fibromyalgia is found as 
primary or secondary to a concomitant rheumatic disorder. 47% of 100 consecutive 
rheumatic patients admitted to a Danish rheumatology department meet criteria for 
fibromyalgia (Rasmussen et al. 1990 in Goldenberg 1991) by examination of tender 
points in soft tissue. In Sweden 1% of a random population (n=900) were surveyed 
and found to meet the criteria of fibromyalgia (Jacobsson et al. 1989). Sleep 
abnormalities have been reported in fibromyalgia notably the alpha intrusion noted 
in slow wave stages of sleep (Modofsky et al. 1984). The similarities between CFS 
and Fibromyalgia are marked in a study by Goldenberg: he shows 19 out of 27 of 
the CFS patients studied to have a mean tender point score identical to that of the 
fibromyalgia patients (Goldenberg 1991). Depression is common in both sets of 
patients; immunological and path o physiological changes as well as cognitive 
changes are reported in both syndromes. In Fibromyalgia certain abnormalities - 
reduced pain tolerance to electric pulse and the effects of epidural - have led to 
suggestions that the pain is of peripheral nociceptive-spinal origin. Bennett (1989) 
suggests that fatigue and physical inactivity lead to unfit muscles which are 
susceptible to microtrauma and that sleep disturbance might exacerbate this. 
Muscle strength was found to be diminished in these patients and it was found that 
muscles did not relax properly after use (Goldenberg et al. 1990). CFS and 
Fibromyalgia could be the same, or an overlapping, syndrome. The difference lies 
in whether muscularskeletal pain or fatigue are considered the primary symptom. 
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2. Hyperventilation 
Some recent papers have claimed that CFS is caused by hyperventilation, i. e. 
overbreathing. Overbreathing occurs in many people but excessive overbreathing 
can cause impairment of muscle function and other symptoms. Hyperventilation is 
seen as a medical condition but is closely associated with anxiety. Anxiety states, 
particularly panic attacks, may bring on overbreathing as patients in such attacks 
often breath much faster. Rosen et al. (11990) say that 100 consecutive ME patients 
when tested met the criteria for hyperventilation. 
Summary 
The diagnosis of CFS is complicated by the existence of syndromes which may be the 
same illness under a different name, e. g. Fibromyalgia. It is also a syndrome which 
shares groups of symptoms with other syndromes. The etiology of some of these 
syndromes is argued to be partly psychological. US may also share organic causes 
with some of these syndromes e. g. toxic poisoning or, in the case of PIVIS, hormonal 
disruption. 
1.6. Who gets CFS? 
Introduction 
There may be a particular type of person/patient who is susceptible to CFS. CFS 
patients are thought by some to have more premorbid psychological problems and 
possibly psychiatric tendencies as shown by the Minnesota Multiphasic Personality 
Inventory (MMPI) (Stricklin et al. 1990). However, the questions discussed here are: are 
CFS patients demographically distinctive? and does that give us any other clues about 
them? 
Archers review (1987) covers some of the main points. Females are up to 10 times 
more likely to be diagnosed as CFS patients than males. The majority of patients are 
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from social classes 1 and 2, rarely more than one person in the family has it. Many of 
those in initial epidemics were medical staff. 
1.6.1 Sex differences in diagnosis of CFS 
The over-representation of women in CFS populations has been widely found. This has 
been used as an argument for the mass hysteria hypothesis (McEvedy and Beard 1970) 
based on the idea that young women are more susceptible and neurotic than men. 
There are, however, other possibilities: it may represent a differential use of the Health 
Service by women (see later), it could also be to do with greater contact with children; 
it could be to do with doctors' attitudes to women and their attitude towards the diagnosis 
of CFS. 
Feiden (1990) points out that such arguments are not necessarily relevant because 
women are generally more prone to autoimmune disorders such as lupus, multiple 
sclerosis (MS) and rheumatoid arthritis (RA) in which the immune system attacks the 
body's own tissue. Since some physicians suspect that CFS is also linked to 
autoimmunity (Lloyd et al. 1988; Klimas et al. 1990; Caligiuri et al. 1987), this sex bias 
could occur in CFS for the same reasons as in other auto-immune illnesses. The 
hormonal difference between men and women could also make women more susceptible 
to the endocrine imbalance sometimes found in CFS (Demitrack et al. 1991 and see 
Section 1.5). 
Another reason for the high number of female patients may be that epidemic ME has 
tended to revolve around a particular building. These buildings tend to be large 
institutions where lots of professional people work, with large numbers of female support 
staff. This pattern shows similarities to Sick Building Syndrome in large new buildings 
(see "Sick Building Syndrome"). 
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Recent studies in which CFS patients have been sought out from a wide area have 
shown less male /female bias: Cluff (1991) finds no sex difference, Lloyd et al. (1 990(a)) 
find 1: 1.3 ratio supporting the view that the larger female bias found in early studies may 
be due to other factors than gender difference. 
1.6.2 Predominance of the middle class in the CFS population 
There is a social class bias in the CFS population. Salit's (1985) study suggests that 
there are more social class I and 2. This class distribution is not however true of all 
studies, in particular some in which patients have been sought out in an intensive way. 
For example, in Lloyd et al. 's (1990(a)) study of the symptoms of CFS in Richmond 
valley New South Wales they find distribution of social class in CFS patients to be similar 
to that of the community. Ho Yen and McNamara (1991) in a survey of G. P. 's in 
Scotland finds that 22% of sufferers are students or teachers but only 5% are 
professional workers (excluding teachers) and 17% are manual workers. This shows that 
CFS is distributed through the classes although some groups such as teachers are over- 
represented. It may be that it is the professional person who both seeks out help from 
the doctor and who is articulate and persistent enough to receive help who finally gets 
a diagnosis of CFS. The over-representation of professional classes as in Salit (1985) 
has led to stereotyping of the 'Yuppie flu' sufferer (Shaw 1987). 
Alongside the view that CFS is a middle class disease has been assumed that this is to 
do with a relationship between class and stress. An assumption is made that job stress 
is associated with the middle class and overstress may cause CFS and this results in the 
'Yuppie flu' stereotype. Shafran (1991) discusses this concept and how the ability of the 
middle class to assert themselves may account for more CFS diagnosis in the middle 
class. (Stress and how it fits into CFS is discussed more fully later Section 3.4. ) 
In the studies that fail to show strong sex and class bias, it seems to be that researchers 
looked at possible patients from a primary source e. g. all in a geographic area or all 
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G. P. 's in an area. In Lloyds et al. 's case, they looked at all people seeking help for 
fatigue and decided whether they were CFS, rather than looking only at those diagnosed 
as CFS by a hospital. This suggests that the pool of CFS patients in the general 
population has a higher percentage of male and working class people than suggested 
by data from diagnosed patients. 
1.6.3 Work: Place and type of work associated with CFS patients. 
In ME's early history, hospitals and schools, and nurses and teachers, are over- 
represented; this bias still remains (e. g. Dumdell 1988, Johnstone 1990). Why should 
hospital staff be more prone to CFS? There are a number of possibilities: they are more 
in contact with cause or trigger illness; they are more prone to the suggestion of illness 
in the case of mass hysteria; they suffer stressors that contributed to the illness. 
A Scottish teacher's report in 1992, described ME as a psychiatric illness and suggests 
that this and other illnesses are due to stress on teachers (BBC 1992). The incidence 
of US has been so high among Scottish teachers that the Scottish Education 
Department has introduced a new retirement policy for CFS sufferers in teaching; 
Johnstone (1990) reports that the Educational Institute of Scotland (EIS) claim that at 
least 200 Scottish teachers are suffering from ME. Stress is not the only possible reason 
why teachers might get CFS: it could again be a question of contact with trigger illness; 
the spread of viral illness is high among children in a school environment and it is 
possible that due to that, or the building environment, teachers are more at risk of CFS. 
1.6.4 CFS in children 
For a long time it was believed that children did not get ME/CFS; Hill et al. (1959), and 
Dillon (1978) remark on children in hospital not getting ME when the staff did. Bell et al. 
(1991) show that children do get ME; adults may be more prone to get it seriously (as 
is the case with mumps and chicken pox). When children get CFS it seems to be in a 
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children's epidemic or as a sporadic case. Hill et al. (1959) suggest that, for some 
reason, puberty might make teenagers and adults more susceptible. It may be that 
epidemics among children are of a different form. 
1.6.5. CFS patients and the over-representation of athletes 
Amongst high profile cases of CFS, athletes predominate (e. g. David Provan (Shaw 
1987), Claire Francis and others (Holoway 1993)). In studies, health workers and the 
higher professional groups are over-represented (Salit 1985). There appears to be an 
over-representation of those who have been athletes or keen at fitness pursuits. In the 
academic literature, Dumdell (1988) shows that joggers seem more prone to the illness 
among academic staff. This could be to do with demographic variables of joggers, i. e. 
joggers are more likely to be middle class and in the 25-40 age group. 
The reason for this over-representation may be to do with personality variables; athletes 
have been shown to be higher in vigour and extraversion, probably necessary factors in 
reaching the top (Puffer and McShane 1991). An alternative explanation is that they 
could be more vulnerable to CFS because they are active (see Literature Survey Section 
1.1.3). It could be due to overstrain/stress on the body; over acidosis of the muscle may 
occur in CFS patients in a similar way to acidosis from athletes overtraining. It could 
also be due to the athletes' heightened sensitivity of any changes in performance. Puffer 
and McShane (1991) suggest a cycle of depression caused by obsession: a slight 
downturn in performance leading to a slight depression in mood leading to further poor 
performance. In this scenario depression and poor performance can lead to symptoms 
and to chronic fatigue. Morgan et al. s (1988) study shows that inadequate muscle 
glycogen stores in athletes due to overtraining correspond to mood disturbance. The 
result of overtraining therefore may be a mood and muscle problem. In respect of type 
of profession and athleticism, Dumdell (1988) shows this is not just a question of 
professional athletes being at increased risk but also regular joggers. 
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1.6.6 The age profile of CFS patients. 
There appear to be peaks in the age profile of CFS patients: Ho Yen and McNamara 
(1991) report an age peak at 35-39 in male patients and in female 25-29 and 40-45. The 
suggestion has been that stress could cause these age peaks (see Brozovic 1989): age 
25-29 in women is a time when many women are coping with new married life and 
working or coping with small children, or both, so that they are very busy and have a 
number of, sometimes conflicting, demands (Malley and Stewart 1988). Interestingly, 
Stricklin et al. (1990) does not find that 'epidemic neuromyasthenia' female patients 
scored any differently on the Meharian Achieving Tendency Scale for females than 
controls; higher achieving tendency might have supported this model. It is harder to 
produce an equivalent argument for the male patients but 35-39 can be suggested as a 
time when a man is stuck where he is in his career, his career is at its most demanding 
etc. For examples of this type of explanation of illness and stress to the patients in 
relation to women see Brozovic (1989) and assumptions made in Rose et al. (1990). As 
yet there is no real evidence that stress is a cause of CFS; however it could fit into an 
argument that CFS is related to psychological profile as discussed later. 
There are other possible reasons for this age distribution. Both sexes are very active in 
the 20-40 period in general and their responsibilities may mean they are unable to take 
proper time off at times of illness or for recuperation. Hormonal disruption, as may occur 
in CFS (Demitrack et al. 1991) may be most upsetting to body systems at this sexually 
active stage and particularly for childbearing or pre-menopausal women (see section on 
"PMS" in 1.5.1). 
1.6.7 Discussion of demographic profile in general 
It is possible that the demographic profile of the CFS patient represents the stereotype 
Type A personality: highly intelligent, overstriving, slightly obsessive and pushing 
themself hard, as the high achieving athlete needs to in order to make it to the top 
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(Holoway 1993). Abbey and Garfinkel (1990) relate this stereotype to illness: 'The 
achievement odentated personality style theoretically places individuals at risk for 
depression and protracted disability'. Another suggestion is that people caring for others 
overstretch themselves to meet demands, as with teachers, nurses and mothers with 
small children. This type of stereotype is not maintained in regard to class and sex in 
new intensive studies (Lloyd et al. 1990(a); Petersen et al. 1991) but the activity/athletic 
level of patients does seem to be high (Dumdell 1988). It may be that the fashion for 
activities such as jogging among the middle class is the key to this distribution. One 
major argument for a middle class bias in diagnosis is, however, utilisation of the health 
service. 
1.6.8. Health utilisation 
In order to be diagnosed as CFS/MEIPVFS formally, the subject needs to be seen by the 
health services. The rate of diagnosis of any disorder can be biased by who is using the 
service. If CFS is widespread in the community, as surveys such as Lloyd et al. 
(1990(a)) and Petersen et al. (1991) suggest, then the inequality of diagnosis may 
depend on who goes to the doctor, their persistence, and the doctors' reaction to them. 
Ham (1990) sums up the evidence of demographic inequality in use of the health service 
in a quotation by Stacey: '7here is evidence, first, of continuing and perhaps increasing 
class differentials in death rates (more in the lower class); second, of more illness in 
lower than in higher classes; third, that the health services are more available to the 
middle classes than the working classes; fourth, that the middle classes use the health 
services more than the working classes; and, fifth, they get more out of them when they 
do use them" (p. 898). 
So a middle class US patient is more likely to go to a doctor than a working class one, 
and more likely to get a diagnosis if he/she does. The diagnoses of CFS may be related 
to those who persistently use the health service rather than just a cross-section of those 
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who have the symptoms. 
Williams et al. (1990), looking at the U. K. Second National Morbidity Survey, point out 
that females' highest rate of utilisation of health services is at age 25-44 (which fits in 
with CIFS age profile) and for men 46-64 (which does not). They also point out that 
women use the health service more than men. Married women use the health service 
more than single women and single men more than married men. Lewis and Wessely 
(1992) write: "It has been suggested recently that the apparent positive social class bias 
in hospital studies is the result of differences in health care utilisation. " 
Anderson's model of health care as summarised in Williams et al. (1990) suggests many 
factors influence utilisation of the health service, as shown in diagram Appendix 1 Table 
10. Apart from cost, which is not so relevant in the UK, he points to predisposing factors, 
demographic and belief structures, and the perception of illness level. 
Koff et al. (1990) in looking at health care utilisation come to the conclusion that 
"psychologically distressed persons appraise their global health status less favourably 
than non distressed persons, have more functional disability and may have a higher 
incidence of chronic disease". According to Koff et al., health-care structures may 
encourage dysfunctional illness behaviour. Thus, if CFS patients are psychologically 
disturbed, this is more likely to lead them to health care whatever the degree of 
symptomatology. Therefore CFS patients, in whom depression and anxiety are high (see 
next section), are more likely to seek health care than if they were not psychologically 
affected. Spilken and Jacobs (1971) state that results of their study on stress coping and 
illness seeking behaviour show "premorbid indicators of unresolved life stress accurately 
predict who will seek care for illness", Le stress may lead to health utilisation. 
Cluff (1991) finds that those who developed CFS sought medical care more frequently, 
prior to the syndrome, than those who also had a bigger' illness like Coxsackie B and 
did not develop the syndrome. This suggests that oversensitisation to physical stimuli, 
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as well as belief in the health service, may influence whether a person goes to see a 
G. P. Cluff (1991) also comments that women tend to utilise health services at least 
twice as much as men; hence, patterns of differential use of the health service by sex 
may account for part of the sex difference in CFS diagnosis. 
Men are less likely than women to seek medical help and they are even less likely than 
women to receive a psychiatric diagnosis. Married women are the most likely group to 
receive psychiatric diagnosis. If CFS is thought of as showing psychiatric problems it 
may also follow that a diagnosis of CFS may be made more frequently in women. 
According to Ho Yen (1990), CFS patients take up a lot of G. P. time and medical care 
seems to have little to offer them. The high rate of depression and anxiety in the group 
leads doctors to suppose that their general symptoms may be the result of psychological 
distress rather than illness. Wessely (1 990(b)) and others take the approach that mental 
health care might have more to offer than general heath care. 
1.6.9 Summary 
The chances of being diagnosed as having CFS are greater if you are female, in the 
medical profession, in the professions that work with CFS sufferers, work in the same 
building as people who are CFS sufferers, or have done a lot of sports/exercise. The 
reasons for this distribution could be exposure of CFS patients to a particular 
environment or contagious element. Alternative psychological explanations include the 
patient's personality type, vulnerability to stress, hysteria or somatisation leading to, or 
predisposing to, developing the syndrome. On the other hand it may be that the 
diagnosis is restricted by factors such as health service use and distribution of services, 
or persistence of the patient. 
These risk factors in getting CFS are displayed in the following diagram (Figure 1). 
Demographic and geographic variables have already been shown to increase one's risk 
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of getting CFS. The diagram also includes personality variables which are discussed in 
the section (3.1) on psychiatric aspects of CFS. In the diagram one can see that the 
reasons for being at risk of CFS are both individual and situational. 
1.7 Recovery from CFS 
CFS is an illness which as discussed earlier may be long term. The evidence suggests, 
however, that most people recover over time without any intervention. Clare (1991) 
describes ME: 'the syndrome in different patients follows a similar course with frequently 
a distinct beginning (usually moderate illness) followed by gradual recovery with relapses 
that decline in frequency'. Strauss et al. (1988(b)) show an effect of placebo treatment 
in US patients, in research over some months, of 41 % recovery, and they estimated a 
20% spontaneous recovery rate. It is likely that the placebo rate generally in CFS reflect 
an element of spontaneous recovery. 
It is extremely important to realise, in the light of claims to be able to cure CFS, that 
spontaneous recovery occurs at a high rate. Therefore spontaneous recovery should be 
controlled for in any study of 'a cure' for CFS. It is important that all longitudinal studies 
of CFS take into account improvement over time. 
1.8 Summary of Section I 
CFS is a syndrome the definition and diagnosis of which is varied. Physical tests for the 
syndrome are not available; e. g. viral screening for Coxsackie B etc is inconclusive. 
Therefore diagnosis is largely by symptoms, with exclusion criteria accounting for a large 
rejection of symptomological cases. Symptoms are mainly those found in high rates in 
the community. CFS patients are disproportionately white, female and middle-class and 
are likely to work in the caring professions or teaching. 
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Explanations of CFS range from wholly organic to wholly psychological explanations. 
Overlapping syndromes suggest hormonal, allergic or toxic influences as well as those 
suggestive of viral or psychological origin (stress or depression). Komaroff (1992) 
suggests a model of CFS pathogenesis (shown in Appendix 1 Table 9) which takes 
account of these factors. 
2. History of CFS/ME 
2.1 Early epidemic ME 
The literature starts with reports of a series of outbreaks in the wake of polio epidemics, 
the bulk of them in the 1950's. The Lancet leading article of May 26th 1956 ("A New 
Clinical Entity" 1956) reports a small outbreak in 1917 (von Economo) and one of 5000 
cases in England and Wales in 1924, but in the following years cases were rare. An 
epidemic occurred in Los Angeles in 1934 and three epidemics were recorded in 
Switzerland 1937 to 1939 (Parish 1978(b)). Retrospectively some other illnesses have 
been claimed to be M. E. Included in these are the 1918-19 outbreak of swine fever (Ho 
Yen 1987) and the 'effort syndrome' treated at Mill Hill during the Second World War 
mentioned by Richter (1978). The list of epidemics in the decade following the Akureyi 
outbreak in 1948 (Sigurdsson et al. 1950) demonstrates a mushrooming of the problem 
(see Appendix 1 Table 3 for list of early epidemics). This crop of epidemics at the one 
time might be explained by: the emergence of a new illness, an increase in prevalence 
of an illness, or a change in perception/diagnosis of illness (one argument for the third 
is that ME is not found in the third world - see below). 
Myalgic Encephalomyelitis, as it became known, was brought to the attention of the 
British public by an outbreak which caused the closure of the Royal Free hospital. The 
epidemic among the hospital staff occurred between 13th July and 24th August 1955, 
when 292 members of staff are known to have been ill and 255 were admitted to 
hospital. The patients experienced a period of initial illness, sometimes severe, when 
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symptoms of encephalitis and paralysis could be present, and it involved high morbidity 
in patients for months or, in some cases, years. Some of the cases were mistaken for 
poliomyelitis which was epidemic in the community at the time of the ME epidemic. 
Compston (1970) maintains that organic involvement of the CNS was indicated. Muscle 
wasting was rare despite the prominence of muscle pain. 
The Royal Free epidemic is typical in many ways of early epidemics. It occurred in an 
institution, it followed a wave of polio, patients often had acute symptoms sometimes 
mistaken for encephalitis in the initial stages and it was accepted by physicians in 
attendance as an organic illness of unknown etiology. Crowley, Nelson and Stovin (1957) 
show the degree of spread of illness in the Royal Free epidemic (Appendix 1 Table 4). 
They report several cases outwith the hospital among relatives and friends. Their 
examples suggest to Crowley et al. an incubation period of between 5-7 days (see 
Appendix I Tables 4 and 5 for progress of the epidemic (Crowley et al. 1957)). Although 
early outbreaks of ME are usually associated with epidemic ME, sporadic cases were 
also reported in the North London area around the time of the Royal Free epidemic 
(Compston et al. 1970). 
The epidemics that followed these original outbreaks were defined by comparison with 
the previous epidemics. For example 'an illness with features in common with what has 
become known as epidemic neuromyasthenia (called EN by Acheson 1959; Henderson 
and Shelekov 1959; Parish 1978(b)) affected the staff of the hospital for Sick Children, 
Great Ormond Street, London between August 1970 and January 1971' (Dillon 1978). 
Definition was therefore by epidemic. Dillon defines the epidemic by giving place and 
time, and little notice was taken of sporadic cases. The early epidemics were identified 
by virtue of similarity of occurrence: 
1) the illness occurred in similar way, i. e. epidemic; 
2) the illness occurred in institutions, mainly hospitals; 
3) the illness followed a recognised polio epidemic; 
4) symptoms were carefully recorded and compared to earlier outbreaks. 
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2.2 McEvedy and Beard 
An important break in the literature occurred after the reinterpretation of the key Royal 
Free reports. In 1970 two psychiatrists, McEvedy and Beard, wrote a paper based on the 
data from the Royal Free epidemic (McEvedy and Beard 1970 and 1973). They place 
great emphasis on the type of patients that were ill in the epidemic and argue that the 
epidemic was an outbreak of hysteria. This is discussed more fully in Part 3.2.1. 
2.3 G. P. Is reports of sporadic illness 
In the late 70's and 80's reports of a fatigue syndrome which was claimed to be the 
same illness came from General Practices. However they did not fit the points of 
similarity stated above defining epidemic CFS/ME. The extent to which these new 
outbreaks had moved away from the defining limitations of the early literature is pointed 
out in the differences below: 
New outbreaks 
1) were not necessarily epidemic; 
2) were not necessarily clustered in the places of work or residence; 
3) patients' reported symptoms were now more chronic and generally less serious; 
4) the illness now followed a number of different viruses. 
For example, Corridan (1978) describes in detail patients from different areas of SW 
Ireland as a group with 'epidemic neuromyasthenia'. He describes the symptoms as 
'fatigue, pallor, headache, neck pain, alterations in mentation, dizziness, nausea and 
vomiting, paraesthesia, weakness and heaviness of limbs and a prolonged relapsing 
course". He goes on to describe each patient in detail over a period from February to 
September 1976. 
The later papers were mostly from General Practitioners; they describe fatigue and 
muscle fatigue over a period of time with additional symptoms such as sleep disturbance, 
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depression and cognitive complaints. They are concerned with the prevalence of the 
illness and its links to glandular fever and Coxsackie B. Keighley and Bell (1983) report 
20 (out a practice with 2500 patients) with suspected ME, 16 of whom had high 
Coxsackie titres. Buchwald et al. (1988) find that 21% of 500 unselected patients 
between 17 and 50 who sought primary care for any reason were suffering from a 
chronic fatigue syndrome, and a significantly greater number than among controls had 
a history of mononucleosis. Both subjects and controls showed evidence of past EBV 
infection. 
The new reports started a whole new impetus to research CFS, the results of which are 
described elsewhere. The difference between early and late reports also lead to 
discussion as to whether the two bodies of literature describe the same illness. 
2.4 ME and CFS: two different illnesses ? 
The difference between the late and early reports has led to two suggestions: 
1) that these are two separate illnesses; 
2) that the illness has changed. 
The simple division between early ME and current CFS has several problems. Although 
the bulk of reports of early epidemics was followed by a relatively quiet period the time 
gap may be artificial for the following reasons: 
1) The early 1950s reports come from hospitals; those of the later 1980s come mainly 
from GPs; because the groups reporting the illness are different this may account 
for the difference in the type of symptoms reported. Hospitals, although reporting 
patients who were staff, still tended to see acute patients with the initial illness, G. P. s 
see patients over the long period of chronic disability following. 
2) Outbreaks of CFS/ME occurred during the 60's and 70's even though they were not 
so well reported (Dillon, 1978; Corriclan, 1978; Behan, 1980). Therefore a separation 
by date of illnesss may be invalid. 
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3) Epidemics and large groups of patients within a building still occurred after 1970 
(Dumdell, 1988; Buchwald et al. 1992) and sporadic ME before 1960 (Scott, 1970). 
4) Severe cases have been reported in the literature since the 1970's (Longden, 1989; 
"Believe M. E. " 1992; Macintyre, 1993). In view of this, this review has included both 
pre-and post 1970 literature. 
3 Neuropsychology of CFS 
CFS is an illness which is imprecisely defined and for which etiology is uncertain. It has 
already been indicated that the risk of getting CFS may be related to demographic and 
psychological factors. This Section looks in detail at the psychology and neurology of 
CFS; both the evidence of their influence and theories of how they affect CFS. 
3.1 Depression and CFS 
3.1.1 Evidence for depression in CFS patients 
Kendall (1967) was the first main study to report serious psychiatric sequels to ME and 
he reports that they appeared not to have a prior psychiatric history. Taerke's study in 
1981 (Taerke et al. 1981) was one of the earliest to show, in a properly designed study, 
an association with depression. His results show 67% of ME patients fulfilling criteria for 
major depression compared to less than 20% of the control group. He also states that 
50% of the patients had a major depressive episode prior to developing ME. Kruesis 
et al. 's (1989) study shows similar results: of CFS patients, 75% had depression and 
67% had predated psychiatric problems. Wood et al. (1991) describes a comparative 
psychiatric assessment between CFS and patients with muscle disease; they show that 
the CFS group have a higher fatigue inventory score, hospital anxiety and depression 
scale score, higher Spielberger trait anxiety and state anxiety, and are more likely to 
have seen a psychiatrist since the onset of their illness, have a relative with psychiatric 
history and say they had had a past psychiatric episode. They report that at least 26% 
-43- 
of the CFS patients had a significant past psychiatric history. These studies' results 
agree that CFS patients score highly on depression and anxiety. 
3.1.2 Methodological problems in data used in depression studies 
The main problem with many of these studies is that they rely on a retrospective recall 
of symptoms from patients or medical notes. This has methodological problems. 
1) Researchers looking at old material may inappropriately re-interpret past symptoms 
(e. g. interpret as major when they were minor) or be selectively biased in their 
interpretation. 
2) Memory of the normal subject is selective and tends to suppress negative events but 
in the case of depressed individual may be more likely to produce more negative 
events. (A review of the literature leading to this conclusion is given in Baddeley 
(1990) Ch 15). 
3) The patient, but not the control, is seeking meaning for their illness and is likely to 
produce more events (usually negative) to explain the illness (Baddeley 1990; Blaney 
1986). Martyn (1990) comments that patients have a 'natural interest in trying to 
understand why they have become ill'. 
4) The subject is inaccurate in recalling when events take place and therefore whether 
they are appropriate to the timescale given by the researcher or even whether they 
are before or after the start of the illness (Davies 1992). 
3.1.3. Difficulties in understanding the meaning of a depressed score in CFS 
There are other problems in testing for depression in CFS. 
1) Somatic symptoms of depression overlap considerably with symptoms of CFS. 
Cavanaugh et al. (1983) and Ray (1991(b)) find that items such as fatigue, weight 
loss and worry about health do not discriminate between psychiatric and medical 
patients. Somatic questions accounted for 31% of questions on the Hamilton 
Depression Scale and 33% on the Beck Depression Scale even though, 
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theoretically, these scales are cognitively rather than somatically based. In CFS, 
fatigue, sleep disorder and other symptoms are present which are also characteristic 
of depression. This may mean CFS patients are depressed, but if they are not they 
are still likely to score high on most depression ratings. 
2) There is disagreement as to what constitutes a depressed score on some scales. 
CFS patients tend to score higher than controls but these scores are often not in the 
clinical range. Petersen et al. (1991) in the Minnesota study find that 48% of 
patients had elevated scores on three psychometric screening tests and so sent 
them for psychiatric assessment. They state that in none of these cases could a 
DSM-111 diagnosis explain the patient's illness and depression which, when present, 
was usually determined to be an adjustment disorder (reactive depression) 
precipitated by the typically acute onset of CFS. The mean and standard deviation 
on the Beck Depression Scale was 15.4+8.6, which is in the mildly depressed range. 
3) Depression is known to be high in endocrine, metabolic and nutritional disorders and 
even some neoplast diseases (Ray 1991 (b)). As discussed in section 1, CFS illness 
shows associations with thyroid illness, and thyroid illness symptoms overlap with 
depressive symptoms; these depressive symptoms often resolve with treatment 
(Szabadi, 1991). 
4) The viral illnesses with which CFS has been associated (see viruses section 1.3.4) 
have also been known to cause severe depression (Abbey and Garfinkel 1991). 
3.1.4. Depression in other chronic conditions 
Severe psychiatric and depressive symptoms have been seen in herpes virus but often 
cease with treatment and recovery from the illness (Crow 1978). The diagnosis of 
depression is often withheld where a medical condition is known. Depression is high in 
chronic conditions in general and the general predisposition to illness may well be 
increased by depression. Katon et al. (1991) compare consecutive Rheumatoid Arthritis 
(RA) patients with CFS patients (their criteria are based on Holmes but including 
psychiatric factors). Katon et al. 's (1991) results show 70% of ME patients are depressed 
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but also 41 % in RA (and 32% in diabetes in other studies). Katon et al. also find CFS 
patients to be higher on all psychiatric categories. However, the scores for both sets of 
patients are high and the length of illness varies considerably between groups. Dakof and 
Mendelssohn (1986) quote studies of Parkinson's disease patients showing a 12-52% 
depression rate (most between 30-40%). In three separate studies they comment that 
Parkinson's disease patients are significantly more depressed than patients with other 
diseases and more disabling diseases; they conclude that the depression may be part 
of the illness. 
Ray (1991(a)) suggests that CFS patients may be particularly prone to depression 
because they have severely limited their activity and social contact and because of the 
ambiguity about their illness which has a direct effect on coping (she quotes Shalit 1977 
in support) and the difficulty they have in obtaining recognition for their illness (she 
quotes Gadd 1989 in support). The stage and the status of the illness may have a 
profound effect on depression. CFS patients have to cope with disbelief in the reality of 
their illness, more uncertainties about nature and duration, and more difficulty with 
employers etc. 'There is growing evidence that in chronic illness of all kinds, 
psychological disturbance is generally greatest in the early stages of the illness' Dakof 
and Mendelssohn (1986). Difficulties in adjusting to CFS due to delays and uncertainty 
in the diagnosis of CFS may increase this early depression. 
3.1.5 Differences between CFS and depressed patients 
Differences between CFS and depressed patients have been noted in some papers: 
Smith (1991) considers that differences in results on visual illusion tasks between ME 
patients and controls distinguish them from depressed or functional patients. Prasher et 
al. (1990) state that delayed P 300 evoked potentials found in ME patients are not found 
in depressed patients. Perhaps more pertinently, Taerke et al. (1987) find the 
Dexamethasone Suppression test, which is used to test for depression, not to back up 
the findings that US patients are depressed (Taerke 1981, Ray 1991(a)). 
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3.1.6 Antidepressant treatment in CFS patients 
Treatment of depression in CFS patients, particularly drug treatments, have had mixed 
results: some reports actually say they have harmful results, more that they appear 
ineffective and some psychiatrists claim to be able to help all CFS patients in this way 
(see Shepherd 1992). Early reports of the use of antidepressants, e. g. Parish (1978), 
suggest that they exacerbate ME. Miller et al. (1986) hypothesise that certain tricyclics 
may inhibit cell-mediated immune response. Gantz and Holmes (1989) warn that 
monoamine oxidase (MAO) inhibitors must be administered carefully but cite successful 
studies using MAO inhibitors. Dowsett and Ramsay (1992, p289) claim treatment with 
antidepressants to be ineffectual in those patients who were so treated, about 29% of 
patients treated that way recovered. This is very low when one considers that the 
spontaneous rate of recovery in US patients may be over 20% (As already stated 
Strauss et al. (1988(b)) show a placebo rate in CFS patients in research over some 
months of 41 % and they estimated a minimum 20% spontaneous recovery rate). Lynch 
et al. (1991) outline the use of antidepressants in CFS. Lynch refutes that there are 
systematic observations of problems in antidepressant therapy and advocates lower rates 
of dosage and slower rates of increase in dosage to prevent problems such as increased 
sedation. Lynch reports 67% of 30 CFS patients responded well to antidepressant 
therapy in terms of depressive symptoms. Lynch, however, says improvement is not 
universal and does not necessarily mean an improvement in fatigue and myalgia. 
Wessely (1990(b)) mentions that Kleinman (1992) reports 65% success with tricyclic 
antidepressants given to neurasthenia patients, and Jones and Miller (1983) report a 
70% success rate treating CFS patients with tricyclic antidepressants , but describes 
these reports as 'anecdotal'. This could also be said of the ME Associations study 
(Shepherd 1992) and that reported by Ramsay and Dowsett (1992). Goldenberg et al. 
(1989) show in fibromyalgia good effects with a combination of tricyclic antidepressant 
drugs and Naproxen, an anti-inflammatory drug. This might be effective therefore in 
CFS. 
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Antidepressants have not, however, emerged as a cure for CFS: Shepherd (1992) 
writes, 'Although these drugs clearly have a role in patients with co-existent depression 
a much larger survey of 336 patients found out that overall they were no more effective 
than therapeutic nonsense such as a regimen to eliminate candida'. 
3.1.7 Summing up of 3.1 
CFS patients have a high level of depression score on testing (see para 3.1.1) and some 
studies indicate a high level of pre-illness psychiatric history in the CFS population. 
Depression may be present as part of the syndrome or as cause of the syndrome, or 
both. Ray (1991(a)) says that 'The presence of psychological symptoms does not in 
itself indicate that a disorder has a psychological basis though the existence of 
depressive symptoms implies that the disorder may involve processes which are in some 
way linked to depression'. Even if depression is linked to CFS causally, it is more likely 
that it is part of a complex process including a number of assaults on health by problems 
of environment and lifestyle, rather than that it is a sole factor. 
3.2. Psychiatric Indicators in CFS 
3.2.1 The Hysteria hypothesis 
McEvedy and Beard (11 970(a) and 1970(b)) review the notes of the Royal Free epidemic 
and come to the conclusion that the outbreak was due to mass hysteria; one of the main 
reasons for their conclusion is the glove and stocking anaesthesias found in 15 of the 
severer cases and the lack of objective evidence of physical abnormality. McEvedy and 
Beard's explanation is not accepted by a number of the neurologists involved (Compston 
et al. 1970). McEvedy and Beard (1973) look at 15 other epidemics and suggest that 
8 are also hysteria, 6 observation of normal ill health in the community and one a 
different illness. The reasons for hysterical epidemics they suggest include 1) a rising 
level of anxiety due to polio; 2) a concentration of medical examination on the nervous 
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system, (points (1) and 2) caused altered medical perception); 3) stress caused by 
overwork in an epidemic of polio; 4) doctors being over-anxious to examine symptoms 
in case the patient had polio; 5) a susceptible population i. e. young and female. In a 
later paper McEvedy and Beard (1973) suggest that these females had pre-illness 
personality and psychiatric problems. 
McEvedy (Moss and McEvedy, 1966) had already done research into hysteria 
and had published a paper about hysteria in a girls school. His arguments were widely 
accepted. There are other documented cases of widespread illness amongst a tight knit 
population which appear to be hysterical, for example in 'the June Bug' (Kerchkoff and 
Back 1968). CFS has also been associated with Da Costa or Effort syndrome (Hyde 
1992(a)) which is also thought to be hysterical. 
Compston and colleagues from the Royal Free (Compston et al. 1970) objected to 
McEvedy and Beard's interpretation and point to: laboratory examinations showing 
morphology of lymphocytes in a substantial proportion of the patients and abnormal EEG; 
symptoms such as fever and palsies as well as lymphadenopathy. They also point out 
that this case is considerably weakened by evidence of concurrent sporadic ME in North 
London at the same time. 
Acheson (1959) points out that similarities in the cases in Los Angeles in 1934 and the 
Royal Free in 1955 were unlikely to be due to preconception on the part of medics as 
argued by McEvedy and Beard (1970). Acheson (1959) argues that the Los Angeles 
epidemic was not known about in detail at the Royal Free. More importantly the patients 
were originally thought to be suffering from two different illnesses - in Los Angeles 
infectious mononucleosis, and in the Royal Free poliomyelitis. They were also treated 
by different specialities: orthopaedic surgeons in Los Angeles and general physicians and 
neurologists in the Royal Free. This has been a common pattern in the history of 
ME/CFS that despite changes in the syndrome over time, similarity in cases at first 
attributed to different causes has occurred. 
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3.2.2 Neurasthenia and CFS 
Wessely (1990(a)) maintains that CFS is not a new illness, it is neurasthenia under a 
different name. Neurasthenia is a syndrome with fatigue as a primary symptom 
(Wessely 1990(a), Beard 1869). Beard (1869,1880,1881) described the symptoms of 
neurasthenia in eight categories: general physical exhaustion, mental exhaustion 
including memory and concentration difficulties, muscle spasm and pain, morbid fears, 
insomnia, autonomic nervous system signs, sexual symptoms, and other symptoms 
including gastric, nausea, balance and visual problems. These symptoms are strikingly 
similar to CFS. Neurasthenia was thought originally to have an organic base, and as for 
US a standard treatment was rest. As with CFS it affected mainly the professional 
classes. It was later accepted as psychosomatic/hysteric, possibly due to environmental 
stresses. The Diagnostic and Statistical Manual III of the American Psychiatric 
Association (DSM-111 American Psychiatric Association 1980) classify it under dysthymic 
disorder, a term for a disorder of a psychosomatic nature. 
3.2.3 Psychiatric Tests and CFS 
A more comprehensive exploration of general psychiatric symptoms in CFS has been 
carried out by Blakely et al. (11991). It has the advantage of comparing CFS patients with 
chronic pain (CP) patients. It shows more similarity on the GHQ between CFS (7.9) and 
CP (7.1) than normals (1.9). In the Minnesota study (Petersen et al. 1991) MMPI 
clinically significant abnormal results were found in 84% of CFS patients, 47% of 
Chronic Pain (CP) and 12% of controls. In CFS and Chronic Pain groups high numbers 
of people were assigned to hypochondrias/depression or hypochondrias/hysteria 
categories when rated according to the MMPI. It is suggested that CFS might be a 
subset of chronic pain. CFS patients also scored higher on anxiety, neuroticism and 
emotionality than CP patients, and CFS patients showed a tendency to direct hostility 
inwardly. CFS patients are shown to have higher anxiety levels than CP patients, but 
lower social dysfunction. 
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Stricklin et al. (1990) examine epidemic neurornyasthenia (NM) patients diagnosed by 
public health physicians in America. These NM patients have CFS type illness but are 
categorised under an older diagnosis. Subjects were tested on the MMPI, and NM 
patients score much higher on the MMPI in general. Scores of NM patients show a 
different pattern of performance indicating depression, tension, anxiety, social withdrawal, 
abulia, stress, somatic discomfort, unhappiness, physical fatigue and exhaustion, feelings 
of helplessness, confused thinking and self doubt. As previously noted this study also 
finds a difference on life events but none on the Mehrabian achievement scale for 
females. Stricklin et al. also say that comparison would have been best done with a 
chronically ill group. 
Manu et al. (1988) find that of 135 referrals to a fatigue clinic, 67% have psychiatric 
diagnosis, 3% have medical diagnosis, 5% CFS and 25% no diagnosis. Wessely and 
Powell (discussed in Wessely 1990(b)) study 47 referrals with unexplained fatigue to a 
specialist neurology clinic using the Schedule for Affective Disorders and Schizophrenia. 
Results classify patients as follows: 50% major depression, 2% conversion disorder, 4% 
anxiety disorder, 2% phobia, 6% minor depression, 13% somatisation and 23% had no 
psychiatric diagnosis. In all three studies, one may not be showing CFS patients as 
psychiatric patients but may be showing US sharing symptoms with other fatigue states 
and psychiatric states. These studies may be looking at different patients from US 
patients since strict criteria are not given and a different name is used. Appendix 1 Table 
13 shows a breakdown of psychiatric results in CFS (taken from Buchwald 1992). 
Smith (1991) finds US patients (n=83) score higher than controls on the Middlesex 
Hospital Questionnaire for anxiety, somatic symptoms and depression. 
Summary of 3.2 
CFS patients do not present with a clear personality profile. Psychiatric indicators that 
have been different to controls in CFS studies suggest a tendency to depression, anxiety, 
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hysteria and sornatisation in CFS patients. 
3.3 Psychosomatic indicators in CFS patients. 
Why is the syndrome CFS often regarded as psychosomatic? 
(1) Symptoms of CFS are general, they involve many body systems and are, in most 
cases, unvedfiable (Grafman et al. 1991). 
(2) Disability and invalidity exceed that expected according to their symptoms (Portwood 
1988). 
(3) CFS patients are generally more depressed and anxious than normal controls 
(Taerke et al. 1987). 
(4) CFS patients often appear to live an unnecessarily dependent lifestyle due to (2) 
above (McEvedy and Beard 1970(b)). 
This view is supported today in the following which suggest CFS patients overestimating 
illness. 
Stewart (1990(a); 1990(b)) suggests that CFS patients are often patients who attach 
themselves to the latest fashionable illness. He maintains that this is proved by taking 
a sample of medical records of such patients that have claimed to be suffering from total 
allergy syndrome or PMT or other well publicised modern illness prior to claiming to have 
CFS. This, of course, does not take into account that these illnesses may have similar 
non psychological origins, or that these previous diagnoses might be part of an attempt 
to diagnosis the same syndrome. 
Digon, Goicoechea, and Moraza (1991), Spanish doctors, complain that now CFS is 
receiving publicity in Spain, they expect more people to present themselves as sick with 
CFS because they put their symptoms into this context. Furthermore, the symptoms they 
have will be greater than they would have had because of this belief. 
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Membership of a support group is associated with poor outcome in CFS (Sharpe et al. 
1992); this may be because it is the more severely ill who join or it could be because the 
support group encourages people to believe they will be slow in recovering. 
The problems with taking a psychosomatic view of CFS are: 
1. Historically many illnesses have been viewed as psychosomatic when they are not 
well understood, including Tuberculosis (Ray, 1991; Dakof and Mendelssohn 1986). 
2. There may be a trend to over-psychosomatise illness, particularly in women, at the 
present time (Gouldsmit and Gadd 1991; Brozovic, 1989; Lennane and Lennane, 
1973). There is evidence of a high proportion of psychiatric patients who may be 
suffering from organic rather than psychiatric disorder (Hall et al. 1981; Koranyi, 
1979). 
3. Doctors familiar with patients prior to their illness have reported that the 
psychosomatic diagnosis is inappropriate (e. g. Judge 1970). 
4. Judgements as to (2) and (4) above may be subjective and indicate that the extent 
of the illness is not fully appreciated. Secondary gain in CFS patients is disputed for 
example by Hartnell (1989) and Salit (1985). 
3.4 Stress, life events, locus of control and CFS patients. 
3.4.1 Stress in CFS 
Studies looking at stress in CFS patients show weak relationships between life events 
and CFS. Wood et al. (1991) find 32% of CFS patients have a major stressful life event 
in the six months prior to their illness. Stricklin et al. (1990) find significantly more life 
events in CFS than controls prior to the illness, mainly due to bereavements of close 
relatives. Psychiatric examination of CFS patients reported later suggest that they rated 
high on neuroticism and emotionality (Blakely et al. 1991); they were also depressed and 
anxious. Powell et al. (1990) show that CFS patients tend to attribute their symptoms 
to an external cause while a depressed group tend to attribute them to internal causes: 
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these factors could make them vulnerable to stress. On the whole the area of stress and 
US still needs to be more thoroughly examined. 
The assumption that stress makes one vulnerable to illnesses like CFS is based on 
evidence. Research has indicated a link between immunosuppression and stress. 
Solomen et al. (1979) discuss how experiments on rats and other animals link stress 
produced in the laboratory with t-cell function, neurochernical and hormonal changes and 
further suggest links with tumours in human beings. 
Greene et al. (1978) show a link between the Profile of Mood States (POMS) life change 
units and a decrease in lymphocyte cytotoxicity; they hypothesise that the POMS high 
vigour score leads to denial which is used as an unsuccessful coping mechanism in the 
face of increased stress. Locke and Hurst (1978)'s study shows a correlation between 
high stress, poor coping and a decline in killer cell activity; this'is the type of immune 
dysfunction found in CFS- 
The hypothalmic-pituitary mechanism is thought to be the link between psychological 
processes and Central Nervous System (CNS) changes (Arnason 1991). The pituitary- 
hypothalmic mechanism has been shown to be abnormal in CFS (Demitrack 1991). 
The role of stress is problematic because a lot of people who are heavily stressed do not 
become ill. Kobasa (1979) suggests that over 75% of highly stressed individuals are in 
this category. Kobasa looks into the differences between the stressed ill and the 
stressed not ill and shows locus of control and powerlessness, alienation from self and 
poor positive response to challenge to be very important in increasing the likelihood of 
becoming ill when stressed. The most highly significant differences between those with 
symptoms and those without are related to their perception of stress. In today's society, 
if stress is part of our fast lifestyles, response to stress is probably more important than 
the amount, or severity, of stressful events. 
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It is possible that some of the social groups that seem to be vulnerable to CFS are 
particularly prone to stress: doctors for example. The British Medical Association have 
recently produced a report (British Medical Association 1992) suggesting that doctors are 
prone to stress due to unsocial hours, high responsibility and traumatic incidents. Stress 
has been widely suggested as a cause of CFS. 
The evidence for stress as a factor in CFS is highly circumstantial. The stress argument 
in CFS is based on assumptions that CFS is the type of illness that can be produced by 
known results of stress. It is also based on the assumption that groups vulnerable to 
CFS have higher than normal stress put upon them. 
3.4.2 Locus of control and learned helplessness 
Skevington (1983) shows that patients with chronic pain tend to have a belief in lack of 
internal control which Skevington attributes to learned helplessness. Skevington also 
suggests that the patient comes to believe no one can help. Langer (1983) argues that 
there is a direct relationship between extent of coping behaviour and degree of belief in 
control. Rodin and Langer (1980) looking at chronic illness say that when people are 
experiencing a traumatic event they typically perceive it as time to give up what control 
they have and their locus of control changes. Persistent pain or illness without power to 
relieve it could lead one to believe one is not in control of that side of one's life. It may 
be that CFS patients have a vulnerability to illness because of the direction of their 
beliefs about control in their lives. Alternatively, or in addition, they may come to a state 
of learned helplessness or more beliefs about externality of control in their lives due to 
the illness. In this study locus of control is measured to see if CFS patients show signs 
of high externality of control. 
-55- 
3.5 Neurology of CFS 
3.5.1 Neurological abnormalities 
Evoked potential abnormalities in CFS patients 
Prasher, Smith and Findlay (1990) examined cognitive event potentials in ME. They use 
criteria of fatigue, myalgia, poor concentration and memory with preceding viral illness 
over 6 months before testing (these criteria exclude non-post-viral patients). They find 
that in ME patients the event potential P3 is absent or significantly delayed in 52% of 
patients. The amplitude of P3 provides an indication of attentional capacity devoted to 
the task and its latency provides a measure of the speed of target detection. They 
conclude that the results suggest two subgroups, one with attentional deficits and the 
other with slower speed of information processing. They find this result consistent with 
complaints of memory and concentration but not with depression, since P3 latency, they 
state, is not found in depressed patients. 
Sleep abnormalities in US patients 
Whelton, Salit, and Moldofsky (1992) show, with a small number of CFS patients, a high 
incidence of sleep apnoea and more alpha EEG activity during NREM sleep. They also 
point to the similarities in patients with cancer, where interleukin2 and lymphocyte 
activated killer cells produce sleep disturbance. 
Abnormality in CFS patients of pituitary/hypothalamic function. 
Dernitrack (Demitrack 1991) tests 40 CFS patients (according to CDC criteria) and 
shows that, compared to controls, CFS have a significant reduction in basal total cortisol. 
This study uses recognised criteria and suitable controls for comparison. He 
hypothesises that this and other abnormalities related to the pituitary/adrenal axis 
suggest a mild hypocortisolism as a result of a defect in the hypothalamus. 
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Vision 
Potazanich and Kozol (1992) show high symptom reporting of ocular problems with little 
objective evidence. 
EEG abnormalities in CFS patients. 
Pampiglione (1978) examines EEG's in 46 patients with a symptomatology of ME and 
find abnormalities - excess of intermediate slow activity in particular areas (no controls 
were used). 
SPECT Scans and decreased blood flow in CFS patients 
Mena (Mena and Villanueva-Meyer 1992) uses SPECT scans to examine blood flow to 
the brain and discovers areas of decreased blood flow particularly in the temporal lobes. 
She considers the decrease significant but not irreversible. These kind of blood flow 
changes are also found in migraine and depressed patients (Dolan et al. 1991), as well 
as subcortical diseases such as Parkinson's disease and Huntingdon's disease (Abbey 
and Garfinkel 1991; Cunnings 1992), so again the significance of such findings in CFS 
patients is not known. Mena and Villanueva-Meyer (1992) find 71% of CFS patients 
scans show unilateral or bilateral hypofusion in the temporal lobes. Individual scans 
(Hyde, Biddle and McNamara 1992 and Bastien 1992) show the areas most affected are 
sub-cortical, left parietal lobe, right medial lobe of the cerebellum and temporal lobe. 
SPECT scans show decreased brain perfusion up to 24 hours after exercise or sleep 
deprivation in US patients. Goldstein (1992) comments on the results of Mena's work 
and concludes that US patients have a lower metabolic rate in the hippocampus and 
amygdala, as well as the caudate nucleus, the premotor cortex and the anterior 
cerebellum. Early reports of similar results from the Middlesex Hospital, London 
conducted by Honorary Consultant Physician Dr Durval Costa (Macintyre 1992) with 500 
patients suggests that these results are found in a large percentage of CFS patients and 
therefore may prove an important finding in CFS. 
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MRI scans on US patients 
Biddle (Hyde, Biddle and McNamara 1992) reports on MRI scans in California. Two 
groups, 142 CFS and controls, were scanned. In 79% of CFS patients areas of 
increased signal intensity occurred; which was significantly different from controls (only 
21% of which showed abnormality). Biddle (Hyde, Biddle and McNamara 1992) 
suggests these unidentified bright objects (UBOs, as they are now known) are 
perivascular spaces caused by lymphocytes congregating in the perivascular spaces of 
the brain causing more frequent occurrence of the spaces in CFS patients. 
McNamara (1992) examining patients from the Lake Tao area observes that UBO's are 
most often found in the white matter, subcortical, frontal and parietal areas of the brain. 
McNamara finds 36 out of 60 patients abnormal on MRI and he suggests that the UBO's 
represent focal oedema probably in the perivascular (Virchow-Robin) spaces. The 
meaning and importance of this finding is not clear, indeed it may be that this finding is 
not very abnormal. 
3.5.2 Theories of neurological abnormality in CFS patients 
The limbic system and the hypothalamus 
Goldstein (1992) discusses the possible role of the limbic system in CFS. The limbic 
system has an important role in the regulating of the autonomic nervous system. The 
hypothalamus co-ordinates electrolyte balance, basal temperature, metabolic rate, 
autonomic tone, sexual libido, circadian rhythms and immunoregulation. From evidence 
in temporal lobe epilepsy he suggests that there is evidence of a fatigue receptor in the 
medial temporal lobe that could be affected in CFS and that vertigo, often a feature of 
CFS, can be produced by stimulation of the temporal lobe. The limbic and paralimbic 
areas have higher levels of endogenous opioid activity and receptor activation in the 
hippocampus could account for weight gain and intolerance of alcohol. 
-58- 
Goldstein says that lesions in the paralimbic structures produce less profound memory 
and leaming impairment and they are less involved in the channelling of drive and affect 
than in the limbic system itself. Goldstein relates problems in the limbic system to 
immunisations and/or altered neuronal or monoamine metabolism. He hypothesises that 
CFS is a limbic encephalopathy in the dysregulated neuroimmune network. Amason 
(1991) also points out that the pituitary can affect the immune system. 
Smith (1991) concludes that the kind of difficulties he finds - slowed reaction time, 
problems with visual illusion and Stroop effects - might be indicative of problems in the 
hypothalmus produced by viral effects on the immune system. 
3.5.3 Abnormality of Arousal in CFS patients. 
Grafman et al. (1991) write that fatigue can be 'viewed as a result of decreased arousal'. 
In CFS both decreased and increased physical arousal may occur. The possibility that 
CFS patients may be physiologically aroused inappropriately is supported by the 
presence of symptoms related to inappropriate overarousal to physical stimuli. CFS 
patients show hypersensitivity to light and sound and temperature. They sweat profusely 
at times, they "go white" and produce a heightened blush type response. They also 
complain of symptoms that relate to sleep problems such as vivid coloured dreams. It 
is possible that fatigue could be related to underarousal in the day and overarousal at 
night, whether depression and anxiety would be caused by over and under arousal or 
cause such disturbance, require careful consideration. The physiology of arousal is 
complex: damage in a number of areas or neurotransmitter abnormalities could cause 
such problems. 
3.5.4 Claims of extensive neurological disturbance 
Observations of general neurology problems in CFS have been very varied and 
comprehensive. The following lists are made from two recent reports (items in the lists 
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which are supported from other papers are marked with a *). Richardson (1992) reports 
the following symptoms in CFS without quoting evidence: bladder dysfunction 
misdiagnosed as cystitis or urinary tract infection in CFS, may be due to hypothalamic 
disorder, akinetic lapses, patients are aware of surroundings but are unable to respond 
or move; seizure activity; absence spells are often noticed by the family; grand mal or 
Jacksonian type seizures do occur but are likely to remit; Cogwheel rigidity; modified 
Romberg Abnormality% failure to focus due to jitter like movement in the eye nystagmus*; 
pain behind the ear, with high sounds, which may be of hypothalamic origin; facial pallor; 
abnormal amounts of thyroid antibodies. 
Hyde and Jain (1992(b)) report in a review paper: anterior horn cell injury-injury in the 
spinal cord; central endocrine system - fluid balance, thyroid balance*, temperature 
regulation and sexual dysfunction; natural killer cell dysfunction*; blood pressure 
regulation dysfunction; acquired cognitive dysfunctions, drop in IQ level dysfunction in 
simultaneous processing, distraction, not able to concentrate, dysphasia, reading 
problems*, visual comprehension and discrimination dysfunction, facial agnosia, 
discalculia, abstract reasoning dysfunction, volition dysfunction, proprioceptive 
dysfunction; sleep abnormalities* and colour dreams; sleep apnoea and hypothermia; 
sensory dysfunction; apraxia; auditory dysfunction; photophobia*; latency of 
accommodation*; failure of the eyes to track together, tunnel vision, night vision loss, 
colour vision loss, palpebral oedema; writing problems, distance and facial dysfunction, 
jaywalking, depth of field dysfunction. 
The reason for reporting these two papers is to indicate the range of neurological type 
symptoms that have been said to exist in CFS but for which supporting evidence is not 
necessarily given. The investigation of these supposed features of CFS has occurred in 
those that have a star* and are discussed throughout this and the following sections. 
Parish (1 978(a)) mentions some of the symptoms such as photophobia, in writing about 
the Royal Free. Ramsay (1981) writes about dysphasic misfinding of words and colour 
dreams. Many of these symptoms could relate to hypothalamic dysfunction. However, 
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if most patients exhibited a number of these neurological symptoms over a long period 
one would expect more evidence of these symptoms would exist. These severe 
neurological-type symptoms are not evident in all CFS patients. It is likely that they are 
particular to certain groups of patients, e. g. Bastien's patients in Nevada or the patients 
in the Royal Free 1955 epidemic. 
3.6 Memory and Psychomotor Testing 
3.6.1. Cognitive Problems in CFSIME 
CFS from the neuropsychological viewpoint raises a number of issues. Patients' 
complaints include: depression, anxiety, memory loss, loss of concentration, word finding 
and particularly naming difficulties, and others (these appear as symptoms in the 
literature, Archer 1987). Physicians report neurological symptoms (Parish 1978(a)) which 
for a few patients are similar to, and as severe as, those found in encephalitis. Peterson, 
Schenck and Sherman (1991) show a large percentage of subjects with 
neuropsychological complaints, from mild to severe, from a more recent outbreak (see 
Appendix 1 Table 11). Parish (1 978(a)) reports 60% mentioning neurological findings 
with 20% showing objective findings in the Dalston epidemic; but suggests that for the 
Royal Free epidemic, 50% had neurological symptoms. Crowley, Nelson and Stovin 
(1957) show a third of patients with moderate or severe objective neurological signs (see 
Appendix 1 Table 7). On the other hand, in most cases patients' objective difficulties do 
not seem to match patients' reports (as mentioned previously), and where patients have 
been tested individually for memory problems etc. recognisable deficits have not often 
been recorded (Parish 1978(a)). 
3.6.2 Recent findings testing memory and psychornotor skills in US 
Studies on memory and cognition in US are of recent origin and are still scarce. Smith 
(Smith 1991) compares cognition in CFS patients with the effects on cognition of the 
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early stage of a cold or injected interferon. Smith's study is done with volunteers chosen 
by their symptoms and a positive VP1 result, obtained through the ME Association, but 
Smith does not give details. This group, no doubt, allows him a large body of patients 
but may be rather unsatisfactory in terms of being representative of the whole CFS 
population and the criteria for diagnosis that are being used are not clear. Smith finds 
differences with controls on reaction time, Stroop and visual illusion (Smith 1991). Smith 
records a pattern of deficit in reaction time with US patients who he classes as severely 
ill according to level of EBV antibodies and positive VP1. Severely ill CFS patients 
scored an average of 409 milliseconds (number--18), mildly ill CFS patients 355 
milliseconds and Normals 253 milliseconds (number--9) on a single choice reaction-time 
task. The difference between severely ill and mildly ill US patients in Smith's study 
might also be seen with the same patients at different testings in a longitudinal study. 
Smith reports that CFS patients are more susceptible to visual illusion and they are 
slower and less accurate on visual search tasks. Smith shows a difference in US 
patients' memory in the primacy effect on verbal learning. US patients score well on 
this test by giving a high number of false alarms which Smith claims to be indicative of 
possible mamilliary body damage. On Stroop CFS are slower in the colour naming 
condition. Smith puts this down to them being more distracted by alternative stimuli. 
Smith's results show strong reaction time differences and problems with visual effects, 
and may indicate possible slight memory problems. He claims that these are results you 
would not expect with depressed patients; however his US subjects scored much higher 
on depression, anxiety and somatic symptoms on the Middlesex Health Questionnaire 
(MHQ). He suggests that longitudinal studies would be valuable to show whether CFS 
patients improve with recovery. 
Kilfedder (1988) found a mismatch between reporting of, and objective testing of, 
cognitive symptoms, but increased ataxia, slower reaction time and increased anxiety 
and depression in CFS patients. The subject numbers are small partly because the CFS 
group was divided into those with or without coxsackie titres but it is reported that CFS 
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patients do less well against normals on Rey Figure immediate recall. 
Bastien (1992) examines 81 patients from the Nevada, Incline Village epidemic; they 
meet the CDC criteria for CFS. Bastien finds significant impairments on a number of 
tests. The term impairment implies below normal functioning, i. e. below norms for the 
particular tests; Bastien states that she is using Halstead-Reitan cut off to judge 
impairment cut off levels; control data are not used. Bastien reports deficits on Wechsler 
Memory Verbal Recall for 85% of CFS subjects, for 80% on Delayed Verbal Recall and 
54% for the category part of the FAS word fluency test. Bastien also find impairment in 
finger tapping with the dominant hand, and tactual performance with both hands. Most 
spectacular of all are her pictures showing gross immaturity in the Draw-a-Person Test 
drawn by CFS patients. This test can be used to show emotional indicators but in this 
case she suggests it is more valid as an organic indicator. Literature surveys of this area 
show no confirmatory evidence of this rather unusual finding. 
Bastien seems to have found a much more impaired group than previous evidence 
suggests. This suggests Bastien's patients may be different from the CFS population in 
general or Bastien's criteria for deficit are less rigorous; it is a pity that Bastien does not 
use control data to show that her patients are impaired in relation to a normal group. 
From Bastien's results she suggests that there are abnormalities in the brain functioning 
in the left temporal lobe (WMS deficits) and parietal lobe (Tactual performance) and left 
frontal lobe motor strip (Finger Tapping). She suggests that the impairment shows a 
multi focal organic brain syndrome and that the most impaired areas are left temporal, 
right parietal and left frontal lobes. 
Lane (1992) reports results from routine examination of a CFS patient group. It is not 
clear by which criteria this group are diagnosed, although he gives a very general 
description: fatigue, malaise, weakness, myalgia, exercise problem and other symptoms 
as a description at the beginning of the paper. He finds no significant decline from 
general estimated pre-morbid IQ capacities. Lane finds 20% of US patients performed 
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badly on visual and verbal memory. But he finds a considerable proportion (50%) who 
had a discrepancy between verbal and visual memory tasks (verbal memory being 
worse), on a forced word versus a forced faces test. 
No controls are used in Lane's (1992) study. He finds surprisingly few of the CFS 
patients to be depressed on Beck's scale. Lane does not take the view that these 
cognitive differences coupled with the neurological abnormalities he finds were 
necessarily due to CFS damage, but suggests that they resemble the symptoms of 
hyperventilation. 
3.6.3 Negative findings of poor cognitive performance in CFS patients 
In Altay et al. 's (1990) study there are 21 patients, using defining criteria of 
fatigue/weakness, a post infectious episode, and an absence of laboratory findings; they 
have an average age of 36 and education mean of 16.5 years. Tests are WAIS R 
Similarities, Trails B Similarities, Digit Symbol and Vocabulary Abstraction. The CFS 
subjects all perform significantly better than controls although 20 out of 21 of subjects felt 
that they were performing poorly. 
The main problem of Altay et al. 's study is that they do not control for IQ; Altay states 
that his post infectious neuromyasthenia patients have higher educational and 
achievement levels than controls. Altay also does not state how ill patients were during 
the study. It would have been an advantage to know how they would test against 
themselves when well. Patients' perceptions of not performing well are attributed by 
Altay et al. (1990) to psychological problems; it may however relate to effort and speed, 
not quality of performance. The person may be performing adequately but below his/her 
is normal. 
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3.6.4 Summary 
The evidence of cognitive deficits so far suggests reaction time slowing in performance 
and verbal and visual memory problems. However, considerable difference of opinion 
remains about whether CFS patients do have memory and psychomotor problems. This 
is because differences between groups in research in the area have not been found in 
some studies, or have only been very small, or they have been studies where CFS is 
poorly defined or a control group has not been used. 
4. Summary of the literature and conclusions for design of further research 
4.1 Summary of symptoms in diagram form 
Symptomatology of CFS and Etiology 
As indicated in the literature survey, the symptoms of CFS patients can be differently 
attributed to an organic or psychological model. Figures 2 and 3 following, show 
diagrams mapping possible symptom causes; they sum up the more important causes 
of symptoms according to the two opposing models. Arrows pointing into the 
"Symptoms" box indicate that these influences cause or exacerbate CFS symptoms. 
Arrows pointing both ways suggest positive feedback loops; for example, depression 
causes symptoms (e. g. psychomotor slowing), and the symptoms of CFS cause 
depression to increase. Some pathways to the symptoms are thus also indicated, for 
example the subject's type of work causing stress, stress causing normal fatigue and the 
fatigue developing into symptoms. These diagrams show how each model could work 
according to either perspective; these diagrams have many possible elaborations, 
however what is important is to see that both theoretical points of view can account for 
CFS symptoms. One of the problems with models of CFS is that the possible 
relationships between symptoms are so numerous. Figure 2 for example has so many 
possible variations that one can end up with a model so complicated and convoluted as 
to be of no value. 
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4.2 Summary of points made in the literature survey 
Part one of the literature survey. 
1. The prevalence of CFS in the population is high. 
2. The symptoms of CFS are of a common nature. 
3. Many studies of abnormality in CFS have used small groups and lacked control 
groups, although some evidence suggest organic damage in CFS. 
4. Clear criteria for CFS diagnosis is necessary; however, many studies of CFS have 
lacked a proper definition of CFS. 
5. Vulnerability to CFS is associated with demographic and geographic variables. 
6. CFS patients recover from CFS spontaneously, in most cases. 
Part two of the literature survey. 
1. There are two main parts of the literature; early epidemic ME and later sporadic 
CFS. 
2. There is disagreement as to whether these two parts of the literature are about the 
same illness. 
Part three of the literature survey. 
1. Complaints about cognition in CFS have not been matched by corresponding 
deficits. 
2. Depression scores are high in CFS patients. 
3. There are great difficulties in assessing whether depression in CFS is due to illness 
or illness is caused by depression. 
4. Other psychiatric differences in CFS patients may include hysteria, somatisation, 
high anxiety and high psychiatric history prior to illness. 
5. Results from tests on memory suggest that there may be a problem with visual and 
verbal memory. 
6. Results from tests of psychomotor skills suggests CFS patients are slower on 
reaction time tasks. 
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7. CFS patients have also been reported by single studies to be susceptible to visual 
illusion and to have problems drawing people. 
8. Bastien's study suggests CFS patients' IQ level is reduced. 
9. Tests of cognition with controls have been rare. 
10. Studies of cognition and psychornotor skills are inconsistent, some studies showing 
CFS patients as better on tests than controls. 
Neurological studies suggest: 
11. that CFS patients may have a problem with hypothalamic - pituitary function; 
12. that US patients may have decreased blood flow to some areas of the brain; 
13. that CFS patients have delayed P. 3 evoked potentials; 
14. that CFS patients may have sleep abnormalities. 
4.3 Further research needs in the neuropsychology of CFS. 
The literature survey shows the need for studies where US is clearly defined and 
suitable controls are used. In the area of neuropsychology the research is patchy. A 
number of studies have proved that CFS populations have high depression levels but 
research is still needed to confirm the existence and extent of other neuro psych olog ica I 
problems in CFS patients. Research into the neuropsychology of CFS has had 
methodological and definition problems. The literature also indicates the need to take into 
account the following: 
1. recovery in CFS; 
2. depression in CFS; 
3. possible IQ changes in CFS. 
In addition the literature shows that one needs to design the study with controls; 
preferably a normal group and a chronically ill or depressed group. 
The following study, therefore, was designed to cover all the points in 1-3 above. 
Subjects were US patients, Crohns/colitis patients and normal controls. The groups 
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were to be matched on the NART (very stable IQ test), by Age and by Sex. The groups 
were to be seen 4-6 monthly and tested on a neuropsychological test battery. This 
battery was to include those areas indicated as being most likely to be affected by US 
i. e. memory both verbal and visual, drawing and spatial memory, reaction time, speech 
and word fluency and other tests to cover common areas of neuropsychological difficulty. 
The studies mentioned in the neuropsychological section were not all available when the 
study was designed, so evidence for decline in IQ, and most of the evidence of poor 
I cognitive performance, were not available at that time. Nevertheless from the evidence 
of patient complaints and other information in the literature these were taken into 
account. 
4.4 Confirmation in later literature of the correctness of the design of the proposed 
study. 
After the study was designed in December 1988, a number of articles came out that 
recommended that similar design and methodology in future studies to that we had used. 
Grafman (Grafman, Johnson and Scheffers 1991) remarks that a number of reports in 
US show a mild drop in performance, but that none include a formal neuropsychological 
evaluation of patients with controls. Since then Smith (1991) neu ro psych olog ical 
assessment has been published (in 1988 Kilfedder's thesis had become available for 
study, although unpublished), but Grafman's remark again shows that this study 
anticipated an area where the lack of information was already being noted. 
Stricklin (1991) regrets not using chronic controls in his study in 1991 although chronic 
controls had only just begun to be used at that time-, Wessely (1989) uses patients with 
muscular illness and Katon et al. 's Rheumatoid arthritis patients in 1991 (an M. Sc. 
student at Glasgow also chose Crohns patients for a comparison of mood and CFS 
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during our study). Sharpe et al. (1991) advocates multiple control groups to compare 
with CFS in order to avoid 'pitfalls' created by sole use of normal controls. This study is 
rare in having used two control groups. 
In doing a longitudinal study this work forestalls Sharpe et al. (1991) who suggests that 
longitudinal studies should be used in CFS to establish temporal sequence. Wessely 
goes further: "perhaps the most valuable, albeit scarce [data] (on both the risk factors 
and prognosis of CFS), comes from longitudinal studies of the outcome of defined 
infections" (Wessely 1992). 
In 1991, after our study was started, Becker (1991) brought out a paper on investigating 
CFS. He produces a similar test battery for looking at IQ, memory (verbal and visual 
recognition and recall), attention (including reaction time and visual attention), Word 
fluency, and depression, anxiety and fatigue. This again is a vindication of the method 
and tests used in the study reported in this thesis. 
Apart from these specific verifications, that show this study was methodologically wise 
and necessary, other aspects of this study now seem more justified rather than less 
justified. When work was started on this research the central importance of 'depression' 
was not so evident. Taerke's (Taerke et al. 1987) work had been published but Katon 
et al. (1991), Kruesi et al. (1989) and Wessely (1 990(b)) had not. There is now no doubt 
that one has to consider depression in any study of cognition in CFS patients, but at the 
time of the study the evidence was less strong. Because depression has been looked 
at in the study this work is much more valuable than it would otherwise have been. 
At this stage, too, work to pin down diagnosis and to define the criteria used had just 
begun; if the research had been done later Sharpe's criteria might have been used 
(Sharpe et al. 1991) but at the time it wasn't available. In basing the criteria of the 
research on Holmes the study utilised the now most widely adopted criteria, even though 
it was to be simplified for use at Rucchill hospital. 
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The CES-D scale has also become quite popular (e. g. Hurwicz and Berkanovic 1993, 
Neugebauer et al. 1992) though it was less widely used prior to 1988, except for 
epidemiological studies. 
In short, this study's design fitted a gap both methodologically and in knowledge which 
became evident in the literature published during its execution. 
4.5 Alms of proposed study 
Previous studies of psychological aspects in CFS have tended to concentrate on the 
affective aspects of the illness (e. g. Taerke et al. 1987; David et al. 1988). CFS patients 
complain of many neuropsychological problems, by far the most common being 
difficulties with memory, concentration and word fluency (Archer 1987). Other neuro- 
psychological complaints include difficulties with speech, photophobia, loss of sensation 
in parts of the body, mood and personality changes. Appendix 1 Table 11 shows the 
percentage of patients with each kind of difficulty in a study by Petersen et al. (1991). 
While those with acute encephalitic symptoms - i. e. a combination of more severe 
symptoms such as stiff neck, photophobia, delirium, severe headache or noticeable 
difficulties with movement or speech - should have had some kind of neuropsychological 
assessment, those with milder symptoms may not have been tested, or not in such a 
way as to pick up a small decrement in performance. This study is a formal assessment 
with controls (two groups); it also looks at changing performance over time on 
neuropsychological tests relevant to problems recorded in CFS. 
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CHAPTER 3. METHOD 
I Alms 
1.1 Introduction 
This study was of CFS patients compared with a chronically ill group of patients and 
normal controls. It examined changing cognitive performance and psychological profile 
during the illness. 
1.2 Objectives 
The objectives of the project were: - 
1) to test neuropsychological performance in CFS patients to assess whether their 
performance is worse on some tasks than controls; 
2) to monitor neuropsychological performance in CFS patients, while they are recovering 
from CFS, and compare them to controls over a similar period; the aim is to see if 
CFS patients improve on neuropsychological performance more than controls; 
3) to compare depression and anxiety levels in CFS patients with another chronic patient 
group and normal controls: to assess whether differences in performance can be 
accounted for by anxiety or depression; 
4) to compare CFS, chronic patients and normal subjects on psychological, 
demographic, health and activity variables. 
1.3 Null hypotheses 
In order to test these aims a number of null hypotheses were used 
1. Average performance of CFS patients, chronic controls and normal controls on items 
from a neuro psych olog ical test battery are the same. 
2. CFS patients show the same improvement as controls on items of the test battery 
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when it is repeated. 
3. Average scores of CFS patients, chronic controls and normal controls on depression 
or anxiety questionnaires are the same. 
4. Average performance of CFS patients is the same as that of normal controls on items 
from a neuropsychological test battery after adjusting for differences in depression 
score. 
5. US patients do not differ significantly from controls on number of major life events 
or locus of control questionnaires. 
6. CFS patients do not differ significantly from controls on demographic, health or activity 
data. 
The use of tests to make multiple comparisons of means (as in 1. and 3. ) is discussed 
further in Section 9.1. 
2. Subjects 
Three groups of subjects were used. The CFS patient group, which were the 
experimental group, and two control groups. The first control group was taken from the 
normal population. The second control group was used to control for the effects of 
chronic illness, particularly depression. Both control groups were matched to the CFS 
group for IQ and age. 
2.1 CFS subjects 
CFS subjects were 45 patients diagnosed as having Chronic Fatigue Syndrome and not 
excluded from the study by criteria shown in Table 2. Two other patients filled in general 
questionnaires but were not available to carry out the cognitive tests. 
The criteria for selection of CFS patients were developed by Dr 1. W. Pinkerton 
(Consultant Physician and Head of the Department of Infectious Diseases, Ruchill 
Hospital Glasgow) and the experimenter and agreed by all consultants referring patients. 
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Table 2: Chronic Fatigue Syndrome: diagnostic criteria 
The diagnosis of Chronic Fatigue Syndrome is based on clinical judgement and 
depends on the following criteria: - 
Maior Criteria (All cases) 
1) Persistent but fluctuating fatigue over a period of 3 months - with or 
without initial febrile illness. 
2) Muscle fatiguability (without demonstrable weakness on clinical 
examination) -with or without muscle pain. 
These otherwise unexplained on full clinical examination and in the absence of 
clinical or laboratory evidence of other disease processes as specified below*. 
Minor Criteria 
It is expected, but not a requirement, that the patient will have several of the 
following: 
1) Muscle pain. 
2) Perception of impaired concentration, particularly on reading. 
3) Sensitivity to light. 
4) Dizziness. 
5) Slightly enlarged lymph nodes. 
6) Difficulty getting to sleep. 
* Patients should be afebrile and have a normal blood count and differential, a 
normal ESR, no significant weight loss and a normal chest X-ray. 
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The criteria were based on Holmes et al. (1988) and on early reports of the comments 
by Ho Yen (1991). The study commenced in early 1989 and, therefore, other criteria 
were not available for study. The six month period after initial illness used by Holmes et 
al. (1988) was reduced to 3 months because the patients were to be studied 
longitudinally. In this way patients with a short history could be studied from the more 
severe phases of their illness and any patients who were no longer ill at six months could 
be regarded as not having CFS and could be dropped from the study (most patients 
came to the study with a longer history and none were ill for less than six months before 
recovering). Patients were not excluded because of depression from the diagnosis of 
CFS. However, patients with previous psychiatric history or on antidepressants were not 
included in the study. This was for two main reasons: 1) they might be expected to 
perform poorly on the tests because of their mental state or medications and 2) it might 
be that those with prior psychiatric illness form a different category (Holmes 1990). The 
CFS subjects were nearly all patients attending Ruchill Hospital. Most of the patients 
were newly diagnosed as having CFS. 
Patients who fitted the diagnostic criteria were asked whether they were willing to take 
part by a consultant general physician in infectious diseases or by letter from the author. 
These patients were told by the consultant or experimenter and by the letter, that the 
study in which they were being asked to take part was looking at memory and 
concentration in US patients. Most patients expressed interest according to the 
ancedotal report but the consultant did not keep a written record of the response rate; 
all those who were sent to the author except two agreed to take part. This was a 
methodological weakness; it was requested that the information be kept, but the reporting 
was outside the authors control, and did not occur. If the patient expressed interest, the 
initial information was sent or given to the patient by the experimenter. This initial 
information consisted of a pro-forma letter informing the patient what the research was 
for and what would happen at the research session; it was sent together with a standard 
consent form (both shown in Appendix 2 Item 2a). 
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Three subjects were diagnosed as having CFS at other hospitals and requested to take 
part after a radio programme. They were tested at Ruchill Hospital or Stirling University. 
Patients were not tested until at least 6 weeks after the initial onset of the illness 
according to their clinical history. 
2.2 Control groups: normal subjects 
The normal control group consisted of 41 normal controls taken from the St Andrews 
Ambulance Service. 
The choice of control group was arrived at by considering several factors. The control 
group would need above average IQ (because CFS patients are typically generally 
higher than average IQ), be predominantly in the age group 18 to 50, and include both 
sexes. It was preferable not to use medical staff because they would be knowledgeable 
about illness and would have beliefs and expectations influenced by their work. 
St Andrews Ambulance volunteers offered a large pool of potential volunteers. They 
might be expected to have above average IQ (because they had to do an examination 
for the course it was expected they would self select themselves as higher than average 
IQ). They were also interested in medicine and were already volunteers so it was thought 
likely that they would co-operate. A disadvantage was that being volunteers might mean 
they were slightly atypical of the general population. However, since the US patients 
also seemed to be people who were very active, enthusiastic and involved in lots of 
activities before their illness, this made the two groups more alike and therefore 
increased the likelihood of endorsing the null hypotheses. Both the pre-morbid CFS 
group and the normal controls seemed more athletic than the general population. 
Normal subjects were volunteers from public classes run by the St Andrews Ambulance 
Brigade. The President of St Andrews Ambulance (Dr Pinkerton) and the experimenter 
spoke to the class explaining the study and they were given an explanation sheet 
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(Appendix 2 Item 2b) and an appointment at a time convenient to them. The President 
explained that CFS/ME was a mysterious disease which had particularly affected 
Scotland and that the study was to test memory and concentration problems in Chronic 
Fatigue Syndrome patients with which their results would be compared. The normal 
controls were required, after studying the explanatory sheet, to fill in a consent form at 
time of testing. They were seen normally in the evening after work so they were expected 
to be more tired than if seen in the day. They were (except for two members of this 
group) seen at St Andrews Ambulance Headquarters in Glasgow. 
2.3 Control groups: Crohns/colitis patients 
This group was chosen for similarity to the CFS group, as follows. It consisted of 28 
Crohns or colitis patients. The choice of a medical group which was similar both in terms 
of length of illness, chronicity and disability was made on advice from consultant 
physician and head of the Infectious Diseases Department, Dr Pinkerton. Two groups 
were considered: a rheumatoid arthritis group and a group with chronic bowel disorder. 
The rheumatoid group were rejected on the grounds that they were too different in age 
composition, the disease had more disability and it was more progressive. 
Of the bowel disorder group, it was decided that Irritable Bowel Syndrome patients 
should not be included because of the lack of objective diagnostic tests and its high 
association with psychological factors. It was decided to use patients from the bowel 
disorder group who had objective signs of bowel disease and two groups were included: 
those with Crohns disease and those with colitis (chronic inflammatory bowel disease). 
Approximately 1/3 to 2/3 Crohns to colitis were seen, but they are not very discrete 
groups in that diagnosis may be switched from colitis to Crohns; illness is normally more 
severe in Crohns disease. One main difference in the two is that inflammation in the 
bowel is generally more widespread in Crohns and harder to cure. The advantage of 
having this combination of Crohns/colitis therefore was that it was similar to the makeup 
of the CFS group, which comprised of about a third of patients who had been patients 
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longer and been more severely affected by CFS than the rest of the group. 
Patients in this group all came from Consultants in Gastroenterology from Stobhill 
Hospital. All but four were seen by the Senior Consultant and then by the author at the 
Consultant's outpatient clinic, the others were contacted by post or while they were in- 
patients. The consultant told his patients that the study being carded out was looking at 
memory and concentration in US and bowel disorder patients; they were given the 
explanation sheet shown in Appendix 2 Item 2c. 
2.4 Exclusion criteria and non-selection of subjects 
Patients are generally not considered suitable for testing on cognitive data (Gillham et 
al. 1988; Dikmen et al. 1986; Wilson et al. 1988; Wechsler 1955; Wittenborn 1990; Lezak 
1983) if 
- they were currently taking tranquilisers or anticonvulsants; 
- they had a history of psychiatric disorder, 
- they had received hospital treatment for head injury; 
- they had a history of drug or alcohol abuse; 
- they were under 16 or over 60. 
Subjects who had one or more of these were excluded from the main study (cognitive 
testing and CES-D and State Trait anxiety tests), although questionnaire data was 
collected from them. Subjects who came into these categories during testing were 
excluded from the point at which they came into the excluded category, e. g. started 
taking tranquilisers or antidepressants. 
Exclusion criteria in detail 
1. Patients were excluded if they were currently (i. e. taken within the last two weeks) on 
sedatives, tricyclics or other antidepressant. They were excluded if they were taking 
anticonvulsants, i. e. Sodium Valporate, Carbamazepine, Phenytoin, or any other of this 
type of drugs or combination of them. 
2. If the subject had had treatment from a psychiatrist as recorded in their notes and 
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checked with the patient (this would not include a referral where no treatment was 
thought appropriate), or if they had been on long term (i. e. over a year) antidepressants 
or tranquilisers for psychiatric symptoms, they were considered to have a psychiatric 
history (only one person came in the second category, and he was taking a cocktail of 
antidepressants and tranquilisers, and had done so over a number of years, without 
psychiatric referral). The exception to this was if these drugs were given for CFS or just 
prior to a diagnosis of CFS, because in that case they might be indicative only of CFS 
symptomatology. 
3. Head Injury. Subjects were excluded if they had been hospitalised over-night for head 
injury. A superficial wound was not included but substantial head injury, e. g. a fractured 
skull, counted, however long since it took place. It was recognised that some hospitals 
keep people in for observation more readily than others, but it was considered that it is 
unusual to do so unless potential damage is expected. 
4. Drug and alcohol abuse. Patients were excluded if they had received treatment for 
addiction to drugs or alcohol, or these were recorded as a problem in their medical notes, 
or if they admitted to a serious problem with alcohol or to taking drugs on a regular basis 
or recently. Scores were taken of alcohol consumption disclosed per week, and if these 
amounts were excessive the client could be challenged about whether they had an 
alcohol problem. 
5. Age criteria referred to age at first referral. 
Exclusion criteria applied affected the following. 
- The consultant indicated to the experimenter why he had decided a patient was 
unsuitable for testing because of the above criteria; the most common reason for non- 
inclusion was psychiatric history or being on antidepressants. This is not surprising, 
since some GP's treat CFS with antidepressants. Since patients were rejected by 
consultants, and the consultants did not keep numbers, the exact numbers are not 
known. Of patients who had had US for over 3 years, a large number seemed to 
come into this category; an estimate of this from case notes of excluded patients 
would be up to 50%. New patients were rejected on these grounds much less often; 
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about twice as often as exclusions for other reasons. A much smaller proportion was 
excluded on the grounds of age or prior head injury (it is estimated this group was 
less than 5% of potential patients). 
- Normal subjects were informed of exclusion criteria before they volunteered to take 
part. Three people indicated that the exclusions applied to them but others may have 
decided not to volunteer because the exclusion criteria applied to them, without 
indicating so. 
- Seven Crohns/colitis patients were excluded by the experimenter; the numbers are 
not known of how many exclusions were made at an earlier stage. 
(Appendix 3 Table 3 gives the breakdown of these figures). 
Non-selection for other reasons. 
Appendix 3 Table 3 also details the reasons why some of the selected patients never 
entered into the study, and why some non-excluded potential subjects were not entered 
into the study. This includes consultants' decisions and numbers of patients who did not 
turn up. The main effect on the study was that of a gastroenterology consultant not 
sending patients who were slightly emotional or upset when they saw him. This was 
often because their condition had deteriorated or they had been told that they needed 
an operation or to go into hospital. This may have resulted in the reduction of the 
numbers of Crohns/colitis patients with minor depression and thereby increased the 
difference on mood between CFS and Crohns/colitis patients as discussed later. One 
normal control and one CFS patient were in mid pregnancy during first testing and 
completed after the babies were born. 
3. Ethical considerations 
The research was approved by the Stobhill and Ruchill Ethics Committee. Patients were 
seen by the investigator, consultant or G. P. initially and asked if they would be willing to 
take part in the study. They received a printed explanation of the study prior to giving 
their consent (Appendix 2 Item 2a shows the explanation for CFS patients). The research 
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at all times conformed to the British Psychological Society ethical guidelines. 
All subjects were given a consent form which was filled in after they had been given the 
written statement (describing the test session) and before the test session. When first 
meeting the subject, general details were taken (name, address etc) and, if time allowed, 
the general questionnaire (see section 5.3.8 and Appendix 2 Item 1) was given and the 
subject given the MHQ and Health Locus of Control (HLOC) questionnaires to do at 
home. 
All subjects were free to withdraw from the study at any time. Subjects who volunteered 
to be reassessed were retested up to three times. Subjects could be withdrawn from the 
study if they became severly unwell during a session. No one was withdrawn for this 
reason but the two subjects who had absences during reaction time testing were given 
neurological examination before continuing and were retested after a longer than normal 
interval. Care was taken that testing would not interfere with the recovery of patients. 
It had been thought (and a couple of patients maintained this) that testing might 
exacerbate the condition by tiring the patient; therefore it was a principle of the study that 
if testing was found to be detremental to the patient in the longer term (i. e. not just in the 
next couple of days) testing would be terminated. It was not found that this occurred; 
patients were of course free to withdraw if they wished. If patients seemed particularly 
ill at time of testing this could be reviewed with the physician; however at most sessions 
the subject saw the consultants around the time of testing. 
4 Independent variables 
4.1 Group factors 
The object of this study is to compare the three groups to see if there are differences due 
to CFS. Other factors may account for these differences and these have to be taken into 
account. 
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4.1.1 Crohns/colitis and effects on neuropsychological testing 
The Crohns/colitis group have been chosen as representing a chronically ill group. It is 
possible that this group may experience loss of performance on cognitive tests 
specifically due to their illness not because of the chronicity of their illness. The 
differences could occur because of a) the illness itself and b) due to the medicine they 
are taking. 
Examination of the literature in these two areas does not give any evidence of loss of 
cognitive performance directly on these two counts. Some psychiatric symptoms are 
associated with diseases of the small intestine, particularly changes of mood and 
personality (Cooke 1978). There is an association between malabsorption and 
Crohns/colitis which, as Cooke (1978) shows, may affect cognitive performance. It is 
possible, therefore, that cognitive performance could be affected by having Crohns/colitis 
but it is not an established fact and is probably rare in the condition. Therefore the 
possibility of cognitive performance declining due to Crohns/colitis has been considered 
in the analysis but decline, if it exists at all, is likely to be small. 
In the Literature survey (Section 3.1.4) depression in chronically ill patients has been 
discussed and this is expected to be seen in Crohns/colitis patients (this expectation may 
have been false in view of a problem in referral of Crohns/colitis patients as discussed 
in section 2.4). This can be used to compare depression with cognitive test performance 
in the two patient groups. 
4.1.2 Controlling for differences between groups - controlling for IQ 
Diagnosed CFS patients are disproportionately middle class and well educated (see 
"Literature Survey" Section 1.6); they are therefore above average in their IQ and can 
be expected to have a higher than average pre-morbid cognitive test score. The 
performance of subjects in general on the Wechsler Memory Scale for example is highly 
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correlated to educational achievement according to Wechsler (1945). Goldstein 
(1990(b)) writes'7he Wechsler Memory Scale is highly correlated with IQ and so it is not 
possible to tell whether the scale measures construct memory specifically or intellectual 
ability" (p. 205). In view of this it is essential that IQ is similar in all three subject groups. 
In this study an attempt is made to ascertain what performance one might expect from 
the US patients if they were well, i. e. as controls are. It is therefore necessary to take 
an IQ measure that is not likely to have dropped significantly due to CIFS. It is entirely 
possible that patients are experiencing loss of performance that is not obvious when their 
scores are taken individually and tested against normal ranges. Normal ranges are 
usually averages for the whole population; they do not tell us how a person of a 
particular age and IQ should score except in some detailed studies. Bastien (11992) 
reports a significant loss of IQ in US patients during the illness. Therefore a measure 
of premorbid ability and a comparable control group is needed for comparison. The 
original National Adult Reading Scale (NART) test of 50 irregular words was used. It is 
quick and easy to administer, but more importantly it has been shown to be relatively 
stable against a fall in IQ level (Nelson and McKenna 1975). Crawford (1992) writes of 
the NART that it is the 'most widely used measure of pre-morbid intelligence' (p. 35) and 
'one of the most reliable tests in clinical practise' (p. 36). 
In addition to using the NART, any change in IQ arising during recovery should be 
evidenced because the study is longitudinal, with CFS patients being tested as they 
recover or relapse from the illness. 
4.1.3 Controlling for differences between groups - subjects pre-morbid functioning 
Becker (1991) says "Individual research subjects differ in their pre-morbid level of 
functioning, with any one individual having strengths and weaknesses in cognitive skills, 
educational background, history of head injury and problems with substance abuse 
which may have impact on cognition function and test performance. " In order to allow 
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for these factors not only were US subjects tested against controls but also against 
themselves in terms of improvement; this should nullify the effect of original weaknesses 
or strengths. We are also controlling for education by use of the NART and we control 
for head injury and substance abuse by excluding patients with this sort of history (see 
Method Section 2.4.1). 
4.1.4 Medication 
The Crohns/colitis group were taking medication, mostly sulphasalazine, which is most 
commonly used in Crohns/colitis. This could not be avoided and may account for the 
Crohns/colitis group being slightly worse on memory tests. Meningitis has occasionally 
occurred with sulphasalazine (Alloway and Mitchell 1993). On searching through current 
literature data bases however, no evidence for direct effects of sulphasalazine on 
cognitive performance was found. 
The CFS patients were not taking antidepressants or other drugs that might be expected 
to effect cognition, although stemetil or stugeron could cause some drowsiness and in 
a very extreme case more dramatic side effects. It is extremely unlikely that the 3 
patients taking these drugs occasionally could significantly affect overall performance on 
tests, especially as outliers were excluded (six individual patient test-scores were 
excluded, as discussed in the Results sections 1.2 and 3.1.3 and Appendix 5). Some 
CFS patients took medication for symptoms, e. g. anti-inflamatories (although this was 
rare) and others remedies such as evening primrose oil. A full list of drugs for each 
group is shown in Appendix 3 Table 4. 
4.2 The profile of the groups 
This section examines characteristics of the populations. The first sub-section describes 
demographic variables. The following two sub-sections cover general illness variables 
that will enable comparison of this CFS group with those used in other research. 
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4.2.1 Demographic variables 
An Analysis of Variance (ANOVA) followed by a Scheffe test was used to established 
that there were no significant differences between the means of the groups, on NART, 
age, alcohol consumption or the number of children of subjects. These variables were 
chosen to make sure that one group were not different in a way that would make them 
different apart from their health status, e. g. likely to be stressed (young children, marital 
status, demographic variables), do more physical activity (less family commitment), or be 
able to do the tests better (IQ and alchohol consumption). Since stress levels (see 
Section 3.4) have been suggested as a cause of CFS it was important to ascertain that 
CFS patients were not different in terms of their family situations. Sex and marital status 
were found to be similarly distributed on a chi-square test of the group distributions. 
Details are shown in Table 3. (Not all subjects were willing to give their age and marital 
status. ) 
Sex 
The male/female ratio was 1: 2.06 for the CFS group, 1: 1.70 for the Crohns/colitis group 
and 1: 3.56 for the normal controls. 
Age and IQ 
The distributions of age and IQ (according to NART) for each group is given in Appendix 
3 Tables 2A and 2B. Age is not significantly different on the mean of groups, but when 
age distribution is displayed one can observe that the Crohns/colitis group have less in 
the 16-25 age group and a high population in the 30-40 age group; however the profile 
is more similar to that of CFS subjects than it would have been with other chronically ill 
groups suggested such as rheumatoid arthritis patients. The IQ distributions are not 
significantly different, but the CFS group has slightly higher percentages in the higher IQ 
groups. 
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Table 3 DemooraDhic data: differences between arour)s. 
This Table compares the demographic variables for the three groups, CFS, 
normals and Crohns/colitis patients. Four variables were compared with an 
ANOVA followed by a Scheffe test. Two further variables were compared with 
a Chi-squared test. 
< ------ GROUP ------ > Significance 
Variable CFS Normal Chronic F-ratio differences 
at 5% level 
(i) NART (errors) 16.60 20.03 19.91 F(2,97)=1.88 Not sig. 
predicted verbal IQ (113) (111) (111) 
(ii) Age (years) 34.73 32.71 35.56 F(2,109)=0.55 Not sig. 
(iii) Alcohol 
consumption 3.16 4.18 3.23 F(2,72)=0.36 Not sig. 
(units/week) 
(iv) Number of 
children 0.67 0.91 0.60 F(2,71)=0.46 Not sig. 
(V) Marital status 
Chi-Square test: 
US Normal Chronic Row Total 
divorced 5 1 1 7 
married 23 16 11 50 
single 17 19 10 46 
status not given 5 1 6 
Column 45 41 23 109 
Chi-Square ignoring missing data (4 V. ) =3 . 46, Not significant at 0.05 level 
(vi) Sex 
Chi-Square test: 
CFS Normal Chronic Row Total 
female 31 32 15 78 
male 14 9 8 31 
Column 45 41 23 109 
Chi-Square (2 V. ) =1.46, Not significant at 0. 05 level 
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This should mean the CFS group does better on cognitive tests, i. e. biasing results in 
favour of the null hypotheses. Levene tests on the age and IQ dist(ibution show no 
significant difference in variance between groups. 
Employment 
Of the CFS group, significantly less were working than controls (see Appendix 3 Table 
21a). A breakdown of the figures for the CFS group (shown in Appendix 3 Table 21b) 
shows that a substantial number (10) had stopped or had lost work directly due to the 
illness, and of the other CFS patients not working, most were impatient to return. 
CFS-related jobs 
Of the group of CFS patients, three were nurses and four were teachers, professions 
linked with CFS (see Section 1.6 of "Literature Survey"). This is not a high enough 
number to confirm that these are CFS related jobs. 
4.2.2 Illness Vadables 
CFS patients initial illness 
The CFS patients differed in whether they had been ill with a particular illness which 
leads into CFS. Of the 47 patients in the study, the following pin-pointed a definite 
illness at the start of the CFS process: 
2 had suspected meningitis 
10 had Coxsackie B 
7 had Glandular fever 
I had pneumonia and pedtonitis. 
Contact with trigger illnesses 
The literature suggests that contact with a trigger illness may start CFS. Subjects were 
marked for number of contacts, prior to their illness, with Coxsackie B, glandular fever 
(EBV) or CFS itself. The mark was derived by adding up the number of close contacts 
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prior to their illness (e. g. family or close friends) and minor contacts (weighted 1/2) to 
give a score for contacts. In Appendix 3 Table 2G the distribution of contact has been 
scored as yes or no: i. e. whether or not the person had had any contact with related 
illnesses. All data collected retrospectively had methodological problems, and therefore 
this is a very rough measure. For example, a problem with this method is that CFS 
patients have become aware of the existence of CFS as an illness and are therefore 
more likely to find out or remember others with the illness. The Table shows the 
distribution in CFS subjects as roughly 2/3 having had contact and 1/3 not having had 
contact, with the control groups having the reverse of that pattern. This distribution was 
significant on a chi square test at the 0.01 level (chi-squared=10.5 with 2 V. ). 
Previous serious illness 
The three groups were compared to see if they had similar numbers of subjects with 
previous serious illness, i. e. any illness or condition on their medical record considered 
by the consultant to be serious. The procedure was that any illness that was unusual or 
known to be serious or an unusually severe infection or long term medical condition was 
marked on their research notes provided it was disclosed in their notes or by themselves. 
Then unless the illness was considered non serious on consultation with the consultant 
it was counted in this category. A list of serious illnesses was not used because only by 
looking at medical notes could one take into account the severity of a condition in a 
particular patient, and because the consultants were in infectious diseases and were 
therefore well aware of what illnesses are considered serious. This does however make 
it harder to define criteria and to replicate the study. The percentages who had had 
serious illness in the past is shown in Appendix 3 Table 2F. This shows more serious 
illness in the CFS group (34%) that in both control groups (5% for normals and 20% for 
Crohns/colitis subjects) which is significant on a chi square test (chi-squared=10.9 with 
2 V., p<0.01). 
Length of illness 
The length of illness of the CFS and Crohns/colitis patients showed slightly different 
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patterns and this is shown in Appendix 3 Table 2H. As discussed elsewhere recovery 
occurs in CFS spontaneously in the majority of cases, while in Crohns/colitis patients 
recovery is more spasmodic. It is not, therefore, surprising that only 18% of CFS 
patients have had the illness for five years or more, compared to 45% of Crohns/colitis 
patients. There is no reason to suspect that this distribution of length of illness in the two 
groups does not represent the distribution in the clinic population of each group. As the 
literature to date (Spracklen 1988) suggests, only a small proportion of CFS patients 
have CFS for longer than five years. The early 1980's in Glasgow saw a number of 
reports of outbreaks of CFS (Keighley and Bell 1983; Behan 1985). It is interesting, 
therefore, that these patients do not now dominate the present CFS population in the 
Glasgow area. 
4.2.3 Symptom Variables 
Fatigue 
The three groups indicated on a scale 1 -10 (exhausted to energetic) how tired they felt 
(see Appendix 2 Item 7). The group distributions (Appendix 3 Table 2C) give an 
indication of fatigue in the three groups. CFS patients' mode score was 2, in the chronic 
group it was 7 and in the normal group it was 9. CFS patients' scores are distributed 
toward the exhausted end of the scale and normals towards the energetic end with 
Crohns/colitis group being in several peaks. The mean for the CFS group was 3.22 
compared with 6.39 for the normal group and 5.56 for the Crohns/colitis group. Table 
6 shows that the CFS patients are significantly (p<. 001) more fatigued than both normal 
and chronic controls. 
Symptom list 
The three groups filled in a comprehensive list of symptoms particularly associated with 
CFS. However, because of the nature of CFS, the symptoms covered were mostly those 
that could be described as common symptoms; the questionnaire is given in Appendix 
2 Item 7. The symptoms were each rated 0-3 and the scores added up to give a total. 
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The distribution of scores for symptoms during the week before testing for this list are 
given in Appendix 3 Table 2D. 
The control groups had no subjects reporting more than 50 symptom points; 33% of CFS 
patients scored above this number. 48% of Crohns/colitis and 46% of normal patients 
scored less than 5 symptom points while only 4% of CFS patients did. Of the symptoms 
reported the CFS group reported a significantly higher amount of problems with memory 
or concentration. The mean for the CFS group was 37.93 compared to 7.63 for the 
normal group and 7.70 for the Crohns/colitis group. Table 10 below shows that the 
CFS patients are significantly (at least p<. 01) reporting more symptoms or greater 
severity of symptoms than both normal and chronic controls, for both that time and that 
week. 
Depression 
The amount of depression in each of our groups was important to the study. Although 
subjects with a psychiatric history or on antidepressants had been excluded in all groups, 
the amount of depression in the included subjects still varied considerably. Appendix 
3 Table 2E shows the distribution of scores on the Centre for Diseases Depression scale. 
A 16 point cut off score, above which depression is deemed to require treatment, has 
been accepted for this scale (Comstock 1976). The table is divided to show separately 
the sections of the populations scoring over this level. Sixty percent of the CFS group 
scored 16 or over compared to 5% of Crohns/colitis patients and 14% of normal subjects. 
At the other end of the scale 50% of Crohns/colitis patients and 46% of normal subjects 
compared to 7% of CFS patients scored 5 or less on the depression scale (see Section 
4.4.1 for more discussion of this scale). 
Summary of 4.2 
The population profile of the groups was similar for age and IQ, with slight differences 
which have been mentioned, and would mean the results would be biased towards the 
null hypothesis. There was a high female to male ratio in all the groups. Marital status 
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and number of children were similar in all groups. The CFS patients had a high number 
of depressed subjects, more previous contact with trigger illnesses and higher amounts 
of previous illness than both control groups. The CFS subjects had a much higher 
number of symptoms ('per week' and 'at the time') and higher fatigue level. The 
Crohns/colitis patients had, on average, been ill longer than the CFS patients. All these 
factors could have been predicted from the literature and fit in with the profile expected 
of CFS groups. 
4.3 Recovery and repetition effects 
4.3.1 Recovery 
Patients with CFS show a typically relapsing progress (Wookey 1986): they appear to 
recover gradually over time, without intervention, with relapses occurring less and less 
frequently. It was expected, therefore, that CFS patients would initially be slightly worse 
on cognitive testing but improve as they recovered, beyond practise effects. Repeating 
the cognitive testing during recovery showed us the changes that were taking place 
during the course of the illness. It enabled the plotting of such change and to compare 
it to other factors such as mood. 
4.3.2 Repetition: test and re-test validity. 
Most of the memory tests were not repeated in the same version consecutively because 
they would lose validity and to reduce practise effects (Logical Memory, Associate 
Learning, Digit Span, Rey Complex Figure and Visual Span). Reaction time tests in the 
same form are expected to be reliable over time (Cronbach 1964); it was expected that 
these tests would not show improvement over time in the control groups. Digit Symbol, 
however, is a test known to be subject to practise effects (see repeat testing of 
WAIS/WAIS R, Matarazzo and Herman 1984) and the Stroop and Block Design were 
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expected to be sensitive to practise. It was expected that all groups would show practise 
effects on these tests but that improvement would only be considered to have taken 
place if a group exceeded the improvement of other groups. The Threshold Task, 
PASAT, Word recognition and the Word Fluency tests also used differing versions. 
4.3.3 Using different versions on some tests. 
The test/re-test design involves some other methodological problems. Some tests, 
mostly those involving simple memory, cannot be reused using the same version of the 
test. Logical memory for example would lose face validity if the same passage was 
given to be remembered, since we might be tapping a different memory storage and 
encoding from the first reading and not just memory from the second reading of the 
passage. It is not normal practise to repeat the same memory test within a short space 
of time unless intervention has taken place or the subjects' memory is so poor that such 
considerations make no difference. The tests have, therefore, to be varied and allowance 
made for the different versions in the analyses of the data. Retest with different versions 
is a standard technique as discussed by Golden et al. (1990)(p3O). 
It was expected that by counterbalancing versions and adjusting analysis for version if 
necessary, the effect of using different versions would not influence the results in any 
way. (The distributions and different scoring on versions were to be examined to check 
that any effect of version was controlled for. ) The different versions were used in similar 
proportions in each group. 
4.4 Mood factors 
4.4.1 Depression 
The patients may experience loss of performance due to factors other than the illness 
itself. Depression and anxiety levels have been shown to be high in CFS (see section 
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3.1, Literature survey) so their effect may be the cause of changes in cognitive 
performance. "Clinically diagnosed depression can have a significant impact on 
information processing and individuals with elevated symptoms of depression perform 
more poorly on cognitive tests" (Miller 1975). In looking at test performance, therefore, 
anxiety and depression need to be controlled for. The design quantified and allowed the 
effect of these variables to be analysed, and the changes to them over time monitored. 
While it has been shown that depression is common in CFS, the direction of causality 
is not known. Taerke et al. (1987) suggest that the majority of CFS patients are suffering 
from clinical depression. However, the level of depression rating they use is very low 
and they use scales with a high somatic element that may confuse the illness's 
symptoms with those of depression. In this study, ratings on a relatively low somatic 
depression scale are taken to decrease the overlap in the physical symptoms of CFS and 
depression questions. This depression score indicates a level of current depressive 
symptomatology; as such it gives an ordinal scale over all groups suitable for group 
comparisons. Although the scale is not a diagnostic tool for major depressive disorder, 
the scale has been shown to differentiate those who have major depressive disorder 
(Somervell et al. 1993) . It has also been shown since the study reported 
in this thesis 
to differentiate between fybromyalgia patients who come out as more depressed than 
both rheumatoid and other clinical patients (Hawley and Wolfe 1993). 
4.4.2 Anxiety 
There is evidence that CFS patients have higher than normal anxiety scores. Anxiety is 
known to affect concentration and increase distractibility generally (American Psychiatric 
Association 1980) and these affect performance on cognitive scales. Corcoran (1989) 
links anxiety and depression in epileptics to high complaints of serious memory difficulty. 
Richardson (1988) suggests that similar complaints in Pre-Menstrual Tension are due to 
anxiety. It is useful therefore to look at anxiety levels in patients to see if this may 
account for differences in subjective and objective ratings of cognitive performance. 
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S. Choice of tests 
5.1. Tests used 
Table 4 shows the tests used in the study. 
5.2 Reasons for test selection 
The tests were chosen because they are tests which have revealed diffuse minor 
neurological problems: in minor head injury (Dikmen et al. 1986(a) and (b)), in epilepsy 
patients (Gillharn et al. 1988) and in alcoholics (Wilson et al. 1988) and toxic poisoning 
cases. The literature describing patients' complaints indicates that US patients 
complain of problems which overlap with these groups' problems, i. e. loss of memory, 
concentration and verbal fluency (see Section 1.5.2 in the literature survey). Pre-morbid 
IQ level was controlled for by using the NART for group comparison but examination of 
verbal IQ has not been central to this study because it is not expected that deterioration 
of verbal IQ is a major problem in CFS. 
Selection of each test occurred for one of four main reasons. 
1. The test was a commonly used standardised test of an aspect of neuropsychology 
and there was evidence to suggest that this aspect is affected by CFS. 
Where a choice of similar and equally suitable tests were available the most widely 
used were chosen. Given the constraints on the length of session, tests which took 
a shorter time were preferred. 
Tests: Wechsler Memory Scale, Reaction Time, Finger Tapping, WAIS Digit Symbol 
and Spielburger Anxiety Questionnaire, Health Locus of Control Questionnaire. 
An exception is the CES-D which is not the most obvious depression scale but was 
chosen because it seemed to have least overlap with physical symptoms. At the time 
it was scarcely used in the field but now has become widely used (for example, the 
Science Citation Index has shown around 60 references to CES-D in the last 3 years, 
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Table 4: TESTS USED 
National Adult Reading Scale NART (Nelson and Mckenna 1975) 
Couition 
Verbal Memory 
Logical Memory, Associate Learning, Digit Span subtests of: 
- Wechsler Memory Scale Form 1 (Wechsler 1945) 
- Wechsler Memory Scale Form 2 (Stone and Wechsler 1946) 
Word Recognition Task (Lezak 1983 pp. 620-621) 
Spatial Memory 
Rey Complex Figure (Rey 1941) and Taylor Complex Figure (L. B. Taylor 1979) 
WAIS Block Design (Wechsler 1955, from Wechsler Adult Intelligence Scale 
NFER 1957) 
Visual Span (Wilson et al. 1988) 
Reading and Word Finding 
Word Fluency (Spreen and Benton 1969) 
Stroop task (Stroop 1935; Perret 1974) 
Psychomotor Speed 
Choice Reaction Time (Van Zomeren 1987) 
Finger Tapping (Halstead Reitan Neuropsychological Test battery: Halstead 
1947) 
Speed and ability 
P. A. S. A. T. (Gronwall and Sampson 1974) 
Visual Change Detection Threshold (VCDT) (Wilson et al. 1988) 
WAIS Digit Symbol (Wechsler 1955, Form Wechsler Adult Intelligence Scale 
NFER 1957)) 
Mood and Symptom Questionnaires 
Centre for Epidemiological Studies Depression scale (CES-D: Radloff 1977). 
State-Trait Anxiety Scale Form X (Spielberger et al. 1970) 
Fatigue on a 1-10 Likert Scale (Likert 1932) 
Symptom List (Wookey 1986) 
Psychiatric and Stress variables 
Multidimensional Health Locus of Control (MHLC) questionnaire Form B 
(Wallston and Wallston 1978) 
Middlesex Health Questionnaire (MHQ) (Crisp et al. 1978) 
Beliefs about Illness scale based on Michielutte and Diseker (1982) 
Short list of major life events (Paykel 1972) 
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mostly in the areas of psychology and medicine). 
2. The test was a new test which had highlighted deficits in other groups with similar 
problems. 
Tests previously used in epileptics and alcoholics to show visual memory, attention 
and signal detection problems (Gillham et al. 1988; Wilson et al. 1988). 
Tests: Threshold task, Visual Span. 
3. The test was not necessarily normally used in a neuropsychological test battery but 
it measured a particular neuropsychological problem which is indicated in the 
literature as a problem in CFS patients. 
For example, CFS patients have been said in the literature to have particular 
problems such as in word finding, and confusion of words which sound the same e. g. 
black and blue. 
Tests: Word Fluency, Stroop, PASAT. 
Questionnaires were also designed or adapted to cover specific problems in CFS 
patients e. g. General Questionnaire and Beliefs about illness questionnaire. 
4. It was a standard test which was being used to fill in a gap in the battery for a general 
neurological assessment. 
Tests: Rey memory, WAIS blocks. 
Alternatives to the WIVIS would be to use a battery including these kinds of variables 
such as the Halstead Reitan Battery (HRB) (Halstead 1947; Russell et al. 1970) but none 
of these would have been tailored to CFS patients in particular. 
5.3 Testing different aspects of neuropsychological functioning 
5.3.1 Introduction 
This battery of tests was used to measure the main aspects of intellectual function. 
Tests are described in the following Section. Questionnaires and score-sheets are given 
Appendix 2. Permission has been sought from the authors. 
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5.3.2 Testing memory 
Tests from the Wechsler Memory Scale and WAIS were used. The Wechsler Memory 
Scale version used was the original 1955 version rather than the new WMS-R (Wechsler 
1987) because at the time of the design of the study, in 1988, the WMS-R was only just 
coming on to the market and therefore it had not been validated by use in different test 
situations. The WIVIS was used rather than the WAIS verbal subtests to test memory 
because they are more suited to testing diffuse brain damage than tests primarily aimed 
at testing verbal IQ which does not normally deteriorate in these type of conditions. The 
WMS also had the advantage of having alternative versions available that were standard 
and had been used in this way before (Stone and Wechsler 1956). 
(i) Verbal memory. 
Wechsler Memory Scale 
Memory tests included parts of the Weschler Memory Scale (WMS). It is universally 
used and is well validated and standardised (Wechsler 1945). The Wechsler Memory 
Scale is a short scale comprising a number of different components: it can be used 
complete or in component parts. The parts used were Logical Memory passage, the 
Digit Span and Associate learning component tests. The Logical Memory and Associate 
learning involve new learning as well as memory. They are therefore sensitive to the 
kind of problems found in toxic poisoning by alcohol, barbiturates etc. which may be 
similar to CFS effects. 
it was not felt necessary to complete the whole scale since that would have involved 
giving tests well within the subjects ability and which may even have been so easy that 
they regarded them as derisory. The tests were given in standard procedure although 
more modem language was sometimes used. 
WMS subtest - Logical Memory 
The Logical Memory test involves the tester reading a short passage to the subject. The 
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subject then has to recall the passage as exactly as possible and is given marks for 
correct words and phrases. The Wechsler Form 1 and the Wechsler Form 2 have four 
different passages, an easier and harder passage for each. The passage could not be 
given twice to the same patient because that would have changed the nature of the test, 
that of immediate recall: residual memory from the previous session and recognition 
memory might produce different results from the immediate recall of the passage done 
at first testing. Therefore three of the passages were given at different times over the 
1 st-3rd testing. Form 1 Passage One was given using the slight alterations normally used 
in Glasgow (Appendix 2 Item 3). 
WIVIS subtest - Associate Learning 
The Associate Learning test involves remembering six usual and four unusual pairs of 
words. The subject is read the list of pairs three times; after each time he/she is asked 
the right pairing for each word. Both versions of the Wechsler Form I and 2 were used; 
the subjects were given either version 1 or 2 to start then the other version on second 
testing and the first version was repeated if they came for a third testing. Form 2 was 
designed to be used as an alternative to Form 1 (Stone and Weschler 1956). Getting 
more hard than easy pairs is thought to show malingering according to Lezak (1983 
p. 620). This test was also used as an indication of whether CFS patients had learning 
deficits which might cause CFS patients severe difficulties in normal living. The test was 
administered according to the advice given in the instruction manual (Wechsler 1955). 
The score is 1/2 for a correct easy answer and 1 for a correct difficult one. 
Word Recognition 
The word recognition test used was based on a test reported in Lezak (1983 pp. 620- 
621). This test is designed on the premise that recognition is easier than recall. Subjects 
are read 15 words and then asked to tick ones they heard from a list including the 15 
which had been read to them and 15 similar words. Word recognition tests should 
confirm the differences between CFS patients and normal subjects but the differences 
should not be very different from results in other memory tests. Word recognition could 
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also be used to test how accurate CFS patients were in their answers by taking marks 
off for errors in recognition. This test was retested by giving a different selection of the 
15 words so ruling out any advantage (indeed making it a slight disadvantage) to 
remember the previous set. This test is very quick and was chosen over other recall tests 
because of its speed of administration and because the equally quick Williams test 
(Williams 1968) (also considered) was concerned with visual recall rather than verbal, 
and visual recall was thought likely to yield less useful results. 
WIVIS subtest - Digit Span 
The Digit Span test involves recalling, in order, strings of numbers (4-7 in length) (digit 
forward) and recalling strings (3-6 in length) in exactly reverse order. The numbers are 
never repeated in the same string. 
(ii) Visual-spatial memory 
Although CFS patients' problems do not normally include those of spatial memory, to 
leave spatial memory out coMpletely would be to have an incomplete test battery of 
memory. In any case one is then able to compare the relative performances of CFS and 
controls on both tasks to see if they are inconsistent. The spatial memory task of the 
Weschler memory scale, however, was not used; instead the Rey and Taylor Complex 
Figure task was chosen. 
Rey/Taylor Complex Figure 
The Complex Figure was chosen as being a more difficult spatial memory task than the 
WMS visual memory task, with the potential for finer grading of spatial memory ability. 
It was of sufficient difficulty that subjects were unlikely to ceiling on the task, which might 
have happened had the Wechsler Memory Scale component been used. The Rey task 
tests perceptual organisation as well as memory. Besides the scoring of the Rey, a 
piecemeal approach to the diagram is also an indicator of possible problems organising 
material. 
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Beaumount and Davidoff (1992) suggest that the Rey-Osterreith Complex Figure 
(Osterrieth contributed the scoring method used in this study) is the best of the copying 
tests partly because of its high reliabiltiy of scoring. 
There are several ways of administering the Rey Memory Complex Figure task. In this 
case, the subjects were given a hard memory task, that is after copying the Rey or Taylor 
Figure they were given 15-20 minutes on other tasks and then asked to recall the 
diagram. The Taylor and Rey Complex Figures were both used since their design 
elements are matched; subjects were randomly given one version at the first session and 
then given the Figure they had not used at the previous session. Instructions given to 
the patients were as standard. 
Visual Span. 
This is a computerised test of retention of visual information. The method of testing this 
aspect of memory is new. The subject is presented with a pattern of blocks of increasing 
complexity; he is presented at a timed interval with the pattern altered by one block and 
has to point to the change. The subject's score is the largest number of boxes on the 
screen prior to making two consecutive mistakes; ceiling score is 28. This test has been 
used to identify memory problems in alcoholics and epileptic patients. It shows how well 
the subject can recall a complicated pattern. 
5.3.3 Testing language problems 
Stroop 
The Stroop task has been used to measure a number of factors: reading fluency, 
distractibility, mental control and response flexibility. It is particularly good, for this study, 
because it tests a specific problem of CFS patients described in the literature, viz word 
confusion, giving a different word with similar sound and or meaning such as blue instead 
of black (Ramsay 1981). The test of the Stroop effect used was similar to trial 11 and IV 
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of the original. One card was used: it was a card with words in different coloured type, 
the colour being different from the colour word (RED BLUE GREEN YELLOW BLACK); 
there were 16 lines of 5 words. A copy of the card is shown in Appendix 2 Item 10. The 
subject was asked to 'Read the words on the card as fast as possible without making 
mistakes'. This was timed, errors were not penalised directly in the timing, subjects 
seldom made mistakes and when they did they penalised themselves by hesitation or 
correcting the mistake. 
After the first 10 CFS subjects it became clear that the US patients did not find this task 
difficult and it seemed unlikely that any differences would be found with controls 
(although later analysis proved there was a difference). Therefore in order to increase 
the difficulty of the task a harder task was added: when they had completed the task 
they were then asked to'Call out the colour names on the card not the words. Like this. ' 
The experimenter then called out the first line of colours on the sheet in order. The 
reading of the colours was timed in seconds. 
5.3.4 Testing psychornotor skills 
Choice Reaction Time 
This is a standard reaction time task: the subject was required to press a button next to 
one of 4 lights when a light came on. The four lights were arrayed in a fan about six 
inches from the movement sensitive button on which the subject put his hand. Next to 
each light was another movement sensitive button onto which the subject had to move 
his hand. Appendix 2 Item 4 shows the layout of the box. The reaction time box was 
plugged into the computer which recorded and calculated means of decision and 
movement time. The subject's decision time was measured by when his hand left the 
start button and his movement time by when he hit the correct button next to the light 
that went on. The subject was given a very short practise because of the problem of 
tiring the CFS patients. 
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The first test run cued the subject (by sound and light) randomly 20 times for each light. 
This gave enough reaction time movements to be sure to get a reasonable measure; it 
was however deliberately shorter than it might have been in order that the CFS patients 
did not get too tired. The test was re-run straight afterwards to measure if the CFS 
patients were slowing at the task; this time ten sets of the four lights were randomly 
displayed. This test gave measures of time taken to initiate action ("Decision Time"), 
time of neuro muscular movement ("Movement Time") and a measure of fatigue. 
Other reaction time tasks could have been used, such as the simpler single reaction time 
task where the subject responds to the same stimuli on each occasion (e. g. one light not 
four) or more complicated tasks where the subject responds indirectly to the light or has 
to press their response in sequences. The first would have been too easy for our 
subjects and the second type would have unnecessarily complicated the results. 
Finger tapping 
The Finger Tapping Task consists of the subject tapping a calculator for one minute. 
The calculator, a Casio College fx-I 00, is set to continuous addition (by pressing 1 ++0). 
The test was used as a measure of speed, co-ordination and fatigue. This test was 
simple and quick and is frequently used as part of a test battery. The experimenter felt 
that this could be used as a test of muscle fatigue without it being injurious to the 
patients. If muscle fatigue was produced in the larger muscle groups then it could have 
a prolonged injurious effect as muscle of CFS patients may take much longer to recover 
after exercise. 
Digit Symbol 
The Digit Symbol test involves turning numbers into a symbol code which is given at the 
top of the test. The digit symbol measures information processing ability and speed. 
The test was done twice with the same code because if the code had been changed it 
would have been difficult to standardise to the existing version. In fact, subjects did not 
seem to remember the code well from the first time. Considerable practise effect was 
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expected on this test because of reuse of the code and the subject learning how to 
approach the task. This task was used because it was felt that it might yield results on 
the problems of information processing at a higher level and at speed. 
5.3.5 Testing attention and signal detection 
P. A. S. A. T. 
P. A. S. A. T is a test of divided attention. Subjects have to add up and give the answer 
to the addition of each pair of consecutive numbers; they have to use each number twice 
and hold the previous number in their head while giving the addition to the sum. The 
task requires concentration and inhibition of the previous answer. This test was quite 
difficult to grasp so detailed explanation and practise was given until the subject could 
answer the practise questions in the right way before commencing. The subject was 
presented aurally with a succession of random numbers between 1 and 9. The subject 
had to add each number to the next number and give the answer. This was explained 
using pencil and paper to show what kind of number would be given and what the 
answer should be. Then the subject attempted to do the practise part of the tape where 
a random sequence of a few numbers were given. The practise part and test part 
numbers were presented at a speed of 1.6 second intervals. Two different sequences 
of numbers were used for different presentations. The score was the total number correct 
out of 60. 
This task was used because it was suggested as a task of possible interest in Kilfedder's 
(1988) study. The use of distraction with this task was originally thought of as a 
progression on Kilfedder's work but rejected as being too difficult for subjects. 
Visual-Spatial abilities 
Block Design WAIS subtest 
The Block Design subtest is a constructional task which tests visual spatial abilities. In 
this, the subjects are asked to reproduce a pattern of squares and triangles using blocks 
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each of which have two red faces, two white faces and two faces with triangles of red 
and white (see Appendix 2 item 6). The test consists of 6 patterns of 6 easier blocks and 
4 of 9 harder blocks to be made from a diagram. Once the solution to a pattern is found 
it is easy to reproduce the pattern again; therefore subjects who did all the blocks on first 
testing were not asked to repeat them but were regarded as having reached ceiling. All 
subjects completed the same simple designs. Some subjects were able to complete all 
the designs and those subjects who failed to complete all the designs were given the 
opportunity to redo the harder designs at second or third testing. The test was chosen 
as a good test of visual spatial abilities in two dimensions and Beaumount and Davidoff, 
in Crawford's handbook of Neurological testing (1992), say of WAIS Blocks that it is the 
'clear choice of a test of this type'. (p. 124). The instructions given to the subject were 
as standard in the test manual. 
Visual Change Detection - Threshold Task 
This task has shown up differences in alcoholic patients (Wilson et al. 1988) and has 
also been used with epileptic patients (Gillham et al. 1988). It shows how well the 
subject can pick up small changes at speed. It was selected to see if CFS patients were 
slow at perceiving input as well as responding to stimuli as in Reaction Time Decision 
Time (RTDT) and Reaction Time Movement Time (RTMT). The task should pick up 
problems of information processing at speed (Gronwell 1977). The question of central 
fatigue is important in the case of CFS. Visual threshold tasks of this nature have a high 
performance workload and need high concentration. As Grafman et al. (1991) say, if 
CFS patients do worse on vigilance tasks this could be attributed to attentional deficit due 
to central fatigue. 
The Threshold Task is displayed on computer. A randomly generated array of an 
average of 50 boxes out of a regular 1 0x1 0 display is displayed (the size of the array is 
185mm x 105mm). The result is a random scatter pattern on the screen. Each box is 
5mm x3mm. One box is presented after a delay (starting delay is two seconds). The 
-105- 
subject has to say which small box on the screen is presented slightly later than the 
others. With each correct response the delay is 20 milliseconds faster. The computer 
calculates the speed at which the subject regularly fails to pick out the new box (i. e. 
sixteen occurrences of a correct next to an incorrect response or vice versa). The 
threshold score is the estimate of milliseconds needed for the subject to get 50% of tasks 
correct. 
Testing for fatigue during the Reaction Time Test. 
It was thought that CFS patients might show an increasing reaction time during testing 
as CFS patients complain of early fatigue of muscles and cognition. To test whether this 
occurs the reaction time test was conducted in two parts. The reaction time test 
consisted of: 
a) practise U4 trials only so as not to increase fatigue; score not taken 
b) then a set of 20x4 trials reaction time 
c) then a second set taken immediately after the first of 1 Ox4 trials reaction time. 
The median of the first set was used as the Reaction Time score and the median of the 
second set was used to measure the effect of speed changes during testing. Only 10 
Crohns/colitis patients had time to complete the second part of the test, so this group 
therefore could not be used in a statistical analysis. The expectation was that, because 
people had little practise and normally get faster at the reaction time task, the second set 
would be faster than the first set for normal controls but not necessarily for CFS patients. 
Note that median scores for the set of reaction time scores were used, not mean scores, 
so that odd lapses of attention did not influence the measure. 
5.3.6 Testing functionally induced poor performance 
In order to rule out subconscious or deliberate distortion by the patients a simple test for 
functional malingering was included. The 15 item test (Lezak 1983 p. 619) was given, to 
the first group of CFS patients. In this test the subjects are shown five rows of 3 
sequenced figures. The rows are easy to remember but the experimenter emphasises 
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the difficulty of remembering 15 items. The subject is asked to recall the 15 items. 
Patients with functionally induced deficits are expected to fail to remember all the items. 
Of the 10 CFS patients who did the test none forgot any of the items. The 15 item test 
was so easy to subjects that some found it derisory and none were convinced it was 
difficult; for this reason it was discontinued. The Associate Learning test (as described 
above) was also used and results were scanned for scores where subjects scored better 
on hard than easy pairs; this did not occur in the CFS subjects. 
Frontal lobe dysfunction 
In view of the fact that fatigue in CFS patients could be related to lack of initiation of 
action and, therefore, be related to frontal lobe dysfunction, it was decided that some 
tests should be aimed at this aspect of brain function. Tests thought to be sensitive to 
such dysfunction in the battery include Stroop, Word Fluency and Block Design. 
5.3.7 Choice of questionnaire: psychological tests and symptom recording 
procedure 
The CES-D scale (Appendix 2 Item 5) and the Spielberger State/Trait Anxiety scale 
(Appendix 2 Item 11) were filled in at each time of testing together with the symptom list 
and fatigue scale. A set of questionnaires was given to patients at the first testing which 
they returned by post. These were the Health Locus of Control (HLOC) (Appendix 2 Item 
12) scale, Middlesex Health Questionnaire (MHQ) (Appendix 2 Item 13) and illness 
questions (Appendix 2 Item 8). They were completed only this once between first and 
second testing. HLOC and illness questionnaires were used to look at differences in 
attitude between the groups that might relate to their illness. The MHQ scale gave an 
indication of psychiatric profile. 
CES-D Scale 
The CES-D Scale of Depression was used. This is a very quick and straightforward 
scale used by the Centre for Diseases Control in America. The reason it was chosen was 
because it was made up from cognitive questions about depression from other scales 
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(Beck 1961; Zung 1965; Dalstrom 1960 and Gardner 1968, all from Radloff 1977) and 
is therefore a very highly cognitive scale with minimal somatic content. This means that 
the scale is least likely to be recording general illness symptoms rather than depression 
Foelker and Shewchuk 1992 show the CES-D to be relatively unbiased by the patient's 
somatic complaints. The CES-D also has the advantage of being quick to administer so 
it can be included at each testing without any difficulty. Although it gives only a 
depression score not a clinical measure of depression, it has been shown to have high 
sensitivity to major depression as scored on the Lifetime Version of the Schedule for 
Affective Disorders and Schizophrenia (Somervell, et al. 1993). The CES-D has been 
used with large populations and a score of 16 used as a cut off point for clinical 
depression. Its validity is discussed in Radloff (1977) and Radloff and Locke (1986). 
The form used was similar to that shown in Appendix 2 Item 5, except that clients 
received copies with boxes instead of scores and they were asked to tick one of the 
boxes. Other scales considered were Becks's Depression scale or the HADS Scale; 
these were much longer and more somatic. 
The Spielberger State/Trait Anxiety Scale 
This is a simple questionnaire using describing adjectives to ascertain a person's anxiety 
levels. It has a measure for shorter term anxiety 'state' and longer term 'trait' anxiety. 
It is quick and straightforward to administer and so could be included at each testing. 
It has been widely used and standardised (Spielberger et al. 1970) and is highly reliable. 
The Form X was used. See Spielberger (1970) for Test and Scoring. 
Middlesex Health Questionnaire 
The MHQ is a straightforward questionnaire widely used and standardised. It is designed 
to measure general mental health. Its scales are designed to measure depression, 
anxiety, obsessionality, somatic propensity, phobic problems and hysteric propensity. 
All the scales correlate well with blind psychiatric interviews except the hysteria scale 
which seems to measure more extrovertness and sociability (Crockett 1969; Crown 
1974). The purpose of their scale was to ascertain if the CFS group during their illness 
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were demonstrating psychiatric distress. See Crisp et al. (1978) for questionnaire and 
marking scheme. The subjects completed the questionnaire before or between testings, 
not under supervision. 
The General Health Questionnaire was considered instead of the MHQ as a scale of 
psychiatric well being, it is shorter to complete but was rejected on the grounds that it 
was far less specific in the kind of results it produced. 
5.3.8 Illness and Psycho-social data 
Questionnaire 
The general questionnaire given to the subjects was done with the experimenter. It 
asked demographic data: how old, whether working, whether married and if they had 
children. It includes data about the illness (if CFS or Crohns/colitis): how long the person 
had been ill, how long to diagnosis, had the doctors been helpful, what drugs was the 
patient on? It includes data about vulnerability: had they had a previous serious illness, 
had they taken lots of antibiotics prior to the illness and also what life events occurred 
in the 18 months before the illness? It also asked about activity prior to the illness (high 
physical activity being associated with vulnerability to CFS) and during the illness (CFS 
is associated with much lower activity). We also asked subjects to rate their illness 
against other illnesses. 
Symptom data 
In order to ascertain how subjects felt about their health at the time of testing, a symptom 
list was used (based on Wookey 1986). The symptom list excluded some of Wookey's 
items on the grounds that they were very subjective or not relevant for the purposes of 
this study knowledge. For example feeling awful, legs feeling heavy, clumsiness and 
difficulty in carrying things are aspects of the illness that are a result of other symptoms 
rather than symptoms in their own right. Looking pale and grey was left out because the 
patient did not experience it and received that knowledge from others second hand. 
Crying a lot was left out as depression was already included. Symptoms specific to 
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women were left out as we were comparing women and men together, i. e. flushing and 
vaginal discharge (see Appendix 2 Item 7 for form used). 
Fatigue was measured on a 10 centimetre line, one end of which registered Exhausted 
(score 1) and one end Energetic (score 10). The subjects were asked to put a mark 
where they felt they came between the two ends of the Liked scale - see the end of 
symptom list in Appendix 2 Item 7 for this scale. 
Life events 
Patients were questioned about the highest scoring life events (Paykel 1972): births, 
marital status change, illnesses and deaths in the family, prolonged stresses, job and 
house change. The number of these high scoring events was recorded. Papers showing 
links between illness, immunity and life events (Solomen et al. 1979) feature 
bereavement as the most prominent link. Two papers have shown a correlation 
between life events and CFS: Stricklin et al. (1990) and Wood et al. (1991) found CFS 
patients to have significantly more, or more serious, life events pre-illness. In 
investigating life events in patients prior to their illness it was decided to concentrate on 
a short list of major life events for two reasons: the inclusion of all life events would have 
made the questionnaire a) too long and b) subject to distortion, since minor life events 
are recalled more frequently if they have happened recently according to Davies (1992). 
Health Locus of Control and beliefs about illness. 
The aetiology of CIFS is still under debate; it is possible that several psycho-social factors 
may relate to onset or to duration. In CFS much lip service has been paid to the idea 
that it is stress related, especially in the media. This idea has been little examined and 
this is why some work has been included on it now. The degree of stress one 
experiences has been related stressful events (some of this can be tested by life events) 
personality in relation to beliefs about stress (this can in part be tested by locus of 
control) and beliefs about the situation (we are looking at this by testing beliefs about 
illness in the subjects). Ability to cope with pain and chronic illness has also been 
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associated with locus of control (Phares 1962; Reid 1984). It may be a contributing factor 
in depression and illness adjustment. Not only may external locus of control hinder 
coping with the illness but Skevington (1983) shows that long periods of illness may alter 
beliefs about locus of control. Powell, Dolan and Wessely (1990) show that CFS patients 
tend to attribute their symptoms to an external cause compared to a depressed group 
who tend to attribute them to internal causes. Whether this externality of control is 
prevalent in CFS patients will be seen by looking at their locus of control beliefs in health 
matters. Whether CFS patients have particular problems in adjusting to their illness will 
be considered by comparing them to Crohns/colitis patients on measures of health locus 
of control and health beliefs. Locus of control beliefs could also be contributory factors 
in depression. 
Health Locus of Control 
This scale is a development of the Locus of Control scale by Rotter et al. (1962); it is 
given in Wallston and Wallston (1978). It is designed to find out how external is the 
subjects beliefs in relation to health i. e how much subjects attribute the quality of their 
health to external factors. It gives three scales of types of belief: 1) to oneself 2) to 
powerful others (like doctors) and 3) to other external forces (like chance). It has been 
examined in relation to other scales of this type (Wallston and Wallston 1978). It is 
particularly useful to test patient populations. 
Not only may external locus of control, as discussed earlier, hinder coping with the illness 
but Skevington (1983) shows that long periods of illness may alter beliefs about locus of 
control. Powell, Dolan and Wessely (1990) showed that CFS patients tend to attribute 
their symptoms to an external cause, compared to a depressed group who tend to 
attribute them to internal causes. Whether this externality of control is prevalent in CFS 
patients will be seen by looking at their locus of control beliefs in health matters. 
Whether CFS patients have particular problems in adjusting to their illness will be 
considered by comparing them to Crohns/colitis patients on measures of health locus of 
control and health beliefs. This questionnaire was completed unsupervised because it 
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was done by the subject at home between first and second testings. 
Beliefs about illness 
This set of Likert scales looks at the beliefs of the three groups about six illnesses: two 
are ME/PVFS/CFS and stomach ulcers, the other four are cancer, Multiple Sclerosis 
(MS), arthritis and a broken leg. These illnesses are chosen to include those concerned 
in the study and as examples ranging from mild to severe illnesses as shown on the 
seriousness of illness rating scale (Wyler et al. 1968). It is suggested in Abbey and 
Garfinkel (1990) that CFS patients over-exaggerate illness, by being somatically 
preoccupied; patients are possibly obsessive about illness. Similar scales were used by 
Cooper and Fraboni (1988) in order to survey people's beliefs about illness. Michielutte 
and Diseker (1982) used the scale to look at how children appraise cancer, and how 
children with cancer view cancer was examined by Jamison et al. (1986). The intention 
is to see if CFS patients are more negative than controls about illness in general and if 
they see people as more vulnerable to illness. The Likert scales were given to the 
subjects and they were asked to fill in how much they agreed or disagreed with the 
statement by marking a section of the Likert scale. These questions were completed 
unsupervised. 
Two questions were combined in this study because they were felt to overlap 
considerably: they refer to the illness as 1) as powerful 2) as scaring people; thus only 
5 questions were asked. See Appendix 2 item 8 for this version of the test; scoring is 1-7, 
with a score indicating a negative attitude being higher. 
5.4 Shortening the test battery 
The test battery had to be shortened for some subjects: 
1) US patients who could not manage the complete battery; 
2) subjects who did not have time to complete the whole battery; (this was usually due 
to a shorter time available due to consultants appointment or the subject stating 
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he/she could only spare a limited time); 
3) Crohns/colitis patients were not all asked to complete the whole battery as this was 
not necessary and it was thought more important to increase the willingness of 
patients to take part. 
Where the battery was reduced the same tests were omitted so that the numbers for the 
most important tests would be consistent. 
Tests sometimes not used: 
WAIS Block Design 
P. A. S. A. T. 
Appendix 3 Table 1 gives the proportions completing the tests. Note that the finger 
tapping scores were faulty for the first appointments, and Stroop Colours was not 
included, so these scores are not given for a number of CFS patients. 
6 Reasons for choice of longitudinal design 
A longitudinal design was chosen to examine how cognition changed over the process 
of the illness. Two main methodological designs are normally used to measure change 
over time. One is to compare different groups with the same attribute, e. g. CFS groups 
at different stages of their illness. (The most common form of this design is testing 
subjects of different ages). This would not be suitable for our purposes because 
individual differences (which exist in CFS severity) might outweigh the differences over 
time. The second method is by longitudinal design, a standard method which tests the 
same patients over time; this is not possible for a long time span in many circumstances. 
In this case it was quite practical to test the same patients at four-monthly intervals. 
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7. External factors 
7.1 Place of testing 
Patients were seen at Ruchi112 Hospital Infectious Diseases Department, Stobhill 
Gastroenterology Department and St Andrew Ambulance Headquarters in Glasgow. 
Those seen in hospital outpatients were seen in the day, those in the St Andrew's 
Ambulance building in the evening. Crossover between groups in terms of place and 
time was encouraged but there was not enough cross over to statistically control for 
place of testing. Most of each group were seen in the place they normally attended. The 
tests took place in a variety of different rooms although most of the hospital rooms were 
similar in size and lighting. Every endeavour was made to ensure that lighting was 
similar and adequate in all the rooms used, however variation of lighting occurred due 
to time of day and season and slight differences occurred in chairs and rooms. The 
equipment and procedure was similar at all locations. Occasionally subjects had to be 
tested concurrently in neighbouring rooms; procedures were kept similar with supervision 
via connecting doors. 
7.2 Time of testing 
The CFS and Crohns/colitis group were mainly seen during the day although a few of 
subjects from both groups came in the evening. The normal controls (except for two) 
were seen in the evening. It was intended that normal controls be seen when they were 
likely to be most fatigued and CFS when least fatigued so that they could cope with 
testing. It seemed appropriate to have tired controls so that the ordinary effects of 
fatigue could be reduced as the cause of any deficit in performance in CFS patients. 
Time of day differences obviously occurred, although some overlap in time as well as 
place happened between the groups. CFS patients were not willing to be tested in the 
evening because they were too ill at that time; normal controls were mostly working and 
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therefore did not want to come to day-time appointments. Most of the normal controls 
took part between 6.30-10.00 p. m. at night after work, and were expected to be fatigued. 
CFS and Crohns/colitis patients took part between 9.00 a. m. and 5.00 p. m. Time of day 
differences would not occur between CFS and Crohns/colitis patients. 
Wood et al. (1992) monitored energy in CFS patients over different time periods. He 
found 10.00-12.00 a. m. to be the highest energy time for CFS patients, and early 
morning and late evening to be the lowest. The controls followed the same energy 
fluctuations, but CFS patients, averages, were always lower in energy at any one time. 
This means that CFS patients were tested at peak energy level times and normals at 
lowest energy times, therefore favouring the null hypotheses. 
7.3 Test Order 
The tests were given in different orders to control for effects of the position of tests in the 
battery. 
7.4 Length of testing 
Patients were tested for approximately 1 to 1 1/2 hours per session and were tested on 
up to three occasions. Patients had been seen by a consultant prior to testing and 
assessed as fit enough to take part in the study. US patients took far longer to complete 
their test battery than normal controls; this occurred at first and second test sessions, 
although for both groups the second testing was shorter than the first. 
7.5 Time between testings 
The study was designed so that retest intervals should be four-six months. In fact, owing 
to problems with subjects not attending or postponing due to illness, the retest interval 
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had a wide range. Retest for US patients took place on average 5.9 months between 
first and second testing (standard deviation 2.8 months), 5.0 months for normal patients 
(standard deviation 1.3 months) and 3.3 months for Crohns/colitis patients (standard 
deviation 1.3 months). The longer recall of CFS patients was largely due to some very 
long individual retest intervals, for example 17 months (removing this patient leaves a 
mean of 5.5 months with a standard deviation of 2 months). In the case of one of the 
controls after such a long interval the experimenter was not able to retest the person, 
because the study was no longer running. Crohns/colitis patients also had to be tested 
three-four months after first testing to fit in with the available time at the hospital clinic. 
Subjects were seen when they could manage and therefore patients were seen serially 
at any time during the 3 years of the project irrespective of their group, providing that four 
months had elapsed since their previous testing. 
We were interested in the improvement of CFS patients per se not over any particular 
time scale. The fact that CFS patients generally had longer between tests is likely to 
mean they benefited least from practise and results are under-stated. 
8 Summary 
The study was designed to discover: - 
1) whether CFS patients were poorer on various neuropsychological tests; 
2) whether this poorer performance improved with recovery from CFS; 
3) whether the poorer performance could be accounted for by depression. 
The design controls for factors such as differences in IQ between the groups. 
Information about beliefs, life events and activity have also been collected. 
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CHAPTER 4. RESULTS 
Introduction 
The CFS, Crohns/colitis and normal groups were compared in two main ways: - 
1) The subjects' general activity, medical aspects of their history and psychiatric tests 
give a profile of the groups. This is considered in Section 2, "Results Part 1". 
2) The subjects' performance on the neuropsychological test battery is compared. The 
performances at first and second testing are analysed and the effect of mood 
variables on scores is analysed. These points are considered in Section 3, "Results 
Part 2". 
Tables of the findings are included in the text. Section 1 outlines the statistical approach 
taken. 
1. Statistical analysis 
1.1 Comparison of all three groups together at first testing. 
The three groups need to be compared together. The F-test from ANOVA tests the null 
hypothesis, but does not pinpoint where the differences are, so a further test is needed 
to decide where the differences are. The comparison of three groups requires careful 
consideration when statistical methods are used. Separate analysis of each group with 
each other would weaken the reliability of the analysis, because the probability of one 
of the comparisons being statistically significant increases with the number of separate 
operations on the same means. The test chosen to show where the differences were 
was, therefore, the conservative post hoc Scheffe test. The Scheffe test gives the 
statistically significant differences for each combination of pairs but takes into account 
the number of comparisons being made. This kind of procedure, adjusting for the 
number of comparisons being made, reduces the likelihood of finding too many spurious 
differences. 
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1.2 Normal distributions 
The use of parametric tests assumes that the variables are normally distributed within 
the groups, and that the variance is constant between the groups. In fact ANOVA, which 
is the test which was proposed to analyse most of the data, is robust in this respect 
except where distributions are extreme, a number of peaks occur within the distribution 
(e. g. bi-modal or tri-modal) or the distribution is highly discrete. Some of the variables 
used in the study might be expected to be at floor or ceiling, and this would upset their 
normality. Possible problems include: 
1) outliers, usually in the US data which could justifiably be removed; 
2) severely skewed distributions, which can be removed by using the log of results (for 
some variables, such as Depression, 1 has to be added first to avoid taking the Log 
of zero); 
3) bimodal distributions. 
In order to ensure that problems of non-normal distribution of scores do not occur, 
normality of scores -was checked and, where appropriate, the data transformed. 
Normality is studied visually by inspecting the distribution, and quantitatively by looking 
at the skew and kurtosis. If either of these latter is significantly different from zero, then 
Normality cannot be assumed. Typically (see e. g. Tabachnick and Fidell 1989), a 
significance level of 0.01 is used, so a null hypothesis of a parameter being zero was 
rejected if it was more than 2.5 standard deviations from the mean. The Levene test is 
used to check for homogeneity of variance between the groups. Details of these tests 
on our data are given in Appendix 5. Details of normality of curvature and 
transformations are also given in Appendix 5. 
The following steps were taken on examination of the data. 
1. To normalise data, the log of results were used for Stroop (colours and reading), 
Visual Span, CES-D, State-Trait Anxiety Scale and Symptoms. It was discovered that 
Rey Copy did not show a normal distribution and was not easily transformed into a 
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normal distribution. 
2. On examination the following outliers were removed; 
- one CFS from Stroop tests which fell outside 2 standard distributions from the 
I mean because the patient performed extremely poorly; 
- one CFS from Threshold test that fell outside 2 standard distributions from the 
mean because the patient performed outstandingly well. 
The variance of the different groups was compared. On four tests, CFS patients were 
significantly worse and more variable, (Log (CES-D), Reaction Time Decision and 
Movement Time, and Finger Tapping) (this was also true for CES-D before the log was 
taken), and this will need to be borne in mind. Note that the results of looking at data 
in this way showed that CFS patients' data was more variable than controls. This is 
consistent with the study's expectations in regard to CFS patients, that is, that some CFS 
patients will be very much worse at tests and therefore become outliers when compared 
to others who are partially recovered and will perform normally or near to normal. 
Illness and activity data used highly discrete scales (e. g. 0,1,2) for which ANOVA was 
not suitable. Therefore non-parametric analysis was used: the Mann-Whitney test for 
compariing two groups of data and Kruskal-Wallis for comparilng three groups. 
1.3 Significance 
The convention followed in this study is to give two tailed significances which are equal 
or below 0.1, placing greaterweight on those results with higher significance as per Efron 
and Tibshirani (1993). They rate evidence against the null hypothesis as borderline if p 
< 0.1, the strength of evidence progressively increasing to very strong if p<0.01. 
Significance levels show either-direction differences. However, for most of this analysis 
only one direction is being considered. For example, on first testing the alternative 
hypothesis is only confirmed if CFS patients are worse than controls. Furthermore, using 
0.1 significances helps to reveal patterns of performance, since accumulations of 0.1 
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significances by chance when the null hypothesis is true is unlikely. Given that this study 
is with small numbers of subjects, 0.1 significance also indicates that these tests are 
likely to be significant with larger numbers; however, no importance is attached to 
individual tests where an 0.1 significance has been found. 
1.4 Missing and excluded data 
It was expected that not all subjects would be able to complete all the tests because of 
illness, because of fatigue or because of lack of time. In addition, questionnaires are not 
always filled in correctly resulting in missing data. Missing data was ignored, but where 
data was missing at first testing all subsequent testings were also excluded on that test. 
Questionnaires where a small number of items were not answered were scored by 
scaling up the percentage of marks collected. 
One patient with dyslexia, whose low NART score was inconsistent with his other 
test-results, was excluded from the analysis of NART and from the analysis of the other 
test that involved reading, Stroop. One subject had forgotten her glasses, so was unable 
to carry out the Threshold and Visual Span tasks; she carried out the Stroop test, but 
due to obvious difficulty on this test, her data were excluded. In addition, her second- 
testing result for this test was also excluded, as it might have been affected by practise. 
Two CFS patients who had absences (asleep or lost consciousness) during the Reaction 
Time test, and hence extremely slow scores, were considered to have an exceptional 
problem; their data were excluded from the Reaction-Time analysis. 
2. Results: Part 1. The subjects: propensity to Illness, psychiatric profile and 
beliefs 
What was expected: 
1. CFS patients would have higher pre-illness activity, higher contact with CFS related 
illnesses, and more treatment with antibiotics. 
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2. CFS patients when ill would have restricted activity compared to control groups. 
3. CFS and Crohns/colitis patients would score higher on psychiatric indicators, life 
events and have more external locus of control. 
2.1 Subject Profile 
2.1.1 Predisposition to illness 
The general questionnaire, given to all the subjects, produced the following differences 
between CFS and control groups. 
In respect of vulnerability to, or predisposition of a subject to CFS, significant differences 
(Table 5) were found between the three groups using a non-parametric test (Kruskal- 
Wallis). These significant differences suggest: - 
- CFS subjects had more contact prior to illness with CFS or its associated illnesses 
(e. g. EBV and Coxsackie B) than control groups. 
- CFS subjects thought they had taken more antibiotics in the two years prior to their 
illness than the control groups. 
- CFS subjects had more serious illness prior to the CFS than normal controls in a 
similar period. 
- CFS subjects, prior to their illness, did more social and fitness activity than 
Crohns/colitis. 
- CFS subjects had more life events of a serious nature than Crohns /colitis patients. 
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Subject Profile - Illness Variables 
- CFS patients had significantly shorter length of illness than Crohns/coritis patients. 
The delay in diagnosis of CFS patients compared to Crohns/colitis patients and the 
feeling that doctors were unhelpful may contribute to the lower level of coping that CFS 
patients seem to experience. CFS patients had had shorter length of illness than 
Crohns/colitis patients, therefore their lack of ability to cope cannot be due to having a 
long illness alone. 
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Subject Profile - Activity Level 
The interaction of fatigue and symptoms was analysed with depression and anxiety, 
activity levels, and other health questions for CFS patients. Analysis of a number of 
variables was carded out to see whether CFS patient symptoms, including feellings, were 
consistently correlated (Table 7). The significant findings showed groupings of correlated 
variables as follows: - 
- Higher fatigue, more symptoms per week, problems with reading, depression, anxiety 
and less coping were all highly correlated (positively) together. Therefore, more 
symptoms or problems on one meant more symptoms/problems/fatigue and less 
coping on the others. 
- Difficulty reading correlated (positively) significantly with more fatigue, more symptoms 
(that week), and more depression and anxiety. 
- The answer that doctors were helpful was correlated (positively) significantly with 
more coping and less fatigue. 
- The length of illness correlated (positively) significantly with increased anxiety. 
- Delay in diagnosis correlated (positively) with a longer length of illness. 
- More symptoms that week correlated highly (positively) with more depression, anxiety 
and fatigue; these all correlate (positively) , but less strongly, to having problems 
reading. 
These results suggest that symptoms, mood, attitude and activity are very interrelated 
in CFS. The direction of causality is not shown but these correlations suggest either 
depression and anxiety are caused by CFS or that CFS symptomatology is caused by 
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Table 7. Correlations between illness and nsychological variables: 12age 1 of 2. 
The following table shows the correlations between the illness and psychological variables. 
The correlafions are pair-wise, that is, each correlation is calculated using all of the subjects 
for which data on both variables exist; the number of subjects used for each calculation is 
shown below each value in brackets, since the correlations are therefore based on different 
numbers of subjects. 
Two4ailed significances 
* p<O. l ** P<0.05 *** P<0.01 **** P<0.001 
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depression and anxiety. Doctors attitudes and diagnosis are external factors that may 
influence recovery since a helpful doctor and early-diagnosis seems to correlate with 
coping and the length of the illness as well as perceived fatigue of patients. 
2.2 Data Personality, Psychiatry Beliefs and Symptoms 
2.2.1 The Middlesex Health Questionnaire 
Table 8 shows the differences between the three subject groups on the the MHQ. It 
shows that the CFS patients are very significantly more Anxious (p<0.001), Somatising 
(p<0.001) and Depressed (p<0.001) than both control groups, and more Phobic (p<0.05) 
and Obsessional (p<0.01) than normal controls. CFS patients also score as more 
depressed an the CES-D (p<0.001) and more anxious on the Spielberger state/trait 
anxiety Scale (p<0.001) than both control groups. No significant differences are found 
between the normal and Crohns/colitis group. On answering the questionnaire more 
CFS patients reply that they had depression than both control groups and Crohns/colitis 
patients significantly more than normal controls. 
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2.2.4 The CES-D 
The CES-D scores show the CFS patients as having significantly higher scores (p<0.00 1) 
on depression and the difference in average score to be very much higher than both 
control groups (an average score for CFS patients of 19, compared to 6 and 8 for the 
Crohns/colitis and normal controls respectively). This is a clear result showing that CFS 
patients report a far higher level of symptoms of depression than controls. 
2.2.5 The Spielberger Questionnaire 
The Spielborger State/Trait anxiety questionnaire results show the CFS patients scoring 
way above controls on anxiety scores. The results are significantly different at the 
p<0.0001 level and show an average score of 42 for CFS patients compared to 33-36 
for controls (for State Anxiety; similarly for Trait Anxiety). This is a very clear difference 
showing CFS patients as scoring very highly compared to controls on Spielberger's 
anxiety questionnaire. 
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3 Resutts: Part 2. Cognitive test battery and mood 
3.1 Results: First Cognitive Testing 
The three subject groups were compared at first testing to see whether there were any 
differences between them; in particular to see whether CFS patients scored worse on 
some of these tests. 
Table 10 shows the results of comparing the scores of CFS, Crohns/colitis patients and 
normal controls on the set of cognitive tests at first testing using an ANOVA. 
Weighting data 
A number of the memory tests and word fluency tests used different versions. This use 
of different versions is commonly used in clinical testing but always involves the problem 
of the interchangeability of the tests (Golden et al. 1990). To overcome this the test 
results have been examined and corrected to allow for any difference whch could 
significantly affect results. The procedure was as follows: 
1) Check that the distribution of versions throughout the groups was not biased by being 
significantly uneven. Significant differences were not found in the proportion of each 
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group doing a particular version although distributions were not exactly the same. 
WhUe every attempt was made to distribute the test versions evenly at first testing this 
could not apply to second testing where the person did an alternative version. 
2) Check that means of different versions were not significanby different. Differencos 
were found between versions on the word fluency test, the Logical Memory test and 
Rey Memory test. 
3) On these tests (in 2 above) the resuits were adjusted by the z score of the version 
used, adjusted for the distdbution of the population doing each version (see Appendix 
4). The use of z scores for weighting data is a standard procedure (Lyman 1963). 
(For details of weighting see Appendix 4). 
3.1.1 Memory tests 
CFS patients do significantly worse than normal controls on several of the memory tests. 
The CFS group perform significantly worse than the normal control group on Rey 
Memory (p<0.01) and Word Recognition (p<0.05) and the Logical Memory test is 
significantly worse at the 0.1 level of significance. The CFS Associate Learning score 
is lower than in the normal group but only significantly different between normal and 
Crohns/colitis patients. 
The differences between CFS patients and normal controls on these memory tests are 
not reproduced between CFS patients and Crohns/colitis patients. The Crohns/colitis 
patients' Associate Learning Score, Word Recognition score and Rey Complex Figure 
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It is noticeable that neither the CFS or the Crohns/colitis group do worse on the Digit 
Span and the Visual Span test. This may be because these tests require immediate/short 
term rather then longer term memory. 
3.1.2 Psychomotor, vigilance and language speed tests. 
The CFS patients score significantly worse (p<0.01) on the less difficult part of the Stroop 
test, ie reading the text in different coloured ink, but much less significantly worse on the 
harder part. CFS patients also score worse, but only at 0.1 level, on the category word 
fluency task. 
3.1.3 The Groups compared over the whole cognitive battery 
The overall results show CFS patients scoring less well than normal controls on 90% of 
the tests at their first attempt, the differences being significant on over half of the tests. 
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3.1.4 Fatigue during the Reaction Time test 
The reaction time test (as discussed Method 5.3.5) was repeated to see if CFS patients 
had an abnormal amount of fatigue and are slower by the end of the reaction time test 
instead of improving due to practise. The results of subtracting the second set of 
movements from the first set of movements was analysed using a West. The result in 
Table 11 shows that the CFS subjects are significantly different from normal controls on 
change during the Reaction Time test. 
On decision time normal controls got faster (p<0.05) but CFS patients get slower (this 
is also true with regard to Crohns/colitis patients). On movement time all the groups get 
slower but CFS patients get slower still (p<0.05) than normal controls. This confirms that 
CFS patients are actually getting slower during testing and that they may be fatiguing 
very quickly. The slowing could also be due to motivational factors. 
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Tablo 11. Slowinn Durin Testing: Difforoncos betwoon CFS. Normal 
Controls and Crohns/Colitis Patients at Flm-t Testing. 
Two-tailed significance ** = p<0.05 
CFS v. 
CFS Normal normal Crohns/colitis 
Test (millisecs) mean s. d. mean s. d. West mean s. d. 
------------------------------------ 
Decision Time -1.76 35.96 14.11 22.78 
--- - -- -- --- - ----- 
t(53.28)=2.17 
- ------------ - --- 
11.50 15.13 
Movement Time -16.09 38.53 -0.50 17.28 t(44.66)=2.17 -4.30 17.81 
(the two t-statistics are the same). 
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3.1.5 Specific problems in the memory tests 
score for first five marks 
CFS 
Normals 
Mean St. Dev. 
2.94 1.01 
3.25 0.92 
score for the last five marks 
Mean St. Dev. 
1.10 1.37 
1.87 1.58. 
Both groups remember less at the end of the passages, but while CFS patients are not 
significantly different at remembering the beginning of the passage (a Mann-Whitney test 
statistic of 1.48, p=0.140), they are significantly worse at remembering the end of the 
passage (a Mann-Whitney test statistic of 2.44, p=0.015). 
3.1.6 Specific test problems in language tasks 
In the word recognition task subjects were scored according to how many items they 
marked and separately on how accurately they recalled the words, and they were 
penallsed for errors. It is found by looking at the number of words guessed (i. e. correct 
and incorrect) that at second testing there is a tendency, by both groups, to guess more 
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words but CFS subjects are more accurate when they do so. 
Summary 3.1.7 
3.2 Results: Changos in perforniance between first and second testing 
3.2.1 Choosing the analysis for comparing the results at first and second testing. 
The analysis of first and second testing was done comparing CFS and normal controls. 
The Crohns/colitis data were not included in this analysis but results are shown, for 
interest, in graph form in Appendix 6. The Crohns/colitis data was not included because: 
- the Crohns/colitis group data at first testing have already shown the information most 
pertinent to the analysis of the three groups; 
- the analysis of all three groups at first and second testing on an ANOVA produces a 
complicated set of interactions that are difficult to disentangle to be sure what they 
mean; 
- the Crohns/colitis control group was smaller to start, with 23; with retesting drop-out 
numbers fell to 17 and thus below the level where significant differences are likely to 
be found behveen first and second testing. 
The Graphs in Appendix 6 show the improvement of Crohns/colitis patients compared 
to that of other groups. It is highly noticeable that Crohns/colitis patients rather than CFS 
or normal controls are most often the group showing least improvement. It is possible 
that the Crohns/colitis group learn less well for reasons that are peculiar to that group. 
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3.2.2 Comparisons between CFS and normal groups on first and second testing. 
performance, for the whole sample; this is the REPETITION EFFECT; 
2) the overall difference between the groups, taking into account both before and after 
scores; this is the GROUP EFFECT; 
3) the interaction between 1) and 2), showing the difference in the change in 
performance between the groups i. e. whether the two groups improve in performance 
differently; this is the INTERACTION EFFECT. 
Performance improvement between first and second testing is only of interest if it is 
greater in the CFS group. If it is the same in both groups this is probably due to practise. 
Table 12 shows the means of the cognitive tests on the first and second testing (for 
subjects for which two testings were available), F-statistics and significance of the 
differences. Note that the data used are only those of the people who completed the 
requisite test at both testings; means shown for the first testing on this Table may 
therefore not be the same as those shown for the first testing on Table 10. 
The Graphs in Appendix 6 show the differential improvement for each group at first and 
second testing and CFS patients who completed three testings (the figures from which 
these graphs are drawn are also given in Appendix 6). 
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Results of compadsons 
The results show a CFS group effect on Stroop Reading (p=0.007) and word fluency 
categories (p=0.092 only); neither group improves significantly but CFS patients are 
worse, to the same degree, on both testings. This suggests CFS patients have a poorer 
performance on these tests which are stable and does not respond to recovery in the 
short term. Appendix 6 Graph 9 shows CFS patients catching up with controls over three 
testings on Stroop reading and suggests recovery is taking place on the Stroop reading. 
Graphs 3 and 4 show word recognition figures to be fluctuating. The results show an 
effect of repetition and an interaction of both effects on Word Recognition and Associate 
Learning. On Word Recognition this is because CFS performance improves while 
normals stay the same. On Associate Learning this is because Normals get worse while 
CFS stay the same; in this test, negative practise effects may cause worsening 
performance, probably due to the order in which test version were given . However in the 
case of US patients, recovery may offset the effect of negative practise. 
An interaction effect only is found on Stroop Colours (p=0.020) here CFS are improving 
but normals get worse at the test. This suggests either that CFS patients are recovering 
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on a test where practise is a disadvantage or that, on this test, the resuits are not very 
reliable on re-test. 
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Illness variables - change over time 
As discussed in the Method chapter, CFS patients have significant large differences in 
the number and severity of symptoms and in perceived fatigue from both controls. These 
group differences occur when both testings are analysed not just at first testing. At 
second testing fatigue is reduced for both CFS and normal groups and reporting of 
symptoms "now" improved in CFS patients siightiy more than controls. By second testing 
CFS measures of illness have improved overall. One must take into account that an 
improvement of the scale from 3 to 4 (almost exhausted to near 1/2 activity level) may 
represent a larger change than from 7 to 8 (representing slightly below normal to normal 
scores). Appendix 6 Graphs 20-25 show the change between first and second testing 
for all three groups. However, change in depression and anxiety are not significantly 
different between CFS and normals and therefore are unlikely to account for 
improvements in cognitive performance in US patients. 
3.2.3 Trends for CFS patients at third testing 
The graphs in Appendix 6 show the means of CFS patients on the cognitive tests over 
three testings, for the patients who were tested three times. They allow us to see the 
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3.4 Depression and anxiety 
3.4.1 Depression scoring at first testing 
Two main measures of mood were taken at the time of each testing: the Spielberger 
state/trait anxiety scale and the CES-D depression scale. At the first testing, CFS 
patients had very significantly higher levels of anxiety on both state and trait scales and 
depression scores than both normal controls and Crohns/colitis patients. 
3.4.2 Depression scoring at second testing 
Depression scores and anxiety improve slightly in both groups, but CFS patients do not 
improve more than normals. The group differences at second testing remain highly 
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3.4.3 Results of looking at depression scores as a covariate 
The results of the correlations, shown in Table 13, show mood is highly correlated with 
most of the tests where highly significant differences are found between CFS and normal 
controls. These are the psychornoter tests - Reaction Time (Decision Time), Finger 
Tapping and Digit Symbol - and Word Fluency and Stroop. These correlations need to 
be treated with caution because the results so far tell us that the depression score for 
the CFS patients is much higher than for controls so that any effect that is associated 
with CFS will for this reason correlate with depression scores. 
-152- 
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It was found that the use of an additional, second covadate (anxiety) made little 
difference to the results, and therefore was unnecessary, according to the statistical 
principle of parsimony. This was not surprising, since depression score was found to be 
highly correlated with both State Anxiety (correlation 0.628 (n=108), p<0.001) and Trait 
Anxiety (correlation 0.737 (n=106), p<0.001). 
The CES-D scores were used as the co-variate in their raw state. Since the commonly 
used covariates are non-normal distributions, such as age and demographic 
characteristics (see Tabachnick and Fichell 1989 p23 and 317), transformation of this 
data would be unnecessary and might lead to a less linear relationship between 
depression and the test measures. The depression score CES-D meets the requirement 
(Tabachnick and Ficheil 1989 p. 319) to be a continuous variable related to the 
dependent variable. 
The effects of type of group are shown to be accounted for by depression (as shown by 
depression score) on Stroop and Word Fluency (scores on these tests are also shown 
to be correlated with depression score for CFS patients in Table 14). Depression score 
is shown to be related to reaction time and finger tapping and Digit Symbol scores but 
not to affect significantly the group differences on those tests. Significant effects remain 
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on Logical Memory, Rey Memory, Reaction Time Movement Time, Reaction Time 
Decision Time, Digit Symbol and Word Recognition, showing that some other factor 
besides depression is likely to be at work. 
4. Summary of Results 
-162- 
CHAPTER 5. DISCUSSION 
I Discussion of method 
1.1 The CFS group as representing the CFS population 
1.1.1 Diagnosis 
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a) Resuh of cognitive tests may be underestimated because some patents are not as 
b) Recovery may be under-estimated, because some patients are already considerably 
improved at first testing. 
c) Psychiatric indicators may be over-estimated, because some of the group should be 
classified as depressed rather than CFS, or under-estimated, because patients with 
previous psychiatric histories or those an antidepressants are excluded. 
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1.1.2 Subject group compared to its whole population: possible bias in the group 
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acutely ill were therefore, with some exceptions, excludýng themselves from the study. 
1.2 The exclusion criteria discussed 
For the type of neuropsychological tests used, it is well known that depression and 
antidepressants, anti-convulsants, substance abuse, head injury and epilepsy can 
significantly affect outcome (Wittenborn 1990; Wechsler 1987 p. 81-87; Wilson et al. 1988; 
Gillham et al. 1988). Age cohorts also differ in performance (Wechsler 1955). Our 
exclusion criteria were dictated by that evidence. However, in respect of studies on CFS 
in general, the problem of only selecting part of the population profile is a serious 
methodological problem. There is now a growing reallsation that 'to tease out 
multifactorial aetiologies will not be aided by excluding the psychiatrically ill from samples 
of CFS, ' Lewis and Wessely (1992) (p95), 'we conclude that the approach of excluding 
people with physical and psychiatric conditions is first impractical, second premature, 
especially since the causes of many psychiatric disorders remains obscure, and finally 
at odds with the common epidemiological approach that assumes a multifactorial 
aetiology. ' The experience of this study backs up this statement: excluding those with 
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1.3 The effects of subject selection on results 
1.3.1 CFS patients 
The criteria used were designed to exclude patients with other illnesses. In other studies 
the inclusion of subjects with other physical illness (for example a case of MS) may lead 
to the conclusion that more abnormalities exist within the CFS group. 
The exclusion of some patients due to past psychiatric history or treatment with 
antidepressants may lead this study to underestimate the presence of psychiatric 
symptoms in the CFS group. However the MHQ, depression and anxiety questionnaires 
show quite clearly that psychiatric indicators are much higher in CFS patients even when 
patients with psychiatric history, or taking antidepressants, are excluded. In excluding 
those with psychiatric history and those taking antidepressants the study shows that 
psychiatric indicators in CFS are not just confined to a small part of the population. 
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1.3.2 Crohns/ colitis group 
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1.3.3 Normal controls 
1.3.4 All groups. 
The subjects were ail volunteers and could leave at any time; the tasks were quite 
demanding of time and energy. Therefore, those who completed the task were possibly 
the most committed, altruistic and able. 
1.3.5 IQ in CFS 
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1.4 Summary of population profile 
1.5 Problems of a longitudinal design 
than the original sample, thus reducing the sample for analysis, and may be different 
in some way from the original group. 
2. Retesting of subjects may be delayed, particularly with an out-patient group. This 
means that time between test and retest may vary between groups. (Patients 
frequently cancelled sessions due to relapse and so were probably not seen at their 
worst nor strictly at 4 month intervals. ) 
3. Tests have to be suitable for retesting, or it is necessary to use different versions 
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and take this into account, and practise and repetition effects must be taken into 
account. 
1.6 Problems In the measurement of depression In the study 
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2 Discussion of Results Part 1: psychiatric and Illness variables 
2.1 Illness and vulnerability to Illness variables 
2.1.1 Previous health and activity 
The results show the CFS patients to be, prior to their illness, significantly more socially 
and physically active than Crohns/colitis patients. They have more likelihood of having 
been seriously ill prior to their illness, and remembered being prescribed more anfiblotics 
prior to their illness and having experienced more life events than Crohns/colitis patients. 
These factors suggest that the CFS patient may actually be vulnerable to CFS due to 
greater activity and due to greater contact and experience of illness. 
illness in the time period before their illness. It could be that serious illness makes one 
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vulnerable to getting CFS; or that serious illness affects the psychology of individua! s so 
that they are more prone to CFS. Alternatively, it could be that sick patients are more 
likely to remember past Wnesses. 
2.1.2 Illness ratings in the groups 
CFS patients report significantly more symptoms and fatigue than Crohns/colftis patients. 
The rate at which symptoms, are recorded, some as high as 70 points, indicates the 
range of symptoms CFS patients experience. These excessively high scores suggest 
that the CFS patients may be very sensitised to 'picking up' symptoms; they report a 
wide spectrum of symptoms. They do not report only those symptoms which are most 
distressing while disregarding symptoms of lesser nuisance, which alternative behaviour 
would suggest more illness and less sensitivity to symptoms. CFS patients seem to 
complain about a wide range of symptoms irrespective of their relative importance. The 
drop in symptoms at later testing may represent a de-sonsitising to symptoms rather than 
recovery (see section 2.4.1). The fatigue level of patients is, however, supported in the 
results by the performance of CFS patients, which shows slowing down during the 
reaction time task. The Threshold task and finger tapping task results also suggest CFS 
patients are suffering from fatigue. 
2.2 Psychiatric Profile and beliefs 
As might be expected from the literature, the CFS patients as a group clearly had far 
more psychiatric problems than the controls, though whether this was a cause of CFS 
or is a result of it is not shown in these results. However, the scores at second testing 
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of depression and anxiety show little improvement over time despite other recovery and 
suggests that the depression (as indicated by depressed score) is not the sole cause of 
these problems, although mood may just be very slow to reco 
2.2.1 Depression in the medically ill 
2.2.2 Misaftdbution of physical illness as psychological/psychiatdc illness 
A recent article in the Psychologist (Goudsmit and Gadd 1991) points out a recent trend 
to consider cases as psychologicallpsychiatric when other conditions were the cause of 
the symptoms. They have two types of illustration: firstly cases like that of the famous 
cellist Jacqueline du Pre'who had MS but was told in the early stages that the symptoms 
were 'psychological' (Easton 1989). Secondly, and more seriously, studies that show the 
high level of undiagnosed serious illness (which would account for psychiatric disorder) 
in psychiatric hospital patients (Hall et al. 1981). Patients with myasthenia gravis are 
shown to suffer from delay in diagnosis due to misinterpretation of symptoms as 
psychological (Nicholson et al. 1986). Given the difficulty of diagnosing CFS and the 
ambiguity about the cause of its symptoms one should be careful in simply thinking of 
CFS as another form of depression, even though CFS patients show clear psychiatric 
problems. 
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2.2.3 Results an the LIHQ 
No differences are shown on the hysteria scale as one might expect from McEvedy's 
work that has labelled ME as hysteric. The failure of the Hysteria scale to show a 
difference may be to do with inherent problems with this scale, which suggests that it 
does not identify hysterical aspects so much as sociability (see Method 5.3.7). 
Neurotic symptoms in CFS patients 
CFS patients, according to the literature are more likely than controls to have high scores 
on neurotic-type psychiatric variables. Petersen et al. (1991) show CFS patients as high 
on hypochondrias, depression and hysteria (MMPI) and anxiety, neuroticism and 
emotionality. Stricklin et al. (1990) show Neuromyasthenia patients as high scoring on 
anxiety, stress and somatisation. Wessely and Powell (1989) show CFS patients as 
mainly depressed or somatising. CFS patients' MHQ responses suggest widespread 
psychological distress of a general nature. The MHQ questions centre on mild, rather 
than bizarre, psychological symptoms, e. g. "Do you worry unduly when relatives are late 
home? ", "Can you get off to sleep alright at the moment? ", "Do you feel panicky in 
crowds? " The literature and the evidence would suggest that CFS patients have a 
comprehensive set of neurotic typo problems. 
The evidence of general anxiety and depression, though not noccessarily at the clinical 
level, also suggests a neurotic tendency in CFS patients. CFS patients report feeling 
significantly more anxiety and depression than Crohns/colitis patients. CFS patients 
report less positively on the helpfulness of doctors. CFS patients had less expectation 
of getting well and more feel they are not coping with the illness. CFS patients, 
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therefore, are much more negative about their illness, despite the evidence that CFS 
does generaHy get better over time. 
2.2.4 Symptoms, mood and depression 
Correlations between symptoms, mood and coping are shown in Table 7. The analysis 
of the relationsNp between symptoms, mood and attitude is something which has not 
been fully explored and which highlights the inter-relatedness of the three. 
2.2.5 Locus of Control 
Locus of control work has not been thoroughly carried out on CFS patients up to recent 
years and may indicate something of the CFS patients' attitude to illness. The Health 
Locus of Control questionnaire shows us that CFS patients are more likely to attribute 
what happens to their health as due to chance. This means that CFS patients will not 
have a feeling of control over their illness, and this may both increase their proneness 
to chronic illness and impede recovery (see a review of this work by Reid 1984 p. 363). 
This type of attitude may also help assuage guilt according to Wessely (I 990(b)) and be 
a sign that CFS patients could use their illness as a way to evade responsibility. 
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2.2.6 Depression and cognitive results 
One might ask too if other negative psychological factors, as shown in the MHQ results, 
could have an effect on cognitive tests results. The use of anxiety in addition to 
depression in an ANCOVA does not significantly change the results. However there is 
little doubt that CFS patients do have high anxiety and depression scores and on the 
MHQ high obssessionality and somatisisation scores; therefore psychological, probably 
neurotic type, problems are indicated. These neurotic problems may affect cognition. It 
is not known, however, if CFS causes this or if it is causal in CFS. 
The linking of perception that 'doctors are helpful' to 'less symptoms, and 'coping' 
suggest that doctors' helpfulness may make an important psychological, if not physical, 
contribution to improvement. Likewise the delay in diagnosis seems to have a negative 
effect on length of illness and symptoms, suggesting diagnosis may improve outcome 
both, in terms of length of illness and coping. 
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2.3 Summary 
The numbers of CFS patients with high previous senous illness, high numbers of 
antibiotics and high contact with CFS and related illnesses all suggest organic 
vulnerability to CFS, the causes being contagion and physical vulnerability. 
2.4 Recovery 
2.4.1 Recovery of symptoms 
The CFS patients show a reduction in symptom and fatigue measures at 2nd testing. 
These measures show that CFS patients' perception of their illness is changing during 
the period of illness. This is confirmed by the number of patients who considered that 
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It is important that the CFS patients appear to be recovedng over the relatively short 
time, in relation to their illness, in which they are seen. The stated partial recovery of all 
but two CFS patients, combined with the reduction of patients symptoms, means that: - 
1) CFS patients normally recover and, since no intervention was given (except the 
occasional patient trying folk remedies), this appears to be spontaneous. 
2) Individuals within any group of CFS patients will be at a different stage of recovery 
when they are seen and there is no way of telling what stage an individual is at 
when he/she is tested. This means early, and more severely ill, patients are more 
likely to show abnormalities than patients who have recovered somewhat. The CFS 
patients show more variance and outliers in testing than controls which suggests that 
they have different severity and/or different rates of recovery from the illness. 
2.4.2 Implication of recovery to the study 
The conclusion is that US patients are not homogeneous. The cognitive problems 
observed in this study will depend on the severity of their illness and on the measure of 
recovery that has taken place. There are indications from the study that recovery, 
-179- 
2.5 Summary and model showing the implications of Section 2 for CFS 
If aspects discussed above and the points of the literature survey are taken all together, 
a diagram of the factors involved in development of CFS could be displayed as that 
below (Figure 4). 
There are five kinds of variables in Figure 4 which seem to increase vulnerability to CFS 
illness: these are demographic and geographic/occupational, as seen in the literature 
survey, and medical, psychological and psychiatric which are shown in the above results; 
all of these factors are higher in the CFS group but the illness itself seems to need some 
kind of trigger. Examples of these factors are: 
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- demographic: class, sex 
- geographic: being in an area hit by trigger illness and/or CFS 
- occupational: stressful job, teacher, nurse, doctor, in a large institution, working with 
others who get CFS 
- medical: prior previous serious iliness, contact with trigger illness 
- psychological: personality, active 
- psychiatric: previous psychiatric history, depression / anxiety 
- trigger stress (Life Event), viruses (EBV, Coxsackie B, Echo virus), medical 
operation. 
These lead to increased likelihood of symptoms that become the CFS syndrome, but the 
symptoms seem to require a trigger, often viral, illness (related to geography or exposure 
via occupation) or possibly some stress factor. Depression and anxiety aggravate 
symptoms at all stages. Recovery takes place, but at differing rates which affects 
cognitive symptoms. Undoubtedly diagnosis and expectation of recovery will mitigate 
recovery; these are not shown on the diagram but it gives us some ideas as to the 
process of CFS. 
3 The nouropsychology of CFS patients 
3.1 Table of cognitive results, recovery and depression 
This section discusses the results of the cognitive tests at: - 
1) first testing comparing all three groups; 
2) between CFS and normal groups at second testing and, 
3) when depression score is used as a covariate, against results at first testing between 
CFS and normal controls. 
A summary table (Table 16) follows; the last column indicates what possible causes may 
be implied from the results found. 
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3.2 Cognitive results at first Testing 
3.2.1 Psychomotor Tests 
The largest and most significant differences that occur, with both normal and chronic 
controls, are on tests which involve psychornotor speed or muscle co-ordination at speed. 
This could be due to a physical problem such as nerve impulse slowness and slowness 
of processing in the brain, but also, at least partly, to more psychological factors, since 
depressed patients are known to be slower on reaction times (Miller 1975). Evidence 
from the reaction time test suggests that CFS patients do not benefit from practise on 
these kind of tests but succumb to fatigue quickly and slow down during testing. In other 
words, psychornotor slowing may be increasing, when compared to controls, as the task 
progresses. The existence of such differences may relate to the lack of alertness and 
difficulties comprehending what was going on which the experimenter observed. The 
difficulties of CFS subjects in everyday life may not in fact be due to specific memory 
problems, but to problems of taking in information and responding to it at normal speed 
while a number of things are happening which call for their attention. 
3.2.2 Memory differences 
The memory differences found between CFS and normal patients are significant but 
small. The results of chronic (Crohns/colitis) patients' tests seem to show that they too 
might experience these difficulties to a lesser extent. This suggests that problems 
common to both CFS and Crohns/colitis groups may be impinging on memory function 
to a small degree or that normal controls might be performing better for some unknown 
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In the Associate Leaming Task CFS patients have a tendency to mix up answers on 
Version Two, where a number of answers related to the same topic. They also seem 
less inclined (according to discussion with them) to use techniques such as imagery to 
link items. 
CFS patients remembered the last five segments of the Logical Memory task less well 
than controls, but not the first five. It could be that CFS patients' learning abilities are 
defective in some way because they are remembering early material better than late 
material (Lezak 1983). However, the CFS patients performed well on immediate / short- 
term memory tasks, therefore this is more likely to be due to a drop in concentration. 
The deficiency in word recognition is slightly worse than might be expected from other 
results and it may be that isolated words pose a particular recall problem. It is unlikely 
that CFS patients are maiingering in their poorer results on these tests because they also 
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From these comments, one can see that the problems may lie with strategies for coping 
with a task as much as with memory itself. 
CFS patients have notably more success with remembering of numbers and this may not 
be due to the difference between language and numbers but between recent/long term 
and immediate/short term memory. Another possibility is that CFS subjects have 
problems with retrieval where two close alternatives are available: on the word 
recognition test several pairs of words that were similar phonetically but not in meaning 
were presented in the recognition task. This would fit in with the word mistakes reported 
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The CFS patients are poorer than controls on the Threshold task (between CFS and 
Normal controls the difference is p<0.05). This test involves vigilance, fast information 
processing and psychornotor skills. On this test the same differences are found between 
CFS and Crohns/colitis patients suggesting that this is a robust difference and peculiar 
to the CFS group. This also suggests a possible attention problem, however it is 
surprising that CFS patients do relatively well on the PASAT if they have an attention 
problem because it is quite a good test of divided attention. 
3.3 Test performance and malingoring, motivation, fatigue and attention 
3.3.1 Malingering 
If the test performance is due to psychological causes, depression is the main candidate. 
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3.3.2 Motivation and fatigue. 
3.3.3 Test performance and the arousal curve 
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3.4 Cognitive results at second testing 
The study shows a pattern of cognitive problems consistent with most previous literature 
involving cognitive tests. These are that CFS patients are slower than controls in 
decision and movement time, on WAIS digit symbol and Stroop tasks and slightly poorer 
than normal controls on some verbal and visual memory tasks. The study observes 
improvement in CFS patients on a number of these poorly done tests during the 
recovery period. So it is possible that cognitive performance is depressed initially by the 
illness but recovers over time. Mood variables, although highly correlated to many of the 
cognitive tests, especially those involving speed, only partially account for test 
differences. 
The study reported in this thesis shows that chronically ill patients are less good than 
controls on some memory tests, but function as well on psychomotor tests. It may be 
that being chronically ill, as for both sets of patients, affects performance on the tests, 
or that Crohns/colitis patients perform worse for different reasons, e. g. taking the drug 
sulphursalazine, or vitamin or electrolyte deficiencies. However, the Crohns/colitis 
patients tested do not show high scores on self rated depression symptarnatology and 
anxiety, and this is unlikely to be the cause. 
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3.5 Recovery, improvement and the learning curve 
Improvement at the second testing by CFS patients may occur because their poor 
performance at first testing makes improvement, easy compared to control groups who 
may already be performing at ceifing. 
The following paragraphs discuss tests for which improvement is most seen. 
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Associate Learning: The use of two different versions of the Associate Learning test 
causes a negative learning effect at second testing, i. e. it appears that subjects do worse 
on the test, having previously been tested on the other version, than if they were doing 
the test for the first time. The results are rather confused, CFS and Crohns/colitis 
patients improving and normals declining in performance. 
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Improvement in the Finger Tapping test is the least likely to have been affected by 
learning and most fikley to show CFS improvement. 
3.6 Useful tests In studying CFS. 
Some tests seem to be very sensitive to CFS and to recovery, and therefore might be 
used to assess CFS patients; these are Reaction Time, Finger Tapping and Digit 
Symbol. The Stroop Test differences are highly correlated to depression 
symptornatology and therefore the results are less useful in the study of CFS. The Rey 
Memory test and Finger Tapping test are also possibly sensitive to CFS but do not 
recover in the time-span of this study. The Rey Memory Test seems the best memory 
test to use, especially if very severely affected people are being tested. 
3.7 Test performance and neurological factors 
In the absence of clearly defined neuropsychological deficits in CFS, one can only 
speculate which areas of the brain, if any, might be suspected to be a factor. However, 
the results, perhaps, offer the following possible avenues for further study. 
1. CFS patients seem to have a problem with speed of movement and response which 
is probably due to a central fatigue or psychomotor problem. 
2. CFS patients show evidence of psychiatric problems, especially depression and 
anxiety. These may be pro-existent to the illness and probably causal. However if 
they are not pre-existent they suggest that CFS creates depressive illness. 
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The results suggest the following possible problems: 
3. There may be a sHght memory/ recall problem in CFS related to an illness factor 
shared with chronic paVents. 
4. CFS patients may have problems with visual search tasks and visual memory tasks. 
One area therefore that could be indicated as being involved in CFS is the limbic system 
The following points givO supporting reasons for limbic system misfunction in CFS. 
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However, the results discussed in relation to memory are not sufficient to indicate 
pathology in this area. 
1) Analysis of the brain's blood flow in some CFS patients suggests that this area is 
affected. (Mena and Villanueva-Meyer 1992). 
2) Damage in this area could account for visual spatial impa;. rment and verbal memory 
impairment depending on the side involved. 
3) The hypothalamus could be involved in problems with regulatory systems (heat, time 
clocks etc), which might account for sleep abnormalities and arousal being 
inappropriate to time of day. 
4) Damage to the fimbic system could account for emotional changes, depression 
anxiety, agitation and impulsivity in US patients. 
5) Damage to the limbic system has been discovered in severe inflammatory and viral 
diseases (Heilman et al. 1985 p. 391) which relates to CFS etiology. 
No clear signs of brain damage or cognitive deficit are found in the results. The results 
show psychomotor slowing that need not be due to brain damage. 
Psychomotor problems 
It is quite clear from these results that the CFS patient has a motor slowing problem. As 
for motor problems, in CFS the general slowing problem might be to do with slowing of 
nerve impulses or synapses relaying the message to the muscle. It could be to do with 
damage to the muscle itself, or problems in the cerebellum or cortex. However it is more 
likely to be a generalised problem, and the sluggishness of response could relate to 
blood flow abnormalities in the brain. 
Minor Head Injury (MHI) and neurology of CFS 
This study has mentioned similarities with MHI patients. The symptoms of patients with 
minor head injury are very similar to those reported by the CFS patients. Studies 
(McLean 1983; MacFlynn et al. 1984) of MHI patients on neuropsychological assessment 
show they initially have problems with the Stroop and four choice reaction time but that 
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these recover within one month to six months. Dikmen et al. (1 986(b)) found, at 3 days 
after MHI, differences betoveen patients and controls on immediate and delayed recall, 
delayed recognition, seashore rhythm test and sum recall and the Stroop. However, after 
one month only seashore rhythm test and a four hour recall test showed any differences. 
Amongst the possible causes of MHI after-effects that have been suggested are reduced 
cerebral blood flow, altered brainstern evoked potentiais and reduced speed of 
information processing, all of which are also indicated in CFS. 
It can be concluded that FAHI patients experience similar neuropsychological problems 
to CFS patients, possibly due to similar neurological problems but comparison of this 
study and Dikmen's (Dikmen et al. 1986(a), 1986(b)) suggest MHI patients have less 
severe problems and recover faster than CFS patients. 
The wide spread of neurological symptoms in CFS suggests that, if the brain is involved, 
more than one area is indicated, i. e. a diffuse rather than focal problem. There is indeed 
no clear evidence from this study that the problems found in CFS patients involve any 
neurological abnormality other than that found in depressed patients. 
4. Comparison with previous nouropsychological testing 
-199- 
Kilfedder (1988) and Smith (1991) both show slower reaction time in US patients. The 
study reported here confirms that result and shows that it is Hkely that this effect is due 
partly to depression. The study also shows that improvement occurs in movement time. 
Smith (1991) shows Stroop effects on the equivalent of our reading test. The study 
reported here confirms this, but the results suggest this is not due to distraction. The 
study reported here also shows that CFS patients' performance seems to be affected by 
depression, so much so that depression might account for this difference. 
Bastien shows drawing to be poor in CFS patients. The study reported here does not 
find this; Rey Copy is not significantly worse in the CFS group, although this effect may 
occur only with drawing not with copying. It is, however, likely that differences might have 
occurred if CFS patients had been timed on the copying task. The Complex Figure test 
is much worse from memory, more at first than second testing (where the need to 
remember was known), and this may reflect drawing problems. 
Smith finds CFS patients slower and less accurate in visual search tasks; this study does 
suggest that CFS performance is poorer on the Threshold task which is similar in its 
visual search requirements. 
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Lane (1991) finds a discrepancy between visual and verbal memory. This study finds 
CFS patients poorer on both. However the fact that no significant difference is found on 
Visual Span suggests visual drawing (as above) may be a factor. 
Summary 
In comparison with past studies the study reported here confirms that CFS patients 
probably have reaction time slowing (DT and MT); movement time improves with 
recovery in our study. CFS patients have a problem with the Stroop task but this may 
be due to depression. CFS patients may have minor verbal memory (not 
immediate/short term memory) problems but not large deficits on these tasks, except 
possibly in very ill groups. CFS patients probably have problems on visual search tasks 
and the Rey Memory task. In addition the study shows the CFS patients to be much 
worse on the WAIS Digit Symbol and this appears only partly accountable by depression. 
This study indicates the severest problems for CFS patients may be in psychomotor 
slowing. 
5 Summary of Discussion 
5.1 Results 
1. CFS patients perform below controls on psychomotor tasks and recent/long term, but 
not immediate/short term, memory tasks 
2. CFS patients improve on second testing, above improvement in normal controls, on 
some of the tasks where they performed worse than controls at the beginning but 
some of this could be due to differential learning. 
3. CFS patients score highly on self-rated depressive symptomatology and anxiety, 
which partially accounts for their poor performance on cognitive tests. 
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6.2 Implications 
the course of a year but may be negligibie in the improvement of mood. 
Previous research has proved the existence of high depression sores in CFS patients. 
This study shows that mood scores do have a relationship to memory and psychomotor 
scores in CFS patients, although they do not necessarily account for the extent of 
psychornotor retardation and poorer cognitive performance. This relationship is not 
demonstrated in other studies although it can be assumed. 
5.3 Contribution of rosults to knowledge of CFS 
The study shows that CFS patients do less well on memory and psychornotor tests than 
matched normal and Crohns/colitis controls and this can be seen in small groups of 
moderately ill CFS patients. The CFS patients do consistently and markedly worse on 
psychomotor tasks and, although results seem to be affected by depression, analysis 
suggests depression does not wholly account for these differences. The CFS patients 
do worse on visual search tasks but only at first testing. The CFS patients also do worse 
on the Stroop and word fluency (language tasks) but these can be accounted for by 
depression. The study is not a replication although other studies discussed in the 
literature survey do show some of these results. The importance of this study is that it 
is a controlled study using a formal test battery (based on similarities to diffuse head 
injury and toxic poisoning) and looking at longitudinal changes in the results. 
This study is unique in showing how CFS patients improve on some cognitive tests 
during recovery. It demonstrates that recovery may be occurring and that cognition and 
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It is probably the combination of memory and speed of response rather than the specific 
problems that cause CFS patients to complain of problems with cognition. The largest, 
and probably the most disabling to the patient in the everyday, are the slowness and, 
possibly, a lack of alertness; this makes some improvement over time. It is tempting to 
see the treatment of depression as the answer to such problems but so far this has not 
been established. Rather, depression seems an integral part of the illness. If counselling 
and/or drugs can be shown to speed this recovery or the lifting of depression, this would 
be valuable and might improve psychomotor speed. 
The CFS patients do worse on tasks that required mainly psychornotor skilis. The results 
suggest psychornotor impairment which is aggravated by depression. The existence of 
specific focal impairment is not supported by the study and the best comparisons would 
be with diffuse head injury and conditions with general psychomotor retardation. The 
evidence recently brought forward as to decreased blood flow to large areas of the brain 
is supportive of generalised brain dysfunction (Mena and Villneuva-Meyer 1992). 
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CHAPTER G. CONCLUSIONS 
The results show the following (statistical significances given are for the CFS group 
compared to the normal control group): 
- CFS patients perform significantly worse than normal controls on 9 out of the 14 
cognitive tests used in the neuropsychological test battery and significantly worse on 
all measures of psychiatric indicators, symptoms and fatigue. 
- CFS subjects are significantly slower on psychornotor tasks than both normal controls 
and Crohns/coiitis patients. These tests included Reaction Time (Movement Time 
p<0.001 and Decision Time p<0.001), Finger Tapping (p<0.001), and WAIS Digit 
Symbol (p<0.001). 
- CFS patients are also poorer than both control groups on the Stroop Test reading 
(p<0.01) and Threshold Task (p<0.05). 
- When self-rated depression symptoms score is used as a covariate it is found that 
depression could account for the differences on Stroop and part of the differences on 
the other psychomotor tests. However, highly significant differences remain on the 
psychomotor tests after depression is taken into account. 
- CFS patients are also, but less significantly, worse than normal controls on memory 
tests: Wechsler Logical Memory Task (p<0.1), Word Recognition (p<0.05) and Rey 
Memory (p<0.01). These are tests of recent/long term memory; they show no 
differences on immediate/short term memory tests. Tests of recent/long term memory 
are, however, performed worse by Crohns/colitis patients compared to normal controls 
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on Associate Leaming and Rey Memory. This suggests that both CFS and 
Crohns/colitis groups may have slight memory problems, but the scores for all groups 
was so high that performance for all groups was above average. 
- CFS patients continue to perform worse than normal controls at second testing on 
Stroop Reading, Reaction Time, Finger Tapping and Digit Symbol (i. e. the difference 
in improvement is not significant). However, they improve more than normal controls 
do (i. e. the difference between the groups becomes smaller) at second testing on 
Associate Learning, Stroop Colours and WAIS Digit Symbol (each at p<0.05) and 
Word Recognition and Reaction Time (Movement) (both only at p<0.1). This 
improvement may be due to differential rates of learning on the learning curve or to 
recovery. 
- CFS patients do not show improvement (beyond that of controls) on depression 
symptom scores and anxiety or fatigue but they do show small improvement above the 
normal group on symptoms that week (p<0.1). 
- CFS patients' performance on psychomotor tasks shows that CFS patients have a 
problem with slowing of decisions and movement. These tasks show improvement 
when retested after a period of more than 4 months. These differences are partially 
accounted for by depression. CFS patients probably have a psychomotor slowing 
problem due to a combination of depression and CFS, which responds to recovery. 
- CFS patients show very high levels of self-reported depression symptoms and anxiety 
throughout their illness despite the exclusion from this study of subjects with a 
psychiatric history or who are taking antidepressants. CFS patients also score highly 
on neurotic psychiatric indicators on the MHQ questionnaire. It is clear that psychiatric 
factors are important in CFS but that they are not necessarily there pre-illness nor do 
they wholly account for differences in cognitive performance. 
- The results show that CFS patients have significantly different pre-illness experience 
(or perception of it). They have had more serious illness and more antibiotics. 
Once ill CFS patients have more problems with everyday activities and do fewer 
housework tasks and social activities than Crohns/colitis patients. 
-205- 
No evidence is found in this study that CFS patients deteriorate on cognitive tests after 
initial testing; indeed there is an apparent trend for them to improve on some tests where 
they have poorer scores than controls at initial testing. 
CFS patients have consistent and highly significant psychornotor slowing on the relevant 
tests, compared to both groups of controls. This slowing can only partly be accounted 
for by depression and is, therefore, probably due to some extent to CFS. It could be due 
to muscle and transmission problems or to neurological problems. 
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APPENDIX I 
TABLES FOR LITERATURE SURVEY 
AMqndlx 1 Table 1. Dorinitions of CFS 
A. Ho! mes et al. 1988/1991 Centre for Diseases Control 
Definition of CFS 
Minor criteria 
Symptomatic or historical criteria: persistent or recurring symptoms lasting >6 
months: 
(1) Mild fever ( 37.5 C- 38.6 C oral if documented by the patient) or chills 
(2) Sore throat 
(3) Lymph node pain in anterior or posterior cervical or axillary chains 
(4) Unexplained generalised muscle weakness 
(5) Muscle discomfort, myalgia 
(6) Prolonged ( >24 h) generalised fatigue following previously tolerable levels of 
exercise 
(7) New generalized headaches 
(8) Migratory noninflammatory arthralgia 
(9) Neuropsychological symptoms 
(a) photophobia 
(b) transient visual scotomata 
(c) forgetfulness 
(d) excessive irritability 
(e) confusion 
(f) difficulty thinking 
(g) inability to concentrate 
(h) depression 
(10) Sleep disturbance 
(11) Patients description of initial onset of symptoms as acute or sub-acute. 
Physical criteria : documented by a physician on at least two occasions at least 1 
month apart: 
(1) Low-grade fever 
(2) Nonexucdative pharyngitis 
(3) Palpable or tender anterior or posterior cervical or axillary lymph nodes (<2cm 
in diameter) 
Appendix 1 Table 1 continued 
3. Malignant disease 
4. Auto-immune disease 
5. Chronic psychiatric illness (including endogenous depression, hysterical 
personality, anxiety neurosis and schizophrenia). This exclusion was changed in 
1991 to prior psychiatric history. 
6. Chronic use, abuse or side effects of prescription or illicit drugs (e. g. major 
tranquilisers, lithium, antidepressants, alcohol, heroin and marijuana) 
7. Toxic agents (e. g. chemical solvents, pesticides and heavy metals) 
8. Chronic 'inflammatory diseases (e. g. sarcoidosis Wegener's granulornatosis and 
chronic hepatitis) 
9. Neurornuscular disease (e. g. myasthenia gravis or multiple sclerosis) 
10. Endocrine diseases (e. g. hypothyroidism, Addison's disease, Cushing's 
syndrome and diabetes) 
11. Chronic disorders (e. g. pulmonary, cardiac, gastrointestinal, hepatic, renal, and 
haematological diseases) 
Appendix. 1 Table 1 continued 
B. Lloyd et al. 1988 (taken from Hickie et al. 
Definition of CFS 
(Note that Lloyd took part in Holmes et al. 's definition above). 
To fulfil the criteria a patient must have chronic, persistent or relapsing fatigue of a 
generalised nature, causing major disruption of daily activities, present for more than 
six months, plus two major and three minor criteria (symptoms, signs or 
assessments): 
(a) Symptoms: persisting at least six months continuously, or relapsing on three or 
more occasions with a similar pattern over six months or more. 
(i) Major: concentration/memory impairment 
(ii) Minor: myalgia, arthralgia, depression, depression, tinnitus, paraesthesia, 
headaches. 
(b) Signs: Present on at least one occasion subsequent to the initial illness: 
(i) Major: lymphadenopathy 
(ii) Minor: pharyngitis, muscle tenderness. 
(c) Immunological assessment 
(i) Major: cutaneous anergy, T4 or T8 lymphopenia 
(H) Minor: hypoergy 
Assessment of patients included tests for thyroid, neurological, haematological, 
hepatic, renal, or autoimmune dysfunction. 
C. Dawson 1990 (quoted in Lynch. Seth. Montgomery 1991) 
Definition of CFS 
Syndrome with fatigue as principal symptom 
Definite onset (not life long) 
Fatigue is severely disabling and affects physical and mental functioning 
Other symptoms may be present, particular myalgia, mood disturbances, sleep 
disturbance 
Minimum six months of fatigue present at least 50% of time 
Suggested baseline investigations 
After comprehensive physical examination, including central and peripheral nervous 
system: 
Haematology: haemoglobin and other parameters, differential B12 and folate, 
monospot 
Biochemistry : profile of serum urea and electrolytes, glucose, liver and thyroid 
function, muscle (including cardiac) enzymes 
Virology/bacteriology: at present this is controversial, but the most widely reported 
screening tests are for monospot and the VP-1 antigen if available. 
Psychiatric assessment 
Psychiatric diagnosis ought to be considered: 
If depressive or anxiety symptoms are prominent and could predate the onset of 
symptoms 
Annendix I Table 1 continued 
If there is a strong family psychiatric history or past psychiatric history OR 
If the somatic complaints are bizarre or inconsistent. 
D. Ho Yen (1990) 
Microbiology Dept. Ralomore Hospital. Inverness 
Definition of PVFS/ME 
1. Generalised, relapsing, fatigue exacerbated by very minor exercise causing 
disruption of usual daily activities for at least 3 months. 
2. A compiaint of prominent disturbance of concentration and short term memory 
impairment. 
3. Exclusion of other organic causes for a similar syndrome. 
Supportive evidence: 
a) History 
i) patient well before illness 
ij) an initiating viral infection 
iii) myalgia 
iv) arthralgia 
V) headaches 
vi) depression 
vii) tinnitus 
viii) paraesthesia 
ix) steep disturbance (usually more sleep needed) 
X) adverse effect of alcohol 
A) adverse effect of heat 
b) Clinically 
i) lymphadenopathy 
H) localised muscle tenderness 
iii) pharyngitis 
c) Laboratory 
i) evidence of viral infection 
ii) abnormalities of T cells 
Appendix I Table 1 continued 
E. Sharpe ot al. (1991) 
Syndromes 
Two broad syndromes can be defined: 
F"u-st-infectious fatigue syndrome (PIFS) 
This is a subtype of CFS which either follows and infection or is associated with a 
current infection (although whether such associated infection is of aetiological 
significance is a topic for research). To meet research criteria for PIFS patients must 
(i) fulfil criteria for US as defined above, and 
(ii) should also fulfil the following additional criteria: 
(a) There is a definite evidence of infection at onset or presentation (a patient's 
self-report is unlikely to be sufficiently reliable). 
(b) The syndrome is present for a minimum of 6 months after onset of infection. 
(c) The infection has been corroborated by laboratory evidence. 
F. McKenzie Criteria 1988 from Blakely et al. (1991) (New Zealand 
An illness duration of more than 6 months; a history of relapse; chronic fatigue; 
muscle pain; and early signs of muscle weakness on exercise. 
G. Whelton. Salit and MgjdgkWl992) 
CFS was defined as the occurrence of new complaints of exhaustion and weakness 
persistent or recurrent for more than 6 months after a "flu-like" illness. Patients were 
excluded if similar symptoms were present before the infection, or if there was any 
underlying primary medical or psychiatric illness. 
App. andix 1 Table 2. Names for. CFS 
The follou'ing descriptitv names have been compiled from the twrk of Dr. Gordon Parish, Dr. David S. Bell. 
Dr. Henri Rubinstein and Dr. Byron Hyde. The following rrpresentiust a few ofthe names that have been given 
to this protean illness: 
The Poliomyelitis Nuftew 
A disease resembling or simulating poliomyelitis; atypical poliomyelitis; abortive poliomyelitis, encepha- 
litis simulating poliomyelitis; encephalitis resembling poliomyelitis; postpolio syndrome; posterior 
poliomyelitis, sensory poliomyelitis. 
Names based upon location: Iceland disease. Akureyrri disease, Coventry 
disease, Tapanui flu. Otago mystery disease. Royal Free disease, Lake Tahoe mystery disease, Lyndonville chronic mononucleosis, the English disease; 
Neuromynstheniii-names: 
Neuromyasthenia. Neurasthenia, Epidemic 
neuromyasthema, Epidemic pseudo myasthe- 
nia, Sporadic postinfectious neuromyasthenia, Neurocirculatory asthenia; 
Personid names: Da Costa's Syndrome. Beard's disease, 
Symptom based names: 
Chmaicfatigue, syndrorne. CFS, LaSpasmophilie. 
(France), Raggedy Ann Syndrome, the English 
sweats, Effort syndrome, Tdtanie chronique 
idiopathique; 
Aerial names: Chronic brucellosis. Chronic lyme disease; 
Combined virus/sy-mptom namcc Post-viral fatigue syndrome, PVFS, Persistent 
viral fatigue syndrome; 
Epstein-Barr Virus based names: Chronic Epstein-Barr virus syndrome, CEBV. Chronic active Epstein-Barrý, Orus infection. CAEBV. Virus epidemic in recurrent waves. Chronic mononucleosis, Familial chronic mono- 
nucleosis, Chronic infectious mononucleosis, Chronic active Epstein-Baff virus infection. Chronic mononucleosis-like syndrome: 
tInmthalarnic Naimes: 
Epidemic vegetative neuritis, Neurocirculatory 
asthenia. vasoregulatory asthenia. vasomotor 
instability, vasomotor neurosis. Habitual chronic h) perverhilation syndrome; 
Ile Atypical Names: 
AtYpical multiple sclerosis, Atypical migraine; 
Media naxnes: 
Yuppie flu. Yuppie plague; 
Miscellaneous nazues: Soldier's heart. Epidemic vasMitis %%-ndrome. 
Taken from Hyde 1992a. 
Apn dix I Ta 3. Outbroaks of MEJf 
Year place 
Number or 
cases 
Nat urc Cr 
epidr-nic 
IZO Louisville. KentucLy. USA 37 Student nurses 
1952-34 Dcnmark over 70 District 
1952 Lakeland, Florid3, USA over 27 District 
1952 Middl=x Hos: pital, London 14* Studdit Vu= 
1953 Coventry. England ova 13 Ho-phal suff 
1953 Rockville, Maryland. USA 50 Student our= 
1954 Tallahasw, Florid3. USA 450 District 
1954 Seward. Alaska 175 Disukt 
1954-55 Johanntsbiag. South Africa 14 District 
1955 Durban, South Afrim 140 Hospital staff 
1955 Berlin, Geramny 7 Xqury 
1955 Doscombe, England 2 Holpital staff 
1955 Valston. rngland 233 District 
1955 Royal Free Hospital. England 292 1 lospital suff 
1955 Perth. Australia Not recorded District 
1955 Cilfach Coch. South Wales Not recorded District 
1955 Segbwena, Sierra Leone 45 District 
1955 11orshoth, Icdand 114 District 
1953-56 North West London 34 District and 
Hospital staff 
1935-56 Ridgefield. Connecticut, USA 70 District 
1956 Coventry, England -7 District 1956 Pittsfield, Massachusetts, USA 7 District 
1956 Punta Gorda. Florida, USA over 150 Disuict 
1956 Newton-le-Willows, Lancashire, England over 162 District 
1957 Mskon, South Australia over 60 D4trict 
1958 Athens. Greece 27 Nursin suff 
1958-59 South West London 2 Disaict 
1939 North West London 7 District 
1959 Newtaide upon Tyne. England, 48 Student teachers 
1960 Missiýpi, USA ? District 
1961 minois. USA 7 District 
1961-62 New York State 26 CDAVent 
Los Angeles. USA aMox. 330 IXTE&I 
(sporadic) 
1964-63 Kentucky, USA 59 Factory and Distria 
196446 North Wen London approx. 370 mzict 
1965-66 Galvwon County, Texas. USA 55 District 
1968 FnA; dck. Ltbanon 7 ? 
190-70 Edinburgh, Scotland 4 DISUICE 
(Sporadic) 
1970 Great Omond Street Hospital, London over 143 Haspiul suff 
1970 Lackland Air Force 11m, Texas. USA 221 Hospital staff 
1975 New York State. USA ? Disuict 
1976 South West Ireland over 65 District 1977 Dallai-Fort Worth. Texas. USA 7 Viact 
Taken fro m Behan (1980) Documented clusters of cases 
1979 Southmpton (May et al. 1980) 45 School 
1980 West Coast Scoband Ayr/Helensburgh 22+38+ GP Area (Fegan et al. 1933. Calder and Warnock 1984. 
1981 Balfron (near Glasgow) (Keighley and Bell 1983) 20 GP Area 1984 Lake T2o, Nevada (Buchwald et al. 1992) so Truckee Levington, Nevada + Lake Tao (Levine 1992R50 Area 1084 Montreal, Ouebec, Ontario (Hyde 1992b) 500 Area 1934 N. Carolina Symphony Orchestra (Gruffman 1992) 7 Orchestra 1985 Lyndonviile, New York (Bell et al. 1991) 33 School 
1938 Glasgaw College of Technology 27+ College 
(Dumdell 1936/1989) 
1988 Minnesota (Peterson et al. 1991) 135 Area 1989 RosewWl California (Hyde 1992b) 11+ Hospital 1990 Elgrcve High School (Hyde 1992b) School 
Appendix 1 Table 4. Cases of epidemic disease. to show spread. 
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Taken from Crowley, Nelson and Stovin 1957 
Appendix I Table 5. Apparent incubation period 
Date of Date Apparent 
exposure to of onset incubation 
first host second host period 
20. vii. 55 27. vii. 55 7 days 
16. vii. 55 22. vii. 55 6 days 
29. vii. 55 3. viii. 55 5 days 
Before 1. i. 56 Not less than 
28. xii. 55 4 days 
Before 27. vii. 55 Not less than 
23. vii. 55 4 days 
Before 15. viii. 55 Not less than 
9. viii. 55 6 days 
Before 21. viii. 55 Not less than 
17. viii. 55 4 days 
Taken from Crowley, Nelson and Stovin 1957 
Appendix I Table 6. Cerebrosninal-Fluid Abnormalities 
Location of N o. of No. with 
outbreak persons abnormal CSF 
examined (pleocytosis) 
California 59 3 
Wisconsin 2 0 
England 1 0 
Iceland 8 5 
Australia 59 5 
Kentucky 3 0 
New York 11 2 
Denmark 5 0 
London, England 6 0 
Coventry, England 9 0 
Maryland 25 0 
Tallahassee, Florida 101 7 
Germany 7 0 
London, England 18 0 
Punta Gorda, Florida 5 0 
Coventry, England 7 0 
Greece 4 0 
Taken from Henderson and Shelokor 1959 
Appendix 1 Table 7. Neurological signs in CFS 
No. of cases with objective No. of cases 
neurological disorder without objective 
neurological 
Severe Moderate Mild disorder 
Changes in mononuclear 
series of white cells 20 72 69 112 
Taken from Crowley, Nelson and Stovin 1957 
AD122ncflx I Table & Viruses Implicated In CFS 
Im York Middlesex Coventry 
Angeles Iceland AdeWde State Hospital Copenhagen Hospital 
AJP. C virus 
Brucellosis 
Coussckie 0(17) 
Ence"itis 
Eastern Equine Nil 0(121 Nil 
Japanese B Nil 0412) Nil 
Encephalitis 
Westem Equine Otl2t 
SL 0(12) 
Enecphale- 
H es Sin Wx 
O(S) 0(10) 
erp v 
hAuenza A 0 (121 
] 
Influenza B 
Influenza C 
LePt"Purems 0(s) 018) 000) 
LAuping M 
MMMOVOCYtic 
Choriocneninp 0f 121 O(S) 0(s) 0(101 
Mumps 0(5) W(81 04100 
Paracolon 
1 
Polio Virus 0(51 0(17) W tIOP 01101 
Psittacosis 
Q. Fever 0(12t 
Rabies 0112P 
Rickettsia Burned 
Taxoplammis 
mamma 
Royal RO%31 
Betbesda SewardL Durban Free Punts Free 
Hospital maska Berlin Hospital Hospital (I I Garda Hospital o2m 
A. P. C. virus OM 01? 1 
Brucellosis f (131 OM 0112P 
Cossmicie, 0(31 
Emicephalitis 
Eastern Equine No 0 112, 
Encephalitis 
Japanese B details Nil 
known 0,12, 
E h k 
Otl2o 
ncep a i.. 
016) 
Herpes Simplez 0 IN 
Influenz; &A OM 0 1? 1 
Influenza a 0(7) 0 IN 
Influenza C 0 IN IA"MPITOM 0 OtI2, 
lAupt'ng 0. 
L i 
00 
Pm=Om:! 4ti2 Smx 
OtIV 
P*nicolon See text 
Bethrid-ft-Henvo Oý 121 
Psho, Virus +1191 
psiýs 0 (? ) Q. Fever 
Rabies 
Rickettsia Burneti 
I 
001 
Taxoplasmosis 
Nair. Jrgurrs indwate namberefpowav gesw in parentheses. number afraws studwd. 0 Immune &does on titrrs JIMAX"t- 
&V mmote isfertw4 fbandin some cams. t T%efladinp avre of doubtful sWaificance andwr disruvwdes the text. 
Taken fmm Acheson 1992 
Ag)pe_ndix 1 Table 9. Model for-the pathogenesis of CFS 
Current Favorite Model 
Atopy (AllerPY, 
Epiphenornenon 
Lymphotropic 
Viruses Reactivate 
Compromise No Latent Viruses Activate 
Toxins Immunity (HHN'6. EBV, Immune 
Stress 
Enteroviruses) System I 'C)-tokines) 
Symptoms 
Chronic Affective 
Disorder 
Disability 
Taken from Kornaroff 1992. 
Appendix 1 Table 10. Individual determinants of health service utilization. 
according to the Anderson model 
PREDISPOSING 
I 
graphic 
age 
sex 
marital stntus 
ENABIANG 
I 
Famar 
insurance (type or. 
access to. source) 
ILLNFM LEVEL 
Perceived 
disability 
symptoms 
diagnoses 
general heRlth I 
Sodal structure 
education 
race 
occupation 
family size 
ethnicity 
religion 
mobil I ty 
Belief( 
values 
attitudes 
knowledge 
Community 
facilities 
cost of services 
region 
urban/rural 
Evalianted 
symptoms 
diagnoses 
Taken from Williams, Wilkinson and Arreghini 1990 
Appendix I Table 11. Severi! y of neuropsychological complaints in 135 CFS, 
patients 
Neuropsychological Complaints 
>"- wl 
-I 
= 
a 2D 40 ia 8D --OD 
N SAWO Percentage of Patients 
EI MOO"e 
04W 
Taken from Peterson, Schenck and Sherman 1991 
App2ndlx I Table 12. Dlaanosls of MS 
Signs and Symptoms of Multiple Sclerosis 
in 1271 Patients* 
Site and Initially Total 
t)pe of involvement course 
Pareses 42.9 47.6 
Sensory changes 40.7, b-.. 0 
Visual alterations 35.9 661 
Cerebral sýrnptoms 31.0 39.2 
Brainstem &-or 
cerebellar signs 22.5 91.6 
Spasticity &; or 
Babinski sign 19.4 65.1 
Diplopia % 12-7, 33.9 
Sphincter &ior 
sezusl dysfunction. 9.6 63.2 
Fifth Wor 
seventh cranial nerve .9 23.1 
0: Adapted from Bauer' 
Taken from Poser 1992 
Signs ond Symptomis in 157 Cases *rAu. 
topsy-Proven Multiple Scleresise 
SIGNS 36 
Spasticity and/or hyperrenexia 98 
Babinski-sign 92 
Absent abdominal reflexes 82 
Dysmetria or intention tremor -99 
. Vvstagmus "a I 
Impairment of vibratory sensation 61 
Impairment of pos-ition seniation 52 
SYI%t? TO. %IS. I 
. 
%Iu. -cle ue3knesi 96 
Ocular problemit - altered vwon or diplopis- 85 
Urinary disturbance 82 
Gait ataxia 60 
Paresthe.. iae 60 
Dývsarthna or scanning speech 54 
0 %lodiried from Poser et 
Appendlx 1 Table 13. Frequency of osychlatric dysfunction 
Frequency of Psychiatric Dysfunction in Adults 
. k. ve!; iment N chistric Psýchiatnc 
Author vied thorder in CFS D., 4rder in Controls 
Current Lifetime Current Lifettirw 
%13nu DIS 59% 77.96 NA NA 
06.57 ) 
Kruesi DIS NA 7,576 NA N. A 
15,31 
Wessely SADS 72% NA 361; N; A 
(59) 
Taerk DIS 67% VA NA 29% 
i6o) 
Katon DIS 451, 8% M 48% 
(61-1 
DIS - National Institute of Mental HeaJth (NIM. H) 
Diagnostic Interview Schedule 
SADS - Schedule for Affective Disorders and 
Schizophrenia 
Taken from Buchwald 1992 
APPENDIX 2 
METHODOLOGY TEST ITEMS 
Appendix 2 Item 1. General Questionnaires 
This Appendix contains the various versions of the general questionnaire used. The 
questions are the same, except that some questions were not relevant for all groups, 
and therefore were excluded. Filling in the questionnaire was assisted by the 
experimentor. 
The versions contained in this Appendix are as follows: 
Item 1(a) General questionnaire for CFS patients 
Item 1 (b) General questionnaire for Crohns/colitis patients 
Item 1 (c) General questionnaire for Normal controls 
Item 1 (d) General questionnaire for CFS and Crohns/colitis patients: second testing 
Item 1 (e) General questionnaire for normal controls: second testing 
Aj)r)endix 2 Item l (a). General questionnaire for CFS patients 
When do you think you started to be ill with ME? 
When were you diagnosed as having ME? 
Was this by a GP or a Consultant? State medical department if Consultant. 
Are you taking any medical drugs? 
Do you think you are getting better? 
Are you working? 
What was your job prior to being ill? 
Were you ill to begin with, with any specific illness? 
Did you have or were you suspected of having encephalitis? 
Did you have an initial illness which was much worse than having bad f lu? 
In the two years before you were ill with ME, how was your health? 
Did you have a lot of antibiotics? 
Have you had any other serious illness? Psychiatric treatment? prior to 
having ME? 
Did you have contact with anyone else with ME? 
AT WORK VERY FREQUENT CONTACT 
FAMILY VERY FREQUENT CONTACT 
Did you have contact vith anyone with Coxsackie B, Glandular Fever, or 
other major viral illness at the time? Specify. 
Did or does anyone else you are in close contact with suffer from similar 
symptoms? What is their relationship with you? Work Family etc. 
What leisure activities did you take part in before were ill? LIST 
How many.. times a week did you do each activity and for how long? 
Have you every won any medals or important races for sport? Specify Year. 
Have you ever competed for a sports club or at borough, area. national or 
international level? 
Tick 
r-l 
El 
E: l 
Fý 
F-I 
El 
Fý 
E] 
F-I 
r--i 
F-1 
F-1 
F-1 
Fl 
F-1 
F-1 
Appendix-2 Item I (a) continued 
Tick 
When you were working before you were ill was your job physically 
active? 
Fý 
Did you have to do a lot of walking? 17 
Did you have to stand for long periods of time? E: 1 
Did your work involve studying? No. of hours per week av. ED 
In the 18 months before having ME did any of the following happen to you? 
Were you working for some particular exams? Specify. F-I 
Were you married /divorced /widowed /your partner pregnant/have a new baby 
in the house/adopted a child/grandchildren? 
Did you move area/house? El 
Has any of your f amily been ill? 
Have you been bereaved? 
Did you or your spouse lose or change job? Specify. 17 
. 
Were you involved in any accident/fore/robbery or other particularly 
stressful situation? E: 1 
Have you found the medical profession helpful? Sympathetic? during - this illness? F I 
Do you do any of your previous leisure activities? 0 
Do you have any particular activities that you do when you are unwell 
eg. reading? TV? Radio? 
Do you do household chores? Most Some A few None 
Do you manage to hoover? Carry and hand up wet washing? most of the - time? F 1 
Are there any things that you can do now that you could not do 6 
months ago? Specify. 
Do you feel depressed or anxious? More than 6 months ago? 
Do you have any particular goals within the next 6 months? Specify. Realistic 
How long do you think it will take you to get reasonably well? 
Do you feel you are coping/not coping well with having ME? 
Which of these do you feel is worse than ME - Arthritis, Stomach ulcers, Angina, Poor hearing, Broken leg. Cancer, Multiple sclerosis? 
Appendb( 2 Item l(b). General questionnaire for Crohns/colitis patients 
Date of Birth 
Tel No 
When did you start to be ill? When did you receive a diagnosis? 
Do you think you are getting better? 
In the two years before your illness how was your health? 
Did you have to take a lot of antibiotics for anything? 
Have you had any serious illness (Specify), psychiatric treatm4nt, 
epilepsy, head injury, or a history of alchohol or drug abuse? 
Are you taking any medical drugs? 
Do you drink alchohol? how much per week? 
Do you have contact with anyone who has Myalgic Encephalomyelitis/ Post 
Viral Fatigue Syndrome or coxsakie B or glandular fever? 
Are you working? What is your job? Is Yo ur job physically 
active? 
Do you have to do a lot of walking? 
Do you have to stand for long periods of time? 
Does your work involve studying ? No of hours per week? 
Do you have any problems with following TV or radio programmes or 
reading? 
Do you do household chores Most Some A few None 
What were are your leisure activities prior to your illness? Specify what 
and how many hours per week. 
Do you still do *these activities? Specify what and how many hours per 
week. 
Have you ever won medals or important races for sport or competed at 
club, borough national or international level? 
In the last 18 months has any of these happenned to you? 
Have you been working for any particular exams? 
Have you been married/divorced you or partner pregnant/ have a new 
baby/ adopted a child /had grandchildren ? 
Have you moved area/house ? 
Have you been ber 
, 
eaved or had a serious illness in the family? 
Have you or partner lost or chasnged job? 
Have you been involved in any other particularly stressful situation 
? eg fire/accident/ robbery 
Ap2endix 2 Item l(b) continued 
Have you found the medical profession helpful? Sympathetic? during the 
illness 
Do you have any expectations as to how long it might take to get 
reasonably well? 
Do you feel depressed or anxious 
Do you have any particular goals in the next six months? Specify 
Do you feel you are coping/not coping with having chronic inflamatory 
bowel disease? 
Which of these do you think is worse than Chronic Inflamatory Bowel 
Disease 
Arthritis 
Angina 
Per.,. -%anent slight poor hearing 
Broken leg 
Multiple Sclerosis 
Cancer 
m f- 
/ 
Appendix 2 Item l(c). General guestionnaire for Normal controls 
Date of Birth 
Tel No 
Have you had any serious illness (Specify), psychiatric treatment, 
epilepsy, head injury, or a history of alchohol or drug abuse? 
In the last two years how has your health been? 
Did you have to take a lot of antibiotics for anything? 
Are you taking any medical drugs? 
Do you drink alchohol? how much per week? 
Do you have contact with anyone who has Nyalgic Encephalomyelitiz/ Post 
Viral Fatigue Syndrome or coxsakie B or glandular fever? 
Are you working? What is your job? Is your job physically 
active? 
Do you have to do a lot of walking? 
Do you have to stand for long periods of time? 
Does your work involve studying ? No of hours per week? 
Do you have any problems with following TV or radio programmes or 
reading? 
Do you do household chores Most Some A few None 
What are your leisure activities? 
Specify what and how many hours per week. 
Have you ever won medals or important races for sport or competed at 
club, borough national or international level? 
In the last 18 months has any of these happenned to you? 
Have you been working for any particular exams? 
Have you been married/divorced you or partner pregnant/ have a new 
baby/ adopted a child /had grandchildren ? 
Have you moved area/house ? 
Have you bden bereaved or had a serious illness in the family? 
Have you or partner lost or chaanged job? 
Have you been involved in any other particularly stressful situation 
? eg fire/accident/ robbery 
Do you feel depressed or anxious ? 
Do you have any particular goals in the next six months? Specify 
Which of these do you think is worse than Nyalgic Encephalomyelitis 
Arthritis 
Stomach Ulcers 
Angina 
Permanent slight poor hearing 
Broken leg 
Multiple Sclerosis 
Cancer - 
Appendix 2 Item 1(d). General questionnaire for CFS and Crohns/colitis patients: 
second testinq 
ME Questionnaire: PVFS/chronic Second Testing 
Date of Birth 
Tel No 
Are you taking any medical drugs? 
Do you drink alcohol? how much per week? 
Do you have contact with anyone who has Myalgic, Encephalomyelitis / Post Viral Fatigue 
Syndrome or Coxsackie B or glandular fever? 
Are you working? What is your job? 
Do you have problems with following TV or radio programmes or reading? 
Do you do household chores Most Some A few None 
Leisure activities: - Specify what and how many hours per week. 
Do you feel depressed or anxious? more or less than when you last saw me? 
Do you have any particular goals in the next six months? Specify. 
Do you have any expectations as to when you might recover fully? 
Do you feel you are coping / not coping with the illness? 
Appendix 2 Item l(e). General questionnaire for normal controls: second testin-q 
ME Questionnaire: Controls Second Testing 
Date of Birth 
Tel No 
Are you taking any medical drugs? Specify. 
Do you drink alcohol? how much per week? 
Do you have contact with anyone who has Myalgic Encephalomyelitis / Post Viral Fatigue 
Syndrome or Coxsackie B or glandular fever? 
Are you working? What is your job? 
Do you have problems with following TV or radio programmes or reading? 
Do you do household chores 
What are your leisure activities? 
Most Some A few None 
Specify what and how many hours per week. 
Do you feel depressed or anxious? more or less than when you last saw me? 
Do you have any particular goals in the next six months? Specify. 
I 
Appendix 2 Item 2(a). Consent form and eimlonation 
You have been asked to take part in a- research study in Po. -, L Viral Pati., u(. - 
Syndrome. 
The purpose of the study is: - 
(a) To find out 
ýow 
memory and , 
concentration improves during recovery from 
Post Vlr*al Fatigue Syndrome. 
(b) To compare psychological factors, for example, mood, attitude to and 
perception during the illness of Post Viral Fatigue Syndrome sufferers 
to other patients with chronic illness. 
What would vnu h3ve to do: - 
GO Yuu would need to attend the Clinic (usually on a day when You would 
be seeing the doctor) normally either for 1ý hours o-F-4e-r-tv.., j 
You would be asked to do some short tests of reaction time, ncmor-. and 
concentration, and fill in sc. -ne quest ionna i res. 
(c) You would be asked to come bac'N 4 months later to re-do some of the 
tests (a shorter session - a', cut 1 hour). 
Your help wrjul-- be greatly appreciated. 
Ap2endix 2 Item 2(a) continued 
C0NSENTF0R4 
I- (full name and address) 
freely and voluntarily consent to take part in a clinical research study on 
which so far as is known should not carry any risk. 
I have read the accompanying information sheet. The nature and purpose of 
the study has been explained to me by Dr. 
I have had the opportunity to ask any questions and I understand fully what 
is proposed. 
I recognise'that I may receive no benefit personally from the study. 
I understand that I am free to withdraw my consent at any time without 
prejudice to me or my medical care. I have been assured that any 
information obtained from me will not be disclosed to any other party in 
a manner which will reveal my identity. 
Signature 
I confirm that I/Dr. have/has explained the 
nature and purpose of the clinical research study and the procedure in 
respect of which consent has been given by the above named. 
Date 
Signature Date 
Appendix 2 Item 2(b) 
You have been asked to take part in a research'study. into Myalgic 
Encephalomyelitis, as a normal subject. 
The pulpose of this study is: - 
To compare your performance with that of patients with Post Viral Fatigue 
Syndrome (PVFS or Myalgic Encephalomyelitis); to find out if patients with 
PVFS suffer from a deterioration in memory and concentration which cannot be 
accounted for by psychological factors. 
What would you have to do: - 
a) You would be asked to come to St. Andrew Ambulance Headquarters 
Ruchill Hospital session of I to I and a quarter hours. 
b) You would be asked to do some short tests of memory, reaction time and 
concentration, and to fdl in some questionnaires. 
c) You would be asked to come back 4-6 months later to re-do some of the tests 
(lasting approximately I hour). 
App@ndix 2 Item 2(c) 
You have been asked to take part in a research study. 
The purpose of the study is: - 
To compare aspects of your illness with that of Post-Viral Fatigue Syndrome 
or Myalgic Encephalomyelitis. 
To find out if patients with Post Viral Fatigue Syn4rome suffer a greater 
decree of depression, different attitude to illness or more problems with 0 
memory and attention than patients with other illnesses of comparable duration 
and severity. 
What would you have to do: - 
a) You would be asked to attend the Clinic - (normally on a day you would be 
seeing the doctor) either for 1ý hours 
b) You would be asked to do some short tests of memory, reaction time and 
concentration. and fill in some questionnaires. 
C) You would be asked to come back 4 months later to re-do some of the tests 
(lasting approximately 1 hour). 
',, 'our 3-=-=4-St3nce w: -Ad be greatly appreciated to help us learn more aý: =. a 
puzzlinz illness which has affected this part of Scotland. 
Apandix 2 Item 3. Weschler Form 1- Scottish Version 
Locical Memorv. 
Anna Thompson/ of East/ Kilbridel 
employed/ as a cleaner/ in an office 
block/ reported/ at the central/ police 
ztation/ that she had been held up/ on 
. 230auchiehall Street/ the night before/ 
and robbed/ of fifteen pounds/. She had 
four/ little children/ the rent/ was 
due/ and they had not eaten/ for two 
days/. The officers/ touched by the 
;; oman's story/ made a collection/ for 
her/ . 
Ap22ndix 2 Item 4. Layout Of Reaction Time box 
00 
0 
9 Start button 
Index finger gresses 
Key 
o light 
s finger button 
Appendix-2 Item 5. Scored 
-CES-D 
form 
CES-D Scale Scoring - 
Circle the number for r3ch st3tement which best describes how n1lon you felt 
nr beh3ved this way-DURING THE PAST WEEK. 
Rarely O%r 
None "f 
UIC Time 
(Lcqs titan 
UAY) 
DURING THE PAST WEEK: 
1. 1 was bothered by things that usually don't 
bother me 
2. 1 did not feet like satingl my appetite was 
. 
Poor *00000*0* go. 0 . 00 
0 
3. 1 felt that I could not shake off the blues even 
with help from my family or Irfends .... 0 
4. I fell that I was just as good as other people 3 
5. 1 had trouble ketping my mind on what I 
6. 1 felt depra"d ............. 
0 
7. 1 felt that everything I did wu an of fort ... 0 
So I felt hopeful about blu future .0.0.0 3 
1 thought my life had been a failure .. 0 
I felt fearful ......... 0 
my sl"O w" restleu ......... : 0 
12. . 'was foggy -.. *09........ 3 
13. 1 taitted lau than usual ......... 
1 Z.. I felt lantly .............. 
15. People wqrs unfriendly ......... 
16. 
1 
1 enjoyed lif a............ 3 
'. 7. 1 had crying spells .......... 0 
13. 1 left sad .......... 0 
19. 1 felt that people disliked me ....... 0 
20. 1 could not got "going .......... 0 
Sco re Js sun of 20 endorsed item veights. 
Pos siblo range: 0-60 
Occ. uionjljlv 
Soome nr a 'fsf 3 %Inqt (at 
little nr Aindente AW af 
the Tifne J%mc, 11"t of the'rame 
(1.2 L)3v 
. 1) 
(3-4 Ua)sl (5-7 Days) 
Ices W*L thts 
3 
3 
3 
1 0 
2 3 
2 3 
2 3 
0 
2 3 
2 3 
2 3 
2 1 0 
2 3 
2 3 
14 3 
2 1 0 
2 3 
d, 
Appendix 2 Item 6. WAIS blocks diagram of pafterns 
............. 
.......... ........................ 
..................... .... .............. ..................... ..................... 
.... ............... .... .............. 
........... 
... 
............ . ......... ................. 
. ...... . .... . 
..... ...... ...... . .. 
........... 
... . ...... 
... . ...... 
IZ.......... 
7 
8 
-2s 8 
Fig. 1.1 Non embedded and embedded items from the WAIS Block Design sub-test. 
From Walsh 1985 
ApDendix 2 Item 7. Symptom data form 
Please mark if you have had any of these symptoms THIS WEEK NOW 
I- Mild 2 Moderate 3 Severe 
Headache 
Muscle pain 
Neck pain 
Sore eyes 
Sensitivity to light 
Excessive fatigue 
Difficulty standing 
Pins and needles or numbness 
Giddiness/Dizziness 
Muscle twitching 
Shivering attacks 
Sickness/Vomiting 
Spontaneous bruising 
Stiff neck 
Pain in abdomen 
Fainting 
Diarrhoea/Constipation 
Blurred vision 
Palpitations 
Abdominal distension 
Sore throat 
Pain in chest 
Tremor 11 
Noise in ears 
Frequent crying 
Nightmares 
Speech difficulties 
Rash or irritation of the skin 
Painful joints 
Earache 
Deafness 
Seeing double 
Cough 
Frequency or difficulty passing urine 
Dryness in the mouth 
Flushing 
Sweating unduly 
Panic feelings 
Guilt feelings 
I 
Appendix 2 Item 7 continued 
Bad taste in mouth 
'Indigestion' 
Loss of appetite 
Depression 
Insomnia 
Felt memory/concentration impaired 
Increased thirst 
Please indicate along the line how active you feel. 
THIS WEEK NOW 
-I ____ 
-I 
-I- 
I, I 
Exhausted Energetic 
Appendix 2 Item 8. Bellefs about Illness scales 
POST VIRAL FATjrT*: ' C -, S/ 
-- ... SYNDRUE/C 
F 
Most people never Most people recover 
recover. 
LLLLLLL[ completely. 
I have a big chance 
of getting it. 
LLLLLLLI 
I have no chance 
of getting it. 
Scares most people Scares hardly anybody 
A very powerful disease. 
LLLLLLI-I A very mild disease. 
Very well understood Hardly anything is 
by doctors. LL LLLI-1-1 known about it. 
Many people get it LL LLLI-1-1 Almost nobody gets it. 
CANCER 
Most people never Most people recover 
recover. LL LLLI-1-1 completely. 
I have a big chance I have no chance 
of getting it. LL LI-1-1-1-J of getting it. 
Scares most people Scares hardly anybody 
A very powerful disease. A very mild disease. 
Very well understood Hardly anything is 
by doctors. known about it. 
Many people jet it. Almost nobody gets it. 
BROKEN LEG 
Most people never Most people recover 
recover. LL LI-1-1-1-J completely. 
I have a big chance 
of getting it. 
Scares most people 
A very powerful disease. 
Very well understood 
by doctors. 
I have no chance 
of getting it. 
LI-LI-1-1-1-J 
Scares hardly anybody 
A very mild disease. 
LI-LI-1-1-1-J 
Hardly anything is 
known about it. 
Many people g6t it. LL LI-1-1-1-J Almost nobody gets it. 
Appendix 2 Item 8 continued 
ARTHRITIS 
Most people never 
recover. 
I have a big chance 
of getting it. 
Scares most people 
A very powerful disease. 
Most people recover 
completely. 
I have no chance 
of getting it. 
Scares hardly anybody 
A very mild disease. 
Very well understood Hardly anything is 
by doctors. known about it. 
Many people get it. Almost nobody gets it. 
MULTIPLE SCLEROSIS 
Most people never Most people recover 
recover. completely. 
I have a big-chance 
of getting it. U1_LLLLI 
I have no chance 
of getting it. 
Scares most people 
A very powerful disease. 
Very vell understood 
by doctors. 
Many people get it. 
STOMACH ULCERS 
Most people never 
recover. 
I have a big chance 
of getting It. 
Scares most people 
A very powerful disease. 
Very well understood 
by dc>ctors. 
Many people get it. 
1-1-1-LLLLI 
Scares hardly anybody 
A very mild disease. 
Hardly anything is 
known about it. 
Almost nobody gets It. 
Most people recover 
completely. 
I. have no chance 
of getting it. 
Scares hardly anybody 
A very mild disease. 
Hardly anything is 
known about it. 
Almost nobody ge-s it. 
Appendix 2 Item 9. Checklist 
PATIEN"I"S NAME ............................ PVFS/CHRONIC/NORMAL 
IXTRODUCrION COMPUTER 
EXPLANATORY LETTER 
Fý REACTION TIME 
CONSENT FORM THRESHOLD 
WESTIOINAIRE El VISUAL MEMORY 
NART El 
F-I 
MEHORY TESTS TIMED TESTS 
WESCHLER BACK El WORD FLUENCY Fý 
FROX`r F71 FINGER TAPPING r-l 
LORD R ECOG. F WAIS BLOCKS F-1 
REY DRAW I 
SYMBOL CODE 17 
%IE4 01 STROOP 
PASAT 
0' 'EST7. OXNA TRES -I 
SPEILBURGER 
QU TIONNATRES -2 
; DAS Fi 
CDES HEAUH L. O. C. 171 
FATIGUE SCALE ILLNESS BELIEF 
SYMPTM LIST F-1 MHQ El 
Appendix 2 Item 10. Copy of Stroop card 
RED WHi RED -: iLUE 
2 BLACK WHITE 
3 WHITE BLACK BLUE 
4 WHITE RED 
5 WHITE BLACK RED 
6 BLUE BLACK BLUE 
7 BLUE RED 
8 BLACK WHITE BLUE LUL 
9 -. -ACK 
RED v,., i HrrE 
10 BLACK WHITE 
11 WHITE BLUE BLACK 
12 WHITE RED BLUE 
13 BLACK RED WHITE 
14 RED ItMlk. BLUE WHITE 
li 5 
__ý 
ýUE RED BLACK BLUE 
16 RE BLACK ACK 
Appendix 2 Item 11. Spielberger State/Trait Anxiely- scale X 
guestionnaire 
SELF-EVALUATION OUESTIONNAIRE 
Developed by C. D. Spielberger, R. L. Gorsuch and R. Lushene 
STAI FORM X-1 
NAME DATE 
DIRECTIO14S: A number of statements which people have 
used to describe themselves are given below. Read each state- 0 ment and then blacken in the appropriate circle to the right of t4 the statement to indicate how you feet right now, that is, at 0 
this moment. There are no right or wrong answers. Do not 
spend too much time on any one statement but give the answer 
which seems to describe your present feelings best. 
1.1 feel calm .......................................................................................................... 
G) 
2. Ifeelsecure ...................................................................................................... 
G) 
3. 
4. 
5. 
6. 
7. 
8., 
9. 
10. 
12. 
13.; 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
CONSULTING PSYCHOLOGISTS PRESS 
577 College Avenue, Palo Alto, California 94306 
rb 
r. 
0 
41 
.C 
0 
u 
$4 
0 
44 
9 
P4 
SELF-EVALUATION QUESTIONNAIRE 
STAI FORM X-2 
0 
U) 
Cd 
to 
0 
u 
14 
0 
44 
0 
NAME 
DIRECTIONS: A number of statements which people have 
used to describe themselves are given below. Read each state- 
ment and then blacken in the appropriate circle to the right of 
the statement to indicate how you generally feel. There are no 
right or wrong answers. Do not spend too much time on any 
one statement but give the answer which seems to describe 
how you generally feel. 
21.1 feel pleasant .......................................................... 
22.1 tire quickly .......................................................... 
DATE 
------------------------- 
------------------------- 
- 
----------------------- ..................................................................... 
Copyright (E) 1968 by Charles A Spielberger. Reproduction of this test or any portion thereof by any process without written permission of the Publisher is prohibited. 
Appendix 2 Item 12. Health Locus of Control form -B _questions 
MHLC Form B 
This is a questionnaire designed to determine the way in which different people view certain 
important health-related issues. Each item is a belief statement with which you may agree or 
'disagree. Beside each statement is a scale which ranges from strongly disagree (1) to strongly 
agree (6). For each item we would like you to circle the number that represents the extent to 
, which you 
disagree or agree with the statement. The more strongly you agree with a statement, 
then the higher will be the number you circle. The more strongly you disagree with a statement 
then the lower will be the number you circle. Please make sure that you answer every item and 
"that you circle only one ' number per 
item. This is a measure of you personal beliefs; 
obviously, there are no right or wrong answers. 
Please answer these items carefully, but do not spend too much time on any one item. As much a 
you can, try to respond to each item independently. When making your choice, do not be 
Anfluenced by your previous choices. It is important that you respond according to your actual 
beliefs and not according to how you feel you should believe or how you think we want you to 
believe. 
14 0 43 0 
8 1.11 lag -0 41 ý4 2 ýI «0 92 in 
1. If I become sick, I have the power to make myself well again. 
2. often I feel that no matter what I do, if I am going to get sick, 
I will get sick. 
3. If I see an excellent doctor regularly, I am less 1ýkely to have 
health problems. 
4. It seems that my health is greatly influenced by accidental 
happenings. 
5. 1 can only maintain my health by consulting health professionals. 1 
6. 1 am directly responsible for my health. 1 
7. other people play a big part in whether I stay healthy 
or become sick. 1 
Whatever goes wrong with my health is my own fault. 1 
9. When I am sick, I just have to let nature run its course. I 
. 10. Health professionals 
keep me healthy. 1 
11. When I stay healthy, I'm just plain lucky. 1 
"12. My physical well-being depends on how well I take care of myself. 1 
13. When I feel ill, I know it is because I have not been taking 
care of myself properly. 1 
14. The type of care I receive from other people is what is 
responsible for how well I recover from an illness. 1 
_15. Even when I take care of myself, it's easy to get sick. 1 
16. When I become ill, it's a matter of fate. 
17. 1 can pretty much stay healthy by taking good care of myself. 
18. Following doctor's orders to the letter is the best way for me 
to stay healthy. 
4A 14 
ic: V. 
:4 
14 
b" 
43 
0 t3, 
ß4 0 r- 0 
.0000 s. 
ß4 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
Appendix 2 Item 13. Middlesex Health Questionnaire guestions 
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APPENDIX 3 
PREPARATORY STATISTICAL 
ANALYSIS 
Appendix 3 Table 1 Proportion of suboects calculated in results for 
comitive tests . 
This Table shows the number and percentage of subjects for whom data 
was collected on each individual test. 
First testinq 
CFS Normal Crohns/colitis 
Logical Memory 45 (100%) 41 (100%) 23 (100% 
Digit 45(100%) 41 (100%) 23(100%) 
Associate Learnin g 43 (96%) 41 (100%) 23(100%) 
Word Fluency 45(100%) 39(95%) 23(100%) 
WAIS Symbols 44(98%) 41 (100%) 23(100%) 
WAIS Blocks 35(78%) 37(90%) 11 (48%) 
Reaction Time 44(98%) 39(95%) 23(100%) 
Threshhold 38(84%) 40(98%) 21 (91%) 
Visual Span 45(100%) 41 (100%) 22(96%) 
PASAT 40(89%) 37(98%) 8(35%) 
Word Recall 43(96%) 41 (100%) 23(100%) 
Stroop Reading 38(84%) 40(98%) 23(100%) 
REY Copy 45(100%) 41 (100%) 21(91%) 
REY Memory 43(96%) 38(93%) 19(83%) 
CES-D 45(100%) 41 (100%) 22(96%) 
Anxiety - State 45(100%) 41 (100%) 23(100%) 
-- Trait 43(96%) 41 (100%) 23(100%) 
Finger Tapping 23(51%) 38(93%) 17(74%) 
Stroop Colours 25(56%) 39(95%) 23(100%) 
Fatigue 44(98%) 41 (100%) 23(100%) 
Symptoms 45(100%) 41 (100%) 23(100%) 
Appendix 3 Table 1 Proportion of subaects calculated in results for 
cognitive tests: continued. 
Second testinq 
CFS Normal Crohns/colitis 
Logical Memory 37(82%) 23(56%) 16(70%) 
Digit 37(82%) 23(56%) 15(65%) 
Associate Learnin g 36(80%) 23(56%) 16(70%) 
Word Fluency 37(82%) 23(56%) 17(74%) 
WAIS Symbols 36(80%) 23(56%) 17(74%) 
WAIS Blocks 31 (69%) 22(54%) 8(35%) 
Reaction Time 37(82%) 23(56%) 18(78%) 
Threshhold 37(82%) 23(56%) 16(70%) 
Visual Span 37(82%) 22(54%) 16(70%) 
PASAT 36(80%) 22(54%) 8(35%) 
Word Recall 37(82%) 24(59%) 17(74%) 
Stroop Reading 37(82%) 18(44%) 15(65%) 
REY Copy 37(82%) 22(54%) 16(70%) 
REY Memory 37(82%) 20(49%) 16(70%) 
CES-D 37(82%) 21 (51%) 17(74%) 
Anxiety - State 37(82%) 20(49%) 17(74%) 
- Trait 36(80%) 20(49%) 17(74%) 
Finger Tapping 22(49%) 21 (51%) 15(65%) 
Stroop Colours 35(78%) 21 (51%) 17(74%) 
Fatigue 37(82%) 20(49%) 17(74%) 
Symptoms 37(82%) 21 (51%) 17(74%) 
Others 
NART 42(93%) 36(88%) 22(96%) 
Psychiatric 
questionnaires 41 (91%) 30(73%) 19(83%) 
Questionnaire 
general questions 47 (104%) 41 (100%) 26 (113%) 
Being ill 
Questionnaire 
Variables 46(102%) - 25 (109%) 
(cf App. 9 Table 3b) 
(*) Note that questionnaire data was collected from two CFS patients and 
three Crohns/colitis patients who were excluded from the cognitive tests. 
Appendix 3 Table 2: Distributions 
Note that some data were collected by questionnaire, so there are a few 
data-points missing. The figure given are percentages, with the absolute 
numbers of subjects given in brackets. 
Table 2A: Age distribution of subjects 
Age CFS_(Lol Normal Chronic 
Controls (%) Controls M) 
16-20 7( 3) 17( 7) 4( 1) 
21-25 23(10) 27(11) 22( 6) 
26-30 16( 7) 12( 5) 7( 2) 
31-35 18( 8) 12( 5) 19( 5) 
36-40 7( 3) 5( 2) 22( 6) 
41-45 11 ( 5) 7( 3) 4( 1) 
46-50 7( 3) 5( 2) 11 ( 3) 
51-55 5( 2) 7( 5) 4( 1) 
56-60 
-7( 
3) 7( 5) 7( 2) 
100(44) 100(41) 100(27) 
(n=44) (n=41) (n=27) 
Table 213: IQ distribution of subjects 
NART IQ CFS Normal Chronic 
Controls (%) Controls 
0-9 120+ 21 ( 9) 11 ( 4) 14( 3) 
10-22 110-120 55(23) 50(18) 41 ( 9) 
23-34 100-110 21 ( 9) 33(12) 36( 8) 
35-50 90-100 2( 1) 6( 2) 9( 2) 
100(42) 100(36) 100 (22) 
(n=42) (n=36) (n=22) 
Table 2C: Fatigue distribution of subjects 
Fatigue CFS Normal Chronic 
Controls (%)I Controls 
(Exhausted) 0 o( 0) 2( 1) 4( 1) 
1 18( 8) o( 0) o( 0) 
2 25(11) ()( 0) 9( 2) 
3 23(10) 12( 5) 17( 4) 
4 11 ( 5) 7( 3) o( 0) 
5 9( 4) 17( 7) 17( 4) 
6 7( 3) 7( 3) o( 0) 
7 2( 1) 2( 1) 26( 6) 
8 2( 1) 34(14) 17( 4) 
9 2( 1) 17( 7) 9( 2) 
(Energetic) 10 o( 0) o( 0) o( 01 
100(44) 100(41) 100(23) 
(n=44) (n=41) (n=23) 
Table 21): Symptom distribution of subjects 
Symptom CFS Normal Chronic 
points Controls (%), Controls 
0 o( 0) 12( 5) o( 0) 
1- 5 4( 2) 46(19) 48(11) 
6-10 2( 1) 12( 5) 30( 7) 
11-20 20( 9) 17( 7) 13( 3) 
21-30 18( 8) 10( 4) 9( 2) 
31-40 16( 7) o( 0) o( 0) 
41-50 7( 3) 2( 1) o( 0) 
51-60 13( 6) o( 0) o( 0) 
61-70 16( 7) o( 0) o( 0) 
71-80 2( 1) o( 0) o( 0) 
81-90 o( 0) o( 0) o( 0) 
91-100 2( 1) o( 0) o( 0) 
100(45) 100(41) 100 (23) 
(n=45) (n=41) (n=23) 
Table 2E Depression distribution of subjects 
CES-D CFS 
_(L/61 
Normal Chronic 
Controls M Controls (Zol 
0- 5 7( 3) 46(19) 5o(11) 
6-10 11 ( 5) 34(14) 27( 6) 
11-15 22(10) 5( 2) 18( 4) 
16-20 13( 6) lo( 4) 5( 1) 
21-25 27(12) o( 0) o( 0) 
26-30 11 ( 5) 2( 1) o( 0) 
31-35 7( 3) o( 0) o( 0) 
36-40 2( 1) o( 0) o( 0) 
41-45 o( 0) 2( 1) o( 0) 
100 (45) 100(41) 100 (22) 
(n=45) (n=41) (n=22) 
Table 2F Proportion of subjects having prior serious illness 
CFS Normal Chronic 
Controls (%) Controls 
34(16) 5(2) 20(5) 
(n=47) (n=38) (n=25) 
Table 2G Proportion of subjects having contact with trigger illness 
CFS (%) Normal Chronic 
Controls M Controls 
62(29) 28(11) 35( 9) 
(n=47) (n=39) (n=26) 
Table 2H Distribution of length of illness of subjects 
Lenqth CFS M) Chronic 
(years) Controls M) 
0- 1 7( 3) 0( 0) 
1- 2 23(10) 17( 3) 
2- 3 23(10) 17( 3) 
3- 4 11 ( 5) 11 2) 
4- 5 20( 9) 11 2) 
5-10 11 ( 5) 28( 5) 
10-15 5( 2) 11 ( 2) 
15-21 2( 1) 6( 1) 
100(45) 100(18) 
(n=45) (n=18) 
Table 21a Employment distribution of subjects 
CFS (%) 
Not working 45(20) 
Working 43(19) 
Students 11 ( 5) 
Normal Chronic 
Controls M. Controls M) 
5( 2) 23( 6) 
82(31) 73(19) 
13( 5) 4( 1) 
(n=44) (n=38) (n=26) 
Significant on a chi-squared test, p<0.001 
Table 21b Breakdown of CFS employment 
(absolute numbers) 
Not working Working/ 
students 
Stopped work due 
to illness 5 6 Off sick 
Lost work due to 10 Working 
illness 2 3 Part-time 
Retired due to illness 3 
- 
(2 reduced) 
Redundancy 1 19 
Others: 5 students 
Not working but (4 absent) 
impatient to return 7 
Not working other 2 
20 24 
Appendix 3 Table 3: Reasons for non-inclusion of potential subjects 
Consultants decided not to send people to the study for reasons other than 
the exclusion criteria, for example: 
1 The consultant judged that it was a particularly unsuitable time to 
ask the patients to join in the study because, for example, the 
patient was in a bad mood or the patient was particularly sick or the 
consultant was discussing an imminent operation. 
2. The case was complicated by other medical problems or diagnosis 
was uncertain. 
3. The patient would not have understood what they were being asked 
to do. 
The experimenter rejected subjects for the study for the following reasons. 
1. They were found to meet exclusion criteria before or during the 
study. 
2. They had complicating aspects to their medical history, such as 
other medical conditions. 
3. They were unable or unwilling to complete the study. 
The details of how this worked out in practice are as follows. 
(i) CFS group 
Consultants rejections 
Subjects who were referred to the experimenter as willing and suitable to 
take part but were not included in the study are as follows: - 1 under age 
1 had fractured skull at 4 
1 was excluded because of having anorexia and a history of abuse 
1 too ill to attend 
7 did not attend 
3 cancelled. 
2nd Testing 
The reasons for not attending at second testing were not always known, 
but those known were as follows: - 
2 moved away 
1 was afraid the tests would make the illness worse - illness 
perceived worse by patient 
1 in hospital 
3 found it inconvenient to be retested as they had returned to work. 
(ii) Normal group 
The experimenter did not include: - 
1 subject who had low IQ (difficulty measuring on NART) and 
emotional difficulties: she did not understand what was being 
asked of her 
1 subject with very low IQ could not be matched with CFS patients 
1 subject had a peculiar and inappropriately familiar response to 
experimenter: experimenter suspected psychiatric condition 
1 excluded due to depression criteria 
1 cancelled 
24 did not attend. 
(iii) Crohns/colitis group 
Consultants rejections 
8-12 were deemed unsuitable due to current depression, 
psychiatric history or upset in consultants appointment 
2 were above the age limit 
2 suffered head injury. 
Subjects who were referred to the experimenter as willing and suitable to 
take part but then excluded by the experimenter at first testing were as 
follows: - 
1 was rejected due to epilepsy 
1 was unwilling 
3 had suffered serious depressive illness 
1 subject's spouse had CFS and the subject was also depressed 
1 had suffered fractured skull at 5 years old 
1 was above the age limit. 
2 cancelled 
3 did not attend 
Subjects who were referred to the experimenter as willing and suitable to 
take part but then excluded by the experimenter at second testing were as 
follows: - 
2 were too ill to carry out a second testing 
1 returned to work 
1 changed work shifts 
2 had been prescribed antidepressants since first testing. 
Appendix 3 Table 4: Subjects' drug takinq 
The following table shows the drugs recorded as being taken by subjects 
during the study; the number of patients taking the drug is in brackets. 
CFS patients 
Anti-inflamatories For Dizziness and/or sickness 
Naprosyn (1) Stemetil (1) 
Brufen (lbuprofen) (1) Stugeron (2) 
Pain Killers Anti-acid Zantac (1) 
Co-proxamol (2) Hormone-replacement-therapy (2) 
Paracetamol (1) Contraceptive pill (1) 
Asthma Creams 
Ventolin(2) Hydrocortisone (1) 
Another (Thalbutomol) (1) Nystatin (1) 
Crohns/colitis 
For the bowel disorder 
Salazopryn (Sulphasalazine) (8) 
Prednisolone(Sodium Phosphate)(2) 
Pentasa (3) 
Asacol (1) 
Colifoam (1) 
Painkillers 
Codeine phosphate (1) 
Iron suplements (2) 
Anti-inflamatory 
Brufen (2) 
Normal Controls 
Anti-inflamatory 
Brufen (1) 
Naprosyn (1) 
Asthma 
Ventolin (1) 
Moduretic (1) 
Contraceptive Pill (4) 
APPENDIX 4 
VERSIONS 
Appendix 4 Table 1 Associate Learning: Statistics on Versions 
The number of subjects on which each version of the Associate Learning 
test was used was as follows: 
< ------ GROUP ------ > 
Version CFS Normal Chronic 
lst testing 1 24 23 13 
2 19 18 10 
2nd testing 1 13 98 
2 23 14 8 
In order to find out if the distribution of test-versions amongst subject- 
groups was even, a chi-square test was carried out on the distribution of 
versions amongst subject-groups for each testing. The results of the Chi- 
square statistic were 0.003 and 0.90 for the two tables respectively (with 
2 V. ), neither were significant at the 5% level. Therefore the null 
hypothesis, that there was not an uneven distribution of test-versions 
amongst subject-groups, was not rejected. 
The chi-square test shows that the test-versions are not unevenly 
distributed, therefore it needs to be shown that the resulting scores are not 
significantly different between the test-versions. An ANOVA of the scores 
on first-testing taken categorising subjects by Group and Version showed 
the effect of the Version significant at 0.174 (an F-statistic of 22.72, with 
1,101 d. f. ). A similar ANOVA on the second-testing scores showed the 
effect of the Version significant at 0.089 (an F-statistic of 40.15, with 1,69 
d. f. ) 
The null hypothesis that the test-versions have the same mean score is not 
rejected. 
The overall mean scores for the Associate Learning test, including both first 
and second testing, were as follows: 
Version Mean score 
1 14.47 
2 14.43 
Appendix 4 Table 2 Logical Memory: Statistics on Versions 
The number of subjects on which each version of the Logical Memory test 
was used was as follows: 
< ------ GROUP ------ > 
Version CFS Normal Chronic 
I st testing 1 16 19 7 
2 23 18 12 
3 6 4 4 
2nd testing 1 16 6 7 
2 20 9 9 
3 1 8 0 
The scores derived from the versions were different: for the first testing, 
an ANOVA of the scores taken categorising subjects by Group and Version 
showed the effect of the Version significant at 0.007 (an F-statistic of 7.537, 
with 1,89 d. f. ). 
Thus, the raw scores cannot be used as they are, but must be weighted to 
remove the effect of the Version. (Alternatively, the raw scores and version 
numbers could both be put into the main ANOVA tests, but there is 
insufficient data to gain significant results from this. ) Because the test- 
versions are not distributed perfectly evenly between the Groups, weighting 
scores by the mean Version-score would give inaccurate results, being 
affected by the number of each Group given that version. Therefore, the 
raw scores are converted in Z-scores depending on the Version, but the 
calculation is adjusted to take into account the numbers of each Group 
taking each Version (see Table 5). 
A Chi-square test on the distribution of test-versions amongst subject- 
groups at the first testing gave a Chi-square statistic (with 4 V. ) of 2.13, 
not significant at the 5% level, showing that this distribution was not 
uneven. 
Appendix 4 Table 3 Word Fluency: Statistics on Versions 
The number of subjects on which each version of the Word Fluency test 
was used was as follows: 
< ------ GROUP ------ > 
Version CFS Normal Chronic 
lst testing 1 20 16 13 
2 17 16 7 
3873 
2nd testing 1 13 88 
2 22 13 8 
3221 
In order to show that there was an even distribution of test-versions 
amongst subject-groups, a Chi-square test was carried out on the 
distribution of versions amongst subject-groups for each testing. The 
values of the Chi-square statistic found were 1.48 and 1.08 for the two 
tables respectively (with 4 V. ), neither were significant at the 5% level. 
Therefore the null hypothesis, that there was not an uneven distribution of 
test-versions amongst subject-groups, was not rejected. 
The scores derived from the versions on the Hardest Letter test were 
different: for the first testing, an ANOVA of the scores taken categorising 
subjects by Group and Version showed the effect of the Version significant 
for the Hardest Letter test-scores at 0.001 (an F-statistic of 21.42, with 2,98 
d. f. ) and for the Categories test-scores at 0.079 (an F-statistic of 2.61, with 
2,98 d. f. ) 
Therefore, the raw scores cannot be used as they are, but must be 
weighted to remove the effect of the Version. (Alternatively, the raw scores 
and version numbers could both be put into the main ANOVA tests, but 
there is insufficient data to gain significant results from this. ) Because the 
test-versions are not distributed perfectly evenly between the Groups, 
weighting scores by the mean Version-score would give inaccurate results, 
being affected by the number of each Group given that version. Therefore, 
the raw scores are converted in Z-scores depending on the Version, but 
the calculation is adjusted to take into account the numbers of each Group 
taking each Version (see Table 5). For consistency, both Categories and 
Hardest Letter scores were so weighted. 
Appendix 4 Table 6 Weighting Scores 
As discussed in Tables 1-4, some of the raw test-results have to be 
weighted due to different test-versions being used. Although test versions 
are not unevently distributed they are not distributed perfectly evenly 
between the Groups. Therefore weighting scores by the mean Version- 
score could give slightly inaccurate results, being affected by the number 
of each Group given that version. Therefore, the raw scores are converted 
in Z-scores depending on the Version, but the calculation is adjusted to 
take into account the numbers of each Group taking each Version. This 
Table gives the details of that calculation. 
Z-scores are found by subtracting the mean and then dividing by the 
standard deviation. 
The mean is found by first calculating the mean score for each subject type 
for each version; then the mean that would have been obtained for Version 
1 had there been a perfect distribution amongst the subject-types is as 
follows: 
(Mean for CFS for version 1) x (proportion subjects that are CFS) 
" (Mean for Normals for v. 1) x (proportion subjects that are 
Normals) 
" (Mean for Chronics for v. 1) x (proportion subjects that are 
Chronics) 
The standard deviation is found by taking the square-root of the variance 
that would have been obtained had there been a perfect distribution 
amongst the subject-types; the variance for Version 1 is as follows: 
(Variance for CFS for version 1) x (proportion subjects that are CFS) 
" (Variance for Normals for v. 1) x (proportion subjects that are 
Normals) 
" (Variance for Chronics for v. 1) x (proportion subjects that are 
Chronics) 
Given this mean and standard deviation, the scores on Version 1 can be 
converted to a Z-score. A similar calculation can be carried out for Version 
2 and, for tests with three Versions, version 3. 
APPENDIX 5 
TESTS FOR NORMALITY 
Appendix 5 Tests for Normalily 
The statistical analysis in this thesis uses a number of parametric tests such as 
ANOVA. Such tests assume that the variables are Normally distributed within the 
groups, and furthermore that the variance is constant between the groups. This 
Appendix looks at the data, to consider whether there is significant non-Normality. 
whether data needs to be transformed, and possible "ceiling" effects. 
Normalily 
Normality is studied by visually inspecting the distribution, and quantitatively by 
looking at the Skew and Kurtosis. If either of these latter is significantly different 
from zero, then Normality cannot be assumed. Typically (see e. g. Tabachnick and 
Fidell (1989)), a significance level of 0.01 is used, so a null hypothesis of a 
parameter being zero is rejected if it is more than 2.5 standard deviations from the 
mean. The following Tables 1-3 show, for the three groups (as raw output from 
SPSS), the values of Skew and Kurtosis (and their Standard Errors) for the all of the 
variables in the analysis. 
All of the variables shown in the tables satisfy the normality tests except the 
following: 
(i) Word Fluency results that are uncomected. these can be ignored, as only the 
corrected versions are used, and indeed this supports the need for correction 
(as described in Appendix 3). 
(ii) Depression (CES-D). This is because CES-D is lower-bounded by zero (and 
only 5% of the sample actually achieved a value of zero). Taking 
Log(CES-D) would therefore avoid this problem. However, Log of zero is not 
defined, so we add 1 to the depression score before taking the Log. One 
CFS outlier is removed as being beyond 2.5 standard deviations from the 
mean. The remainder can be seen below to satisfy the Normal criteria. This 
variable will be used in place of CES-D in the analysis. 
(iii) Visual Span; however LOG (Visual Span) satisfies the Normal criteria, as 
shown in the Tables. This variable will be used. in place of the raw Visual 
Span score. 
(iv) Rey Copy has a ceiling and is significantly non-Normal. The non-Normality 
in this variable should be noted, and any results gained considered in the light 
of this. In fact, this ceiling and the discreteness of the results meant that no 
significant results were gained from this variable. 
(v) State Anxiety; again, LOG (State Anxiety) is much nearer normal, although 
there is still a little too much Kurtosis in the CFS patients. 
(vi) Both Stroop Reading and Colours. Again, LOG of both of these is much 
nearer Normal. In the case of CFS patients, there is one Outlier, and Table 
2 shows that when this outlier is removed, the distribution is closer to 
Normality. LOG variables are thus used in the data, and the outlier ignored 
for these tests (second-testing of Stroop also removed for this outlier, as the 
subject will have practised). 
(vii) Both of the Symptoms variables are significantly non-Normal; again these are 
bounded by zero. LOG of the variables (again with one added to the scores 
to avoid taking the Log of zero) is much closer to Normal, and these variables 
will be used in the analysis. However, it should be noted that the CFS 
Symptoms figures are now negatively skewed, and this will be considered 
further in the analysis. 
Homogeneily of variance 
SPSS provides the Levene test to check for homogeneity of variance, which is 
assumed by ANOVA. Table 4 shows the values of the Levene test taken by the 
variables in the First testing shown in Tables 1-3 when the data is divided into the 
three subject types. 
Some of these variables are no longer relevant, for the reasons discussed under 
"Normality" above: relevant variables are marked with a (*). 
Of the relevant variables, four show a significant difference in variance: 
Log (CES-D), Reaction Time Decision and Movement Time, and Finger Tapping 
On these four tests, CFS patients are significantly worse and more variable, and this 
will need to be considered in the analysis. 
Appendix 5 Table 1. Summary statistics for CFS subjects 
Kurt- Stand. Error Skew- Stand. Error 
Variable osis of Kurtotis ness of Skewness N 
Logical memory(uncorrected . 25 . 69 . 60 . 35 45 Logical memory (corrected) . 81 . 69 . 72 . 35 45 Associate learning -. 36 . 71 -. 13 . 36 43 word recognition: 
Correct -. 35 . 73 -. 35 . 37 40 Correct - Errors -. 32 . 73 -. 43 . 37 40 Digit forward + digit back -. 92 . 69 -. 15 . 35 45 
Rey memory (uncorrected) -. 55 . 71 . 10 . 36 43 Rey memory (corrected) -. 37 . 71 . 21 . 36 43 
Rey Copy . 48 . 69 -1.25 . 35 45 Threshold task (score) -1.00 . 75 . 24 . 38 38 Visual span 3.88 . 69 1.08 . 35 45 WAIS blocks (raw score) -. 32 . 78 -. 59 . 40 35 Reaction time (milliseconds) 
Decision time . 01 . 70 . 58 . 36 44 
Movement time -. 92 . 69 . 44 . 35 45 Finger Tapping (per minute) -. 86 . 90 . 21 . 46 25 
Language word fluency (per minute) 
Hard letter (uncorrected) 2.80 . 69 1.35 . 35 45 Hard letter (corrected) -. 43 . 69 -. 04 . 35 45 Categories (uncorrected) . 66 . 69 . 75 . 35 45 Categories (corrected) . 47 . 69 . 66 . 35 45 Stroop Reading . 62 . 74 . 85 . 38 39 Stroop Colours 7.80 . 92 2.34 . 47 24 PASAT (out of 60) . 22 . 73 -. 52 . 37 40 WAIS Digit Symbol (raw) -. 24 . 70 . 25 . 36 44 
Mood: 
CES-D -. 39 . 69 . 04 . 35 45 Anxiety: state 2.79 . 69 . 94 . 35 45 
Anxiety: trait . 01 . 71 . 25 . 36 43 
Symptoms: that week -. 36 . 69 . 44 . 35 45 
now 1.82 . 69 1.26 . 35 45 Fatigue . 87 . 70 1.08 . 36 44 
Log-variables 
Log (CES-D) . 52 . 70 -. 86 . 36 44 Log(Visual span) . 78 . 69 -. 40 . 35 45 Log(Anxiety: state) 2.53 . 69 -. 29 . 35 45 Log(Stroop Colours) 3.03 . 92 1.25 . 47 24 Log(Stroop Reading) -. 17 . 74 . 28 . 38 39 Log(Symptoms that week) 1.16 . 69 -1.07 . 35 45 Log(Symptoms now) . 49 . 69 -. 97 . 35 45 
with single outlier removed: 
Log(Stroop Colours) -. 48 . 93 . 09 . 48 23 Log(Stroop Reading) -. 10 . 75 . 34 . 38 38 
Appendix 5 Table 2. Summary statistics for Normal subjects 
Kurt- Stand. Error Skew- Stand. Error 
variable osis of Kurtotis ness of Skewness N 
Logical memory(uncorrected -1.07 . 72 -. 01 . 37 41 Logical memory (corrected) -. 53 . 72 . 02 . 37 41 Associate learning -. 25 . 72 -. 54 . 37 41 Word recognition: 
Correct . 13 . 74 . 27 . 38 39 Correct - Errors -. 53 . 74 -. 59 . 38 39 Digit forward + digit back -. 50 . 72 -. 32 . 37 41 Rey memory (uncorrected) -. 03 . 75 -. 73 . 38 38 Rey memory (corrected) . 14 . 75 -. 47 . 38 38 Rey Copy 3.21 . 72 -1.69 . 37 41 Threshold task (score) 1.19 . 73 -. 32 . 37 40 Visual span . 99 . 72 . 81 . 37 41 WAIS blocks (raw score) -. 96 . 76 -. 27 . 39 37 Reaction time (milliseconds ) 
Decision time -. 17 . 74 . 16 . 38 39 Movement time -. 35 . 73 -. 16 . 37 40 Finger Tapping (per minute) -. 55 . 75 . 15 . 38 38 Language word fluency (per minute) 
Hard letter (uncorrected) . 96 . 74 1.11 . 38 39 Hard letter (corrected) -. 43 . 74 . 52 . 38 39 Categories (uncorrected) . 82 . 74 -. 87 . 38 39 Categories (corrected) . 63 . 74 -. 75 . 38 39 Stroop Reading . 36 . 73 . 98 . 37 40 Stroop Colours 1.87 . 74 1.10 . 38 39 PASAT (out of 60) -1.32 . 76 . 21 . 39 37 WAIS Digit Symbol (raw) . 16 . 72 . 57 . 37 41 
mood: 
CES-D 6.78 . 72 2.25 . 37 41 Anxiety: state 3.95 . 72 1.50 . 37 41 Anxiety: trait . 61 . 72 . 75 . 37 41 Symptoms: that week 5.54 . 72 2.06 . 37 41 
now 4.64 . 72 2.15 . 37 41 Fatigue -. 32 . 72 -. 71 . 37 41 
Log-variables 
Log (CES-D) -. 16 . 72 -. 37 . 37 41 Log(Visual span) . 08 . 72 -. 26 . 37 41 Log(Anxiety: state) . 58 . 72 . 50 . 37 41 Log(Stroop Colours) 1.60 . 74 . 35 . 38 39 Log(Stroop Reading) -. 21 . 73 . 63 . 37 40 Log(Symptoms that week) -. 29 . 72 . 21 . 37 41 Log(Symptoms now) -. 57 . 72 . 72 . 37 41 
Appendix 5 Table 3. S11-ary statistics for Chronic subjects, 
Kurt- Stand. Error Skew- Stand. Error 
Variable osis of Kurtotis ness of Skewness N 
Logical memory(uncorrected -. 37 . 93 . 44 . 48 23 
Logical memory (corrected) -. 76 . 93 . 42 . 48 23 
Associate learning -1.04 . 93 -. 38 . 48 23 
Word recognition: 
Correct . 34 . 95 -. 65 . 49 22 Correct - Errors -. 60 . 97 -. 09 . 50 21 
Digit forward + digit back -. 87 . 93 -. 20 . 48 23 
Rey memory (uncorrected) . 12 1.01 -. 59 . 52 19 
Rey memory (corrected) . 40 1.01 -. 89 . 52 19 
Rey Copy 9.94 . 97 -3.07 . 50 21 
Threshold task (score) 2.70 . 97 1.29 . 50 21 
Visual span -. 32 . 95 . 83 . 49 22 WAIS blocks (raw score) 2.95 1.28 1.64 . 66 11 
Reaction time (milliseconds) 
Decision time 2.25 . 93 -. 34 . 48 23 
Movement time -. 40 . 93 . 31 . 48 23 
Finger Tapping (per minute) 2.33 1.06 -. 62 . 55 17 
Language word fluency (per minute) 
Hard letter (uncorrected) -. 24 . 93 . 89 . 48 23 
Hard letter (corrected) -1.12 . 93 . 17 . 48 23 Categories (uncorrected) 1.25 . 93 -. 73 . 48 23 Categories (corrected) 1.61 . 93 . 06 . 48 23 
Stroop Reading . 24 . 93 . 83 . 48 23 
Stroop Colours 2.05 . 93 . 90 . 48 23 
PASAT (out of 60) -1.53 1.48 -. 65 . 75 8 
WAIS Digit Symbol (raw) 1.75 . 93 -. 38 . 48 23 
Mood: 
CES-D -. 66 . 95 . 53 . 49 22 
Anxiety: state -. 27 . 93 -. 30 . 48 23 
Anxiety: trait -. 61 . 93 . 02 . 48 23 
Symptoms: that week 4.71 . 93 2.15 . 48 23 
now 4.95 . 93 2.24 . 48 23 
Fatigue -. 79 . 93 -. 52 . 48 23 
Log-variables 
Log (CES-D) -. 70 . 95 -. 59 . 49 22 
Log(Visual span) -. 62 . 95 . 34 . 49 22 
Log(Anxiety: state) . 44 . 93 -. 85 . 48 23 
Log(Stroop Colours) . 66 . 93 . 23 . 48 23 
Log(Stroop Reading) -. 18 . 93 . 52 . 48 23 
Log(Symptoms that week) . 22 . 93 . 21 . 48 23 
Log(Symptoms now) . 08 . 93 1.26 . 48 23 
Appendix 5 Table 4. Levene's Test of homogeneity of variance 
dfl df2 Significance 
Logical memory(uncorrected . 4427 2 106 . 6435 Logical memory (corrected) . 4070 2 106 . 6667 Associate learning . 5200 2 104 . 5960 word recognition: 
Correct 1.3212 2 98 . 2715 Correct - Errors 3.5323 2 97 . 0331 Digit forward + digit back . 0086 2 106 . 9915 Rey memory (uncorrected) 2.1033 2 97 . 1276 Rey memory (corrected) 1.8419 2 97 . 1640 Rey Copy 5.2302 2 104 . 0068 Threshold task (score) 2.0200 2 96 . 1382 Visual span . 3475 2 105 . 7072 WAIS blocks (raw score) 1.0393 2 80 . 3584 Reaction time (milliseconds) 
Decision time 18.5636 2 103 . 0000 Movement time 14.8858 2 105 . 0000 Finger Tapping (per minute) 9.9008 2 77 . 0001 Language word fluency (per mi nute) 
Hard letter (uncorrected) . 8018 2 104 . 4513 Hard letter (uncorrected) . 1601 2 104 . 8522 Categories (uncorrected) 1.0709 2 104 . 3464 Categories (corrected) . 8342 2 104 . 4371 Stroop, Reading 3.6183 2 99 . 0304 Stroop, Colours 1.8863 2 83 . 1581 PASAT (out of 60) . 3968 2 82 . 6737 WAIS Digit Symbol (raw) . 6883 2 105 . 5047 
Mood: 
CES-D 2.3482 2 105 . 1005 Anxiety: state . 0952 2 106 . 9093 Anxiety: trait . 3202 2 104 . 7267 Symptoms: that week 26.6804 2 106 . 0000 now 21.2466 2 106 . 0000 Fatigue 3.1220 2 105 . 0482 
Log-variables 
Log (CES-D) 6.1225 2 98 . 0031 Log(Visual span) . 8494 2 105 . 4306 Log(Anxiety: state) 1.2146 2 106 . 3009 Log(Stroop Colours) . 8580 2 83 . 4277 Log(Stroop Reading) 1.5932 2 99 . 2084 Log(Symptoms that week) . 5259 2 101 . 5926 Log(Symptoms now) . 1491 2 69 . 8617 
with single (CFS) outlier re moved: 
Log(Stroop Colours) . 1680 2 82 . 8456 Log(Stroop Reading) 1.4789 2 98 . 2329 
APPENDIX 6 
MAIN RESULTS: GRAPHS 
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